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ABSTRACT 
Depression is a debilitating psychiatric disorder affecting approximately 10% of the 
world’s population. Cognitive dysfunction is an often ignored aspect of depression, and predicts 
patient response to antidepressants. While several classes of antidepressants have been developed 
for the treatment of depression, over one-third of patients do not respond to conventional 
antidepressants, and all currently available antidepressants require weeks of continuous 
administration to achieve therapeutic effects. The delay in the onset of therapeutic effects from 
the time of taking antidepressants can put patients at risk for suicide. Therefore, there is a need in 
the literature to develop and identify novel antidepressants that do not work on conventional 
targets and that have fast-acting properties.  
The primary goals of this dissertation were to investigate the pattern of cognitive 
impairments following CORT treatment and to examine the antidepressant potential of TNF-α 
receptor inhibition and reelin. To begin, in Chapter 2, I examined the effect of repeated CORT 
injections on depression-like behaviour using the forced swim test, the object-location, object-in-
place, and object-recognition memory tests, and sensorimotor gating using prepulse inhibition. 
These data suggested that CORT increases depression-like behaviour while simultaneously 
impairing hippocampal and prefrontal cortex-dependent memory and sensorimotor gating. In 
Chapter 3, I examined the effects of the TNF-α inhibitor etanercept on CORT induced 
depression-like behaviour, cognition, and markers of synaptic plasticity through post-mortem 
analysis of brain tissue. I found that CORT increased depression-like behaviour on the forced 
swim test and impaired object memory. CORT also impaired several post-mortem markers of 
hippocampal plasticity, and etanercept restored these measures back to control levels.  
In Chapter 4 I examined the antidepressant potential of intrahippocampal reelin infusions 
and its effects on cognition and markers of synaptic plasticity. I found CORT treatment increased 
depression-like behaviour on the forced swim test and impaired object memory. Reelin treatment 
restored both of these measures back to control levels within one day. CORT also decreased 
markers of hippocampal plasticity, and reelin restored these measures back to control levels. 
Finally, in Chapter 5, I examined the contribution of AMPA signaling to the antidepressant 
effects of reelin. I found that infusion of the AMPA antagonist CNQX blocked reelin’s 
antidepressant effects on the forced swim test, without altering CORT’s pattern of changes on 
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markers of hippocampal plasticity. The results of this dissertation reveal novel compounds with 
antidepressant properties that warrant further investigation into their potential use in humans. 
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CHAPTER 1 
GENERAL INTRODUCTION 
1.1. Thesis Outline  
Depression remains the most common psychiatric disorder, effecting approximately 350 
million people worldwide (World Health Organization, 2012). In Canada, around 11% of 
individuals aged 15-24 suffer from depression (Statistics Canada, 2017). Accordingly, 
depression now ranks as the most common cause of global disability in terms of years lost due to 
disability. The defining characteristics of depression include anhedonia, a loss of interest in 
pleasurable activities, and lowered mood (Nestler et al, 2002). Depression is further 
characterized by alterations in weight, sleep, irritability, thoughts of suicide, and decreased 
sexual function/interest (Centre for Addiction and Mental Health, 2012). Depression is comorbid 
with several other disorders, including anxiety (Zimmerman et al., 2013) and in recent years 
there has been a growing recognition that depression frequently co-occurs with immune system 
disorders, for example rheumatoid arthritis (Margaratten, Julian, Katz, & Yelin, 2011). These 
comorbidities can influence the course of the disease, increase risk of relapses, and delay 
recovery (Hirschfeld, 2001). Therefore, given the prevalence and societal burden of depression, 
understanding the etiology and developing effective treatments is of paramount importance. 
Medications that target the monoergic system remain the primary course of treatment for 
depressed patients. These medications include monoamine oxidase inhibitors (MOAI’s), tricyclic 
antidepressants (TCA’s), and selective serotonin reuptake inhibitors (SSRI’s). The serendipitous 
discovery of the first class of antidepressants targeting the monoamine system lead to the first 
major theory of depression, the monoamine theory of depression (Schildraut, 1965). This theory  
posits that depression results from reductions in monoamine systems in limbic regions of the 
brain, and that restoring monoamine levels back to a non-diseased state will produce an 
antidepressant effect. Patients generally tolerate antidepressants well, with the most common 
side-effects including decreased sexual function and weight gain (Clincial Depression Learning 
Path, 2018). Despite the widespread use of antidepressants, they remain effective in only 30-60% 
of patients, and many patients become treatment resistant, or become resistant to multiple rounds 
of antidepressant therapy (Pubmed Health, 2017). Moreover, antidepressants require several 
weeks of continuous treatment until a therapeutic effect emerges, which is known as the 
therapeutic lag of antidepressants (Frazer and Benmansour, 2002). Despite the appealing 
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simplicity of the monoamine hypothesis, it has not gone without criticism, the most prominent 
being that if monoamine levels are being targeted within hours of taking an antidepressant, then 
why do therapeutic effects take weeks to occur? This has led to the current favored hypothesis of 
depression -- the neuroplasticity hypothesis. This hypothesis posits that depression dampens 
transcriptional regulation of proteins and growth factors which modulate plasticity in the adult 
brain. This hypothesis dovetails nicely with the therapeutic lag of antidepressants, as these 
alterations comprise slower-acting processes that can take weeks to occur. Therefore, the high 
occurrence of non-responders to antidepressants and the time lag it takes for antidepressant 
effects to occur reinforces the need for novel antidepressants that are not reliant on the 
monoergic system and that have fast-acting properties. The focus of this dissertation is on 
experiments investigating novel antidepressants and their effects on behaviour and corresponding 
neurobiological changes using a well validated preclinical model of depression -- the CORT 
model of depression. 
The first experiment of this dissertation focused on characterizing cognitive deficits as a 
potential side-effect of repeated corticosterone (CORT) treatment in rats. In the second 
experiment, I utilized the behavioural tests developed in the first experiment to examine how 
treatment with the TNF-alpha antagonist etanercept affected CORT-induced alterations in 
hippocampal-dependent memory and markers of hippocampal plasticity. In the third experiment, 
I investigated the antidepressant potential of the extracellular matrix protein reelin and its effects 
on markers of hippocampal dependent memory and markers of hippocampal plasticity. Finally, 
in the fourth experiment, I investigated a potential mechanism underlying reelin’s antidepressant 
effects and looked at changes in hippocampal neurogenesis, Fos expression, and microglial 
morphology.  
The remaining sections of this chapter will provide an overview of depression, its 
neurobiology, and the major theories dedicated to explaining its etiology. I will then discuss the 
stress response and how hippocampal plasticity changes in response to stress. I will then discuss 
the link between depression and inflammation, and then turn my attention to the role of the 
extracellular matrix protein reelin and glutamate in depression. Finally, I will conclude this 
chapter with an overview of remaining unanswered questions in the field of stress and depression 
research. Chapters 2, 3, 4, and 5 will describe the experimental data addressing the questions 
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outlined in Chapter 1. Chapter 6 will finish with an overview and discussion of my experimental 
research, the implications and limitations, and directions for future research.  
1.2. Introduction to Depression 
Depression is a psychiatric disorder that affects 350 million people worldwide, and 11% of 
Canadians aged 15-24 (World Health Organization, 2012; Statistics Canada, 2017). Depression 
is not a new disorder; historical cases of depression have been around for thousands of years. 
The first written accounts of depression occurred over 4000 years ago in Mesopotamia (Horwitz, 
Wakefield, & Lorenzo-Luaces, 2016). However, with no understanding of the etiology of the 
disorder, patients’ suffering was attributed to demonic possession. Understanding of depression 
improved by the time of the Greeks. For example, the father of medicine, Hippocrates, suggested 
that mental illness was related to the bodily humors (Horwitz, Wakefield, & Lorenzo-Luaces 
2016). Hippocrates further classified mental illness into discrete categories, including mania and 
melancholia (depression). However, further understanding of depression remained stagnant for 
some time after Hippocrates. The understanding of depression took a significant leap forward 
when psychology first emerged as a science. At the forefront of this understanding was on one 
spectrum behaviourism, which believed that human behaviour was shaped by interactions with 
the environment, and at the other end determinism, which would say that human beings have no 
choice in what they develop into (e.g., human nature is determined by genes). Finally, the largest 
leap forward in our modern understanding of depression occurred in the 1950s. A physician 
treating patients for microbial infections serendipitously discovered that patients taking 
Iproniazid reported elevated mood. Following this discovery, a flurry of research ensued and it 
was discovered that Iproniazid was working to inhibit the monoamine oxidase enzyme, 
increasing the levels of serotonin and dopamine in the brain. This discovery shifted the view of 
depression to an explanation of arising from a chemical deficiency in the brain, and thus is an 
illness that requires treatment like any illness of the body.  
Although the monoamine hypothesis of depression was revolutionary for its time, it is now 
generally accepted that depression involves more than deficiencies in monoamines. The currently 
favored hypothesis of depression is the neuroplasticity hypothesis, which posits that depression 
involves alterations in gene transcription and regulation, protein synthesis, and growth factors 
that modulate brain plasticity. This hypothesis nicely explains the downstream signalling 
cascades that might account for the delayed onset of relief of symptoms from antidepressants. 
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1.3. Classification of Depression 
Depression is characterized by the presence of at least 1 of 2 cardinal symptoms, which must 
persist for a minimum of 2 weeks (American Psychiatric Association, 2013). The first cardinal 
symptom is anhedonia. Anhedonia refers to the loss of ability to experience pleasure in what 
were previously pleasurable activities. For example, a patient who was once a voracious reader 
may no longer feel like picking up a book. The other cardinal symptom is depressed mood, 
which includes a mood that is characterized as hopeless, discouraged, or sad (American 
Psychiatric Association, 2013). These cardinal symptoms are required to persist for nearly all 
daily activities, for most of the day. In addition to the presence of cardinal symptoms, there must 
be the presence of 4 out of 9 other symptoms for at least 2 weeks. The first and most frequently 
reported symptom is significant weight loss or gain, or gain or loss of appetite. Hypersomnia or 
insomnia is also frequently reported. Insomnia can manifest as trouble falling asleep, frequently 
waking up during the night, or waking up and not being able to get back to sleep. Not as 
common as alterations in weight or sleeping patterns include psychomotor agitation or 
retardation. This includes the inability to sit still or making repetitive movements of the hands 
(agitation) or talking slower or exaggerated purposeful movements (retardation). In addition to 
alterations in sleep, fatigue is a common symptom, and the feeling of menial tasks requiring 
more energy than normal. Feelings of worthlessness or guilt are also a common complaint. This 
is frequently seen in the act of excessive rumination over past events, particularly past failings. 
Increasingly recognized are difficulties or impairments in the ability to think, concentrate, or in 
one’s memory. Patients may find that they are more forgetful than they used to be, or that they 
cannot maintain their focus on a task (partially overlapping with psychomotor agitation). The last 
symptom is suicidality. Here, patients may have comparatively benign thoughts of death, to 
thinking about not existing, to formulating specific thoughts about a suicide plan (American 
Psychiatric Association, 2013). There has been an increasing recognition that depression as 
currently classified might not be a single homogenous disorder, but rather a complex 
constellation of separate yet related disorders. This is illustrated by the fact that 2 depressed 
patients can present with completely different symptoms. For example, patient A can present 
with weight gain, insomnia, psychomotor retardation, and anhedonia, while patient B can present 
with weight loss, hypersomnia, psychomotor agitation, and anhedonia. A number of explanations 
have been put forward to explain this variability, including that subsets of depressed patients 
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experience neuroinflammation (described later) or glutamate dysregulation (described later) 
rather than the classically presented monoamine dysfunction. A recent report attempted to 
identify depression subtypes using magnetic resonance imaging and found 3 unique profiles 
relating to antidepressant treatment outcomes that correspond with different profiles of brain 
connectivity (Tokuda, Yoshimoto, Shimizu, Okada, & Takamura et al., 2018). It remains to be 
seen if the focus of depression research shifts to reflect the growing recognition of the proposed 
subtypes of depression.  
The development of depression typically occurs after puberty, although childhood depression 
can occur (with a different presentation) (American Psychiatric Association, 2013). Depression 
is approximately 1.5-3 times more likely to occur in females than males. This increased 
occurrence of depression in females is attributed to a number of factors, both environmental and 
biological. Biological factors include differences in hormones, while environmental explanations 
include societal expectations placed on women. The progression of depression is quite varied, 
with some patients never experiencing true remission of symptoms (treatment resistant 
depression), whereas other patients can go years between depressive episodes. A key feature of 
depression that has begun to be recognized in recent years is the chronicity of the disorder. What 
this means is that depression is typically not a single time occurrence, but rather comprises 
multiple episodes over the lifetime, whether it be continuous or sporadic. A major limitation of 
the depression literature in animal studies is the focus on 1 cycle of depression and not multiple 
cycles. However, recent reports have begun to explore this question and suggest that the 
depressed brain becomes more vulnerable to repeated bouts of stress (Lebedeva, Caruncho, & 
Kalynchuk, 2017). The cyclicity of the disorder underscores the need for the development of 
more efficacious treatments for the disorder. Once patients undergo antidepressant therapy, 
recovery typically begins after 1-3 months (Willner, Scheel-Jruger, & Belzung, 2013), with 
remission occurring after 1 year. However, the course of recovery from depression is 
significantly decreased in patients whose depressive episode was severe, and in those who have 
had a high number of depressive episodes previously.  
Before depression can be diagnosed, a number of other disorders must first be ruled out. The 
most common disorder to be mistaken for depression is bipolar disorder, which is differentiated 
from depression by the occurrence of mania. Another frequently confounding diagnosis is 
substance abuse disorder. Here, the difference between the two is the presence of a substance 
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resulting in the depressive episode. A further diagnosis that must be ruled out, while rare, is 
depression with psychotic features. Ruling out other diagnoses that could be causing depression 
is key to ensuring appropriate treatment for the patient (American Psychiatric Association, 
2013).   
1.4. Drugs used to Treat Depression 
The first line of defence for treating depression are antidepressant drugs. Currently available 
antidepressant medications are effective in approximately 60-70% of depressed patients 
(Willner, Scheel-Jruger, & Belzung, 2013). However, this definition has been criticized for not 
defining the percentage of patients experiencing remission but instead response rate. When the 
percentage of patients experiencing remission is considered, the number drops to 45% (Thase, 
Entsuah, & Rudolph, 2001). This means that upwards of 55% of depressed patients will not 
experience remission of symptoms, indicating that the underlying pathology initially causing the 
depression may not be treated by the drug. This stresses the need for more efficacious 
pharmacological treatments in the management of depression. Antidepressant medications fall 
into several categories, based on their mechanism of action: MAOI’s, TCA’s, SSRIs, selective 
norepinephrine reuptake inhibitors (SNRIs), and atypical antidepressants (Table 1.). Each class 
of antidepressant medications will be discussed in greater detail below. 
MAOI’s were the first class of antidepressant compounds to be discovered, and 
revolutionized the treatment of depression. MAOI’s work by inhibiting the enzyme monoamine 
oxidase, preventing the breakdown of monoamine neurotransmitters, and thereby allowing for 
higher concentrations of the monoamines (serotonin and norepinephrine) in the brain. While 
MAOIs were initially the first line of treatment in depression, their use has seen a decrease due to  
their lack of specificity mechanistically and their unwanted side effects. Some of the most 
frequently reported side effects include weight gain, fatigue, and hypertension. Other more 
serious side effects may emerge, including potentially lethal interactions with certain foods (e.g., 
tyramine) (Santarsieri & Schwartz, 2015). In terms of efficacy, MAOI’s are generally reported to 
be less effective in the treatment of depression than TCA’s and SSRI’s (Thase, Entsuah, & 
Rudolph, 2001). Therefore, due to unwanted side effects and lower efficacy than other 
compounds, MAOI’s are largely out of favor for the treatment of depression. However, MAOIs 
tend to be more efficacious in treating depressed patients with atypical features (Stewart, 
McGrath, Rabkin, & Quitkin, 1993). TCA’s represent the next evolution of depression 
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Table 1-1. Classes of Antidepressant Medications 
 
Class Drugs Common Side Effects 
Monoamine Oxidase 
Inhibitors (MAOIs) 
 
Isocarboxazid 
Phenelzine 
Tranylcypromaine 
Selegiline 
Weight gain, sexual 
dysfunction, hypotension 
Triclylic Antidepressants 
(TCAs) 
Imipramine 
Amitriptylyine 
Doxepin 
Desipramine 
Nortripyline 
Weight gain, sedation, 
tachycardia 
Selective Serotonin 
Reuptake Inhibitors 
(SSRIs) 
Fluoxetine 
Paraoxetine 
Sertraline 
Citalopram 
Escitalopram 
Headaches, sexual 
dysfunction, weight gain 
Selective Norepinephrine 
Reuptake Inhibitors 
(SNRIs) 
Venlaflaxine 
Desenlafaxine 
Duloxetine 
Levomilnacipran 
Nausea, sexual dysfunction, 
weight gain 
Atypical Bupropion 
 
Headache, weight loss 
 
Mirtazapine 
 
Sedation, weight gain 
 
Trazodone 
 
Sedation, nausea 
 
Vilazodone 
 
Nausea, insomnia 
 
Vortioxetine Nausea, dizziness 
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Modified from (Santarsieri & Schwartz, 2015). 
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pharmacotherapy, developed in the 70s-80s. TCA’s get their name from their chemical 3 ring 
structure, and work primarily by elevating serotonin and norepinephrine levels through uptake 
inhibition. They represent an improvement over the MAOI’s, and are significantly more effective 
in the treatment of depression (Thase, Entsuah, & Rudolph, 2001). However, like the MAOI’s, 
TCAs tend to have several undesirable side effects. Most prominent are weight gain, sedation, 
and tachycardia, an increase in the resting heartbeat. Additionally, due to downstream effects on 
acetylcholine signalling, patients frequently report dry mouth and blurry vision (Santarsieri & 
Schwartz, 2015). Like the MAOI’s, TCA’s have largely fallen out of favor in the treatment of 
depression due to the widespread use of SSRI’s, however TCA’s can be beneficial in treatment 
resistant depression (Santarseiri, 2015).  
  The 1990s saw the development of the SSRI’s and the SNRI’s. These compounds 
constituted a marked improvement over both the MAOI’s and the TCA’s, largely due to their 
reduced side effects and higher tolerance from patients. Some of the most common side effects 
of the newer generation antidepressant compounds include headaches, gastrointestinal 
irritability, initial anxiety, and sexual dysfunction (Santersieri & Schwartz, 2015). The increased 
patient adherence to these compounds arises from their selective nature. SSRIs’ and SNRI’s are 
selective for serotonin or norepinephrine reuptake inhibitors, and do not antagonize acetylcholine 
signalling like the TCAs. The result is a net increase in serotonin or norepinephrine at neuronal 
synapses in limbic brain regions. However, criticism in the literature has emerged regarding the 
over prescription of antidepressants, as 1 in 10 people are prescribed an antidepressant 
compound in North America (Santersieri, 2015). Although at first glance this number seems 
excessive, it coincides with the rate of depression observed in the population.  
 The last group of compounds used to treat depression are the atypical antidepressants. 
Atypical antidepressants get their name from their mechanism of action. Unlike MAOI’s, TCA’s, 
or SSRI’s, atypical antidepressants do not act directly on serotonin or norepinephrine, although 
they may impact these chemicals through downstream mechanisms. One example is mirtazapine, 
which is classified as a noradrenergic antagonist-specific serotonin antagonist. This compound 
inhibits norepinephrine alpha-2 autoreceptors and blocks 5-HT2A/2C receptors, allowing more 
norepinephrine and serotonin in the cortex (Santersieri & Schwartz, 2015). What is notable about 
the atypical antidepressants is that the majority of these compounds were initially prescribed for 
other conditions, for example smoking cessation (Roddy, 2004). Due to atypical antidepressants 
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different mechanism of action, a different panel of side effects are commonly reported than for 
traditional antidepressants. For example, sedation is the most frequently reported side effect of 
atypical antidepressants, in addition to nausea. Loss of appetite and weight loss are also 
commonly seen (Santersieri, 2015). Atypical antidepressants are typically not the first line of 
treatment in the management of depression, although they can be quite useful due to their 
sedative effects, which can also have beneficial effects on comorbid anxiety (Golden, Dawkins, 
& Nicholas, 2009).  
 An atypical antidepressant medication that has seen increasing research interest is 
ketamine. Ketamine is a non-competitive antagonist of the NMDA receptor which blocks 
receptor activation through binding to the phencyclidine site of the complex (Sanacora et al., 
2008). Ketamine is remarkable in the fact that a single intravenous infusion can reduce 
depression symptom severity in as little as 2 hours, and remission can be achieved in 24 hours 
(Diazgranados et al., 2010; Murrough et al., 2013). Ketamine has also been shown to be 
efficacious against treatment resistant depression (Cusin et al., 2012). The mechanism behind 
ketamine’s fast-acting antidepressant effects is beyond the scope of this dissertation, however it 
is hypothesized that this mechanism involves rapid changes in glutamatergic signalling and 
alterations to neuroplasticity, including brain derived neurotrophic factor (BDNF), which has 
important effects on long-term potentiation (LTP) (Yoshi & Constantine-Paton, 2010; Korte et 
al., 1996).  
 With the exception of ketamine, currently available antidepressant medications take 
weeks to achieve their therapeutic effects. As levels of serotonin and norepinephrine at the 
synapse are increased hours after taking an antidepressant, it is argued that there are downstream 
signalling mechanisms responsible for the actions of antidepressant compounds. For example, 
serotonin and norepinephrine bind to g-protein coupled receptors. This in turn stimulates cyclic 
AMP (cAMP), which then alters the activity of protein kinase A, and then interacts with other 
protein kinases (CaMK), which finally influences the expression of cAMP response-element 
binding (CREB) (Willner, Scheel-Kruger, & Belzung, 2013). Antidepressants have been 
demonstrated to elevate CREB expression in the hippocampus following chronic administration 
(Nibuya, Morinobu, & Duman, 1995). CREB is a member of a family of transcription factors 
that can influence gene transcription and in turn proteins. One of CREB’s most prominent targets 
is BDNF, which is altered in both human post mortem samples and preclinical models (Duman 
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& Monteggia, 2006). CREB also influences the activity of vascular endothelial growth factor 
(VEGF), a member of the neurotrophin family (Willner, 2013). All of these alterations represent 
long-acting changes, which might in part explain the slow-acting actions of antidepressants. 
Another view of the slow-acting actions of antidepressants posits that their delayed response is 
due in part to the brain initially viewing the increased levels of serotonin as toxic. In order to 
adapt to this, stress-related adaptations occur in the brain, including increased levels of neuronal 
enzymes, and receptors becoming desensitized and down regulated in order to accommodate this 
increased level of serotonin (Santersieri & Schwartz, 2015). This process of gene activation can 
take several weeks to occur, which fits with the timeline for the response to antidepressants. 
Regardless of the exact mechanism behind the slow-acting actions of antidepressants, it is 
imperative that antidepressants with fast-acting properties are discovered, particularly for the 
case of depressed patients with suicidal ideations. A better understanding of the stress response 
and how this becomes deregulated in the context of chronic stress will contribute towards this 
understanding. 
1.5. The Stress Response  
      The body’s stress response is initiated when an organism encounters a stressor in the 
environment (be it physical or psychological) that is strong enough to activate the hypothalamic-
pituitary-adrenal (HPA) axis. Activation of the HPA axis involves a cascade of neuroendocrine 
events, which include: 1) corticotrophin-releasing hormone (CRF) is released from neurons in 
the paraventricular nucleus of the hypothalamus, 2) which travels to the anterior pituitary gland 
and regulates the transcription of the proopiomelanocortin gene (a member of the corticotrophin 
peptide family) (Tafet & Nemeroff, 2016), 3) which then triggers the release of 
adrenocorticotropin hormone (ACTH) into circulation, and 4) ACTH then travels to the adrenal 
cortex, which stimulates the release of cortisol in humans and corticosterone (CORT) in rodents 
(Sterner & Kalynchuk, 2010). Upon release, glucocorticoids act on bodily tissues to deal with the 
stressor by limiting non-essential functions and mobilizing energy. In addition to peripheral 
effects, glucocorticoids also travel to the brain and exert an inhibitory influence on the 
periventricular nucleus through a negative feedback loop (Sterner, 2010). Stress receptors in the 
brain include both mineralocorticoid (MR) and glucocorticoid receptors (GR), which are 
expressed in the hippocampus, amygdala, and prefrontal cortex, and are the main site of 
glucocorticoid action. In the hippocampus, glucocorticoids bind to GR, which activate 
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GABAergic projections located in the paraventricular nucleus of the hypothalamus that inhibit 
HPA axis activity (Tafet, 2016). Although MR have a high affinity for CORT and are thus 
activated when circulating CORT levels are low, GR have a low affinity for CORT and are 
activated when CORT levels are high (Sterner; Willner, Scheel-Kruger, & Belzung, 2013). Tight 
control of the HPA feedback inhibition mechanism is crucial to maintaining homeostasis. 
However, when hippocampal GR levels are low, feedback inhibition becomes deregulated, and 
stimuli that instigate an HPA axis response lead to exaggerated levels of CORT (Sterner).  
Activation of the HPA axis under conditions of acute stress is essential for an organism to 
mount an appropriate behavioural and biological response to the stressor. During an acute 
stressor, the amygdala activates the HPA axis to ultimately result in the release of 
glucocorticoids. Acute activation of the HPA axis triggers CRF neurons in the amygdala, 
initiating a positive feedback loop associated with fear and anger reactions, in addition to 
catecholaminergic neurons which serve to stimulate arousal and improve cognitive functioning 
for brief periods (Tafet & Nemeroff, 2016). This activation helps divert energy away from non-
essential functions and mobilize the body to effectively deal with the situation. However, when 
this becomes a problem is under conditions of chronic stress. During chronic stress, the negative 
feedback mechanism described above fails, resulting in increasing accumulation of 
glucocorticoids. Excess levels of glucocorticoids are neurotoxic, and over time this toxicity can 
lead to a loss of hippocampal granule cells and dendritic atrophy in the hippocampus and 
prefrontal cortex (McEwen & Morrison, 2013; Sapolsky, 2000). Interestingly, the effects seen in 
the amygdala with chronic stress run in the opposite direction, with dendritic hypertrophy 
observed (Mitra & Sapolsky, 2008).  
This pattern of neuroanatomical alteration aligns with the roles of the hippocampus, 
prefrontal cortex, and amygdala during the stress response. The function of the hippocampus and 
prefrontal cortex during stress is to inhibit HPA axis activity, whereas the amygdala serves to 
heighten HPA axis activity (Feldman, Conforti, & Weidenfeld, 1995). The picture that emerges 
is that during periods of chronic stress and excessive glucocorticoid release, dendritic 
hypotrophy and volumetric reductions of the hippocampus and prefrontal cortex accrue, 
interfering with their ability to inhibit HPA axis activity. Meanwhile, dendritic hypertrophy in 
the amygdala enhances the HPA axis, leading to even more glucocorticoids being released 
(Sterner & Kalynchuk, 2010). In addition to the demonstrated effects of prolonged 
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glucocorticoid release on brain neuroanatomy, glucocorticoid release can lead to 
immunosuppression, sleep disorders, impaired memory, and depression (Sterner, 2010). With an 
understanding of how the brain reacts to stress, the link between stress and depression will now 
be discussed below.   
1.6. The Link Between Stress and Depression  
Stress is a significant risk factor for the development of depression in human populations. 
For example, the development of depression is typically preceded by stressful life events 
(Kessing, Agerbo, & Mortensen, 2003). Relatedly, children with stressful environments while 
growing up are significantly more likely to develop depression in adulthood than children in non-
stressful environments, and have a sensitized HPA axis response (Essex, Klein, Cho, & Kalin, 
2002). Half of depressed patients display the hallmarks of a deregulated stress response, 
hypercortisolemia (Sachar and Baron, 1979), and antidepressant treatment reverses this 
deregulation (Holsboer, 2001). Furthermore, Cushing’s disease, characterized by chronically 
high circulating levels of glucocorticoids, shares a significant comorbidity with depression 
(Sonino & Fava, 2002). It is not surprising that elevated levels of CRH are observed in the 
cerebrospinal fluid of depressed patients, in addition to elevations in urinary free cortisol (Nestler 
et al., 2002). A way to characterize the link between stress and depression in the clinical 
population is through the dexamethasone suppression test (DST). In the DST, dexamethasone (a 
synthetic glucocorticoid analog) is administered and cortisol is later measured. In control 
patients, dexamethasone suppresses the activity of ACTH and subsequently cortisol secretion 
through binding to GR’s. However, in depressed patients a typical response is elevated cortisol 
concentration after dexamethasone administration (Dam, Mellerup, & Rafaelsen, 1985). This 
elevation in cortisol concentration after the DST tends to correlate with poor patient outcome and 
early relapse (Sterner & Kalynchuk, 2010). What emerges is a consistent pattern of a deregulated 
stress response which has pathological consequences for the development of depression. 
However, all of these data are correlational. Animal models can bridge the gap in understanding 
the link between stress and depression by offering tight control over extraneous variables and 
allowing the researcher to see the causal effects of stress and its relation to depression.  
1.6.1. Animal Models of Stress and Depression 
Animal models of depression permit a high level of experimental control over potential 
confounding variables which allow the researcher to carefully delineate the contributing factors 
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Figure 1-1. The Hypothalamic-Pituitary-Adrenal Axis. When an organism encounters a stressful 
stimulus the HPA axis becomes activated. Corticotrophin-releasing hormone (CRH) is released 
from the paraventricular nucleus of the hypothalamus which then travels to the anterior pituitary 
gland where it transcribes the proopiomelanocortin gene. This then triggers the release of 
adrenocorticotrophic hormone (ACTH), which is released into circulation. Upon reaching the 
adrenal cortex cortisol is secreted in humans or corticosterone in rodents. Glucocorticoids then 
bind to receptors in the hippocampus which serves as a negative feedback signal for the HPA 
axis. Figure adapted from (Stephens and Wand, 2012). 
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to a particular disorder. Several animal models of depression have been developed, including 
exogenous stress exposure, genetic manipulation, and surgical approaches (e.g., olfactory 
bulbectomy). However, due to the nature of this dissertation I will only focus on stress models of 
depression.  Stress models of depression focus on the effects of stress on the development of 
depression-like behaviour in the rodent. Due to the complex nature of depression, an attempt to 
capitulate the entire disorder cannot be made; rather, specific aspects of the disorder are targeted. 
And although the ultimate goal for any rodent-derived treatment for depression is to improve 
patient outcomes, it is simply not feasible (yet) to model suicidal behaviour in rodents. 
Therefore, depression-related behaviours that can be observed in animal models are instead a 
focus of interest. For example, learned helplessness (despair), or anhedonia are frequently 
targeted for observation. The following sections will focus on the concept of animal models of 
depression, common animal models of depression, and ways to measure depression-like 
behaviour in these models. 
Any model of a disorder must meet certain criteria for it to be considered useful. Perhaps 
the most important aspect is validity. Validity in the case of models of a disorder means that 
what you are measuring is valid. When designing an animal model of depression, 3 types of 
validity have to be ensured. First is construct validity (Nester, 2010).  Construct validity means 
that the methods used to create the disorder are representative of those seen in the population. 
This is clearly seen in animal models of Huntington’s disease. As it is known that the diseased 
form of the huntingtin gene contributes to the disorder, animal models can recreate this mutation 
and thus achieve construct validity. However, in the case of depression there is no single 
identified disease-causing genes or proteins. These factors contribute to a difficulty in fully 
achieving construct validity in animal models of depression. Therefore, researchers must focus in 
on the most likely contributing factors to the development of depression with the available 
evidence and manipulate those. As the majority of depressed patients experience some form of a 
stressful event before the onset of symptoms, stress is frequently targeted in some form. The 
second consideration for any animal model of depression is face validity. Face validity indicates 
that the model you are using produces similar alterations to those seen in the human population, 
particularly similar anatomical and biochemical alterations. For example, depressed human 
patients typically have reduced hippocampal volume and decreased levels of monoamines. A 
rodent model of depression would be said to have good face validity if it produced a similar 
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pattern of neurobiological alterations. The last criteria that should be met is predictive validity. 
Predictive validity in the case of animal models of depression indicates that treatments in the 
animal model result in similar responses to those seen in the human population (Nestler). For 
example, antidepressants should produce similar antidepressant responses in rodents to those 
seen in humans. While it is unlikely that any current animal model of depression will meet all of 
the above 3 criteria, the more criteria met the more the researcher can be confident that the model 
they are using is a good one. Designing animal models of depression that can fulfill all of the 
above 3 criteria should remain a focus for all researchers.  
Once a researcher chooses an animal model of depression, there must be tools available 
to assess if the model is successfully producing depression-like behaviour. A number of 
behavioural assays to screen for depression-like behaviour have been developed. Perhaps the 
most commonly used tool is the forced-swim test (FST). In this task, rodents are placed in a tank 
filled with water. The tank is high enough that rodents have no opportunity to escape. The 
rodent’s behaviour is recorded by a camera for upwards of 10 minutes. A number of behaviours 
are then scored for later analysis. The first behaviour is immobility. Immobility refers to the total 
time the rat spends immobile while in the swimming tank. This is typically measured as the most 
minimal movements used to keep the rodent’s head above water. For example, the rodent might 
make subtle paw movements while floating in an attempt to keep its head above water. The 
amount of time spent struggling is also recorded. Struggling is defined as an active behaviour 
where the rodent is trying to escape from the swimming tank. This is typically manifested as 
using all paws to scratch at the corners of the tank in an attempt to swim out. The last behaviour 
scored in the FST is swimming. Swimming is an active behaviour where the rodent swims from 
point to point in the tank with no apparent goal. The rodent may also dive to the bottom of the 
tank, which still falls under the category of swimming. Animal models of depression typically 
result in a clear stratified set of behaviours in the FST. Total immobility time is typically 
increased, whereas time spent struggling and swimming is decreased. This set of behaviours 
(increased passive behaviours, decreased active behaviours) is indicative of learned helplessness, 
or the act of learning that fighting the situation will not help (Lucki, 1997).  
Another commonly used measure of depression-like behaviour is the sucrose preference 
test. Here, animals are trained to drink both unflavored water and sweetened water. The 
percentage of sucrose solution consumed is reported. Typically, a control rodent will consume 
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significantly more sucrose than unflavored water, while a stressed animal will not show a 
preference for the sucrose solution. This is inferred to mean that the animal is experiencing 
anhedonia, or the loss of ability to experience pleasure in what were previously pleasurable 
activities (Der-Avakian & Markou, 2012). Importantly, both the sucrose preference test and FST 
respond to antidepressant therapy, indicating that they are indeed accurately measuring 
depression-like behaviour in the rodent.  
A number of animal models have been developed to study the role of stress in the 
pathogenesis of depression. These models differ in the mode that they employ stress. For 
example, one of the earliest developed models of depression is repeated restraint stress. Here, a 
rodent is placed into a plastic restrainer, immobilizing the rat. The rodent is left in the restrainer 
for several hours per day, and this is done daily for days to weeks. While this model is initially 
stressful for the rodent, over time the animal becomes habituated to the restrainer and learns that 
the period of discomfort is only temporary (Table 1-2). Additionally, a further problem with this 
model is that it often fails to produce depression-like behaviour (Gregus, Wintink, Davis, & 
Kalynchuk, 2005). Therefore, this model has fallen out of favor in the field of chronic stress, 
however it is still useful for studying the effects of acute stress. Chronic unpredictable stress 
(CUS; or chronic mild stress, CMS) represents an improvement in validity over the restraint 
stress model. In the CUS model, an animal is exposed to several different stressors each day for a 
period of several weeks. Examples of stressors include cage tilting, lights on during sleeping 
hours, wet bedding, cage shocks, etc. (Bondi, Rodriguez, Gould, Frazer, & Morilak, 2008). This 
model is particularly interesting as it attempts to recapitulate the unpredictable nature of stressors 
that humans encounter in day-to-day life. Several reports have shown this model to successfully 
induce both depression-like and anxiety behaviours (Yohn & Blendy, 2017; Chakravarty et al., 
2013) in rodents.  
In contrast to chronic unpredictable stress, which targets the unpredictable nature of 
stressors in our daily lives, social defeat stress targets the stressors that emerge from our social 
lives. In this model, a rodent watches a smaller rodent being attacked by a larger “bully” rodent 
for short periods of time over the course of several days. Alternatively, the rodent will not 
observe but will instead be placed in the cage with the “bully” rodent. This model is intriguing as 
it is able to replicate the feeling of defeat that individuals can experience in social interactions. 
Additionally, this model has the added benefit of stratifying rodents into a group of responders 
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and non-responders to antidepressant medication, similar to what is observed in the human 
population, and is therefore effective in creating depression-like behaviour (Wood & Bhatnagar, 
2015). However, despite the different ways in which the mode of the stressor is manipulated in 
the above models, it can be argued that an inherent weakness is that the individual response to 
the stressor is not being controlled. For example, one animal might perceive stimulus A as highly 
stressful, whereas the same stimulus might elicit little to no stressful response in another animal. 
Therefore, a successful animal model of depression should control for the individual variability 
in response to stress. The repeated CORT model of depression aims to achieve just that.  
1.6.2. The CORT Model of Depression 
The CORT model of depression seeks to control for the amount of stress experienced by 
each individual animal. To achieve this, exogenous CORT given at the same dose is 
administered to each animal over the course of several weeks. Importantly, our lab has shown 
that the effects of CORT are both time and dose dependent. For example, although 10 mg/kg of 
CORT starts to increase immobility time in the FST, longer durations of immobility are observed 
at 20 mg/kg, and still greater effects are seen at 40 mg/kg (Johnson, Fournier, & Kalynchuk, 
2006). Additionally, although a single injection of CORT does not alter FST behaviour, increases 
in immobility time are observed after 7 days of injections, with the largest effects appearing after 
21 days. A large number of studies have validated the effectiveness of 21 days of 40 mg/kg of 
CORT injections in producing depression-like behaviour in the FST (Brummelete, Pawluski, & 
Galea, 2006; David et al., 2009; Gourley et al., 2008; Gregus et al., 2005; Kalynchuk, Gregus 
Boudreau, & Perrot-Sinal, 2004; Marks, Founier, & Kalynchuk, 2009; Murray, Smith, & Hutson, 
2008; Zhao et al., 2008;), which includes increased immobility time and decreased time spent 
struggling and swimming. The effects of repeated CORT injections also extend to other 
behaviours typically seen in the depressed clinical population. For example, repeated CORT 
injections can impair sexual behaviour (Gorzalka, Hanson, & Hong, 2001; Gorzalka & Hanson, 
1998), inhibit grooming behaviours (David et al., 2009), and decrease sucrose intake (David et 
al., 2009; Gorzalka, Hanson, Harrington, Killam, & Campbell-Meiklejohn, 2003), all of which 
are indicative of an anhedonic-like phenotype. Furthermore, repeated CORT injections can also 
produce anxiety-like behaviours in rodents (David et al., 2009; Lee, Shim, Lee, Yang, & Hahm, 
2009). This is an important aspect of the CORT model of depression, as in the clinical population 
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anxiety is frequently comorbid with depression (rates between 20-50%) (Hirschfeld, 2001). This 
serves to further improve the face validity of the model.  
In addition to the behavioural effects produced by repeated CORT injections, accompanying 
physiological changes also occur. For example, decreases in body weight (Brymer et al., 2018; 
Coburn-Litvak, Pothakos, Tata, McCloskey, & Anderson, 2003; Fenton et al., 2015; Lussier et 
al., 2013a) are observed, as well as a dysregulated HPA axis (Johnson et al., 2006), and reduced 
adrenal weight (Murray et al., 2008). Finally, it is important to note that the CORT-induced 
behavioural changes described above can be ameliorated by chronic antidepressant treatment 
(Brymer et al., 2018; Fenton et al., 2015). This suggests that the model possesses predictive 
validity, as treatments that work in clinically depressed human populations also work in this 
animal model. Therefore, all of the above observations reinforce the idea that the CORT model 
of depression is producing effects in line with those observed in humans, and validates its use as 
a model of depression. 
While the CORT model of depression is a useful model to help probe the behavioural and 
physiological underpinnings of depression, like any model there are drawbacks that limit its 
utility. The major limitation of the model is the physiological relevancy of the dose used. The 
standard dosage used in the model is 40 mg/kg, although smaller doses have been used elsewhere 
(with conflicting results). This dose of CORT is high, and this is reflected in how the animals 
respond to the drug: decreased body weight and adrenal gland weight. This is in contrast to the 
normal amount of cortisol or CORT released in response to a stressor, which is significantly less. 
For example, the mean amount of corticosterone released during stressful events in rodents is 
usually below a milligram (Thanos et al., 2008). Therefore, the issue that arises when utilizing 
the CORT model of depression is that of physiological relevancy. This raises the question of 
whether the behavioural and physiological effects produced by repeated CORT injections are 
result of the of the animals simply being sick from a supraphysiologic dose of CORT? This does 
not appear to be the case. Work in our lab has demonstrated that CORT-treated animals do not 
have alterations in locomotor activity and are not impaired on tests of muscle strength. Although 
CORT-treated animals do weigh less than their vehicle-treated counterparts, the total amount of 
food consumed is similar between the two, suggesting that metabolic changes are occurring 
(Kinlein, Shahanoor, Romeo, & Karatsoreos, 2017). This reinforces the idea that CORT 
treatment effects on physiology and behaviour are not reliant on making the animals sick. 
 20 
Table 1-2. Comparison of Animal Models of Depression 
Model of Depression Strengths Weaknesses 
Social Defeat Stress Produces robust depression-
like behaviour and stratifies 
rats into a group of 
responders and non-
responders 
Potential for individual 
variability in responses to 
stress 
Restraint Stress Produces depression-like 
behaviour on a number of 
behavioural assays 
Animals sensitize to the 
effects of the restrainer 
Chronic Unpredictable 
Stress 
Successfully recapitulates the 
unpredictable nature of 
stressors seen in the human 
population 
Potential for individual 
variability in responses to 
stress 
Repeated Corticosterone 
Injections 
Amount of stress each 
animals receives is carefully 
controlled 
Dose frequently used is not 
representative of a stressful 
event in a human 
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Overall, these results suggest that the 40 mg/kg dose is not so high as to be making the animals 
sick/weak. 
1.7. Neuroanatomy  
The temporal and frontal lobes are critically involved in the pathogenesis of depression. 
The temporal lobes have received special interest in the context of depression as the temporal 
lobes are the house of the limbic system. The limbic system comprises the hippocampus, 
amygdala, hypothalamus, and septal area (Rajmohan & Mohandas, 2007) and is involved in the 
regulation of emotional behaviour. Importantly, the limbic system is known to be compromised 
by stress, as the hippocampus is demonstrated to decrease in volume and dendritic atrophy is also 
reported, while the amgydala shows the opposite pattern (Willner, Scheel-Jruger, & Belzung, 
2013). While not technically part of the limbic system, prefrontal cortex neurons show dendritic 
atrophy as well (Radley et al., 2006). Therefore, understanding the neuroanatomy of prefrontal 
cortex and the hippocampus is critical to an understanding of depression.  
1.7.1.  The Hippocampal Formation 
The hippocampus remains one of the most studied structures in the brain. This is because 
it is involved in many behaviours, most prominent being its role in learning and memory, and the 
ease of performing electrophysiological recordings from the area. The hippocampus derived its 
name for its resemblance to the seahorse, and the structure sits in the temporal lobe of the 
mammalian brain. The term hippocampus is often used interchangeably with the hippocampal 
formation, which refers to a series of structures comprised of the hippocampus proper (Cornu 
Ammonis), dentate gyrus (DG), the subicular cortex (subiculum, presubiculum, and 
parasubiculum), and the entorhinal cortex (EC) (Amaral & Witter, 1989; Amaral, Dolorfo & 
Alvarez-royo, 1991).   
The hippocampus proper comprises 3 regions: CA1, CA2, and CA3. A fourth region, 
CA4, has also been proposed. The principal cell layer in all of the subfields of the CA subfields 
is the stratum pyramidale, made up of excitatory glutamatergic pyramidal neurons. Located 
superficial to the stratum pyramidale is the stratum oriens, a largely cell-free layer where the 
dendrites of pyramidal neurons receive innervation from classes of GABAergic interneurons. 
Located above the CA3 stratum pyramidale layer is the stratum lucidum, an acellular zone 
occupied by mossy fiber terminals projecting from the DG. The stratum radiatum and stratum 
lacunosum-moleculare are located immediately adjacent to the stratum lucidum and above the  
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Fig 1-2. Schematic of the rodent hippocampus. The major source of input to the hippocampus 
starts from the entorhinal cortex. Neurons from the entorhinal cortex project to the dentate gyrus 
(DG), which give rise to mossy fiberes that synapse onto the pyramidal cells of CA3, which form 
Shaffer collaterals onto the CA1. The CA1 in turn projects back to the entorhinal cortex and to 
the subiculum. Adapted from (Garcia Lopez, Garcia-Martin, & Freire, 2010). 
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stratum pyramidale in layers CA1 and CA2. The stratum radiatum contains the projections of the 
Schaffer collaterals, the major output of the CA3 to CA1. Finally, the stratum lacunosum-
moleculare represents the most peripheral layer in the hippocampus proper, and is the source for 
extrahippocampal outputs (Amaral & Witter, 1989).  
1.7.2.  The Dentate Gyrus  
The DG serves as the major source of cortical input to the hippocampus. It forms a part of 
the trisynaptic circuit, one of the most extensively studied circuits in the brain. In the trisynaptic 
circuit, cortical input goes into the DG from the neurons in the EC, forming the perforant path.  
From here, neurons give rise to mossy fibers which synapse onto pyramidal neurons in the CA3. 
Mossy fibers from CA3 then give rise to Schaffer collaterals which synapse onto dendrites of 
CA1 pyramidal cells. The CA1 then synapses into the subiculum and back to the EC, forming the 
major source of excitatory output of the hippocampus, and in so doing completing the circuit 
(Knierim, 2015). The DG is comprised of 3 layers: the stratum granulosum (granule cell layer; 
GCL), polymorphic layer (hilus), and the stratum moleculare (Amaral & Witter, 1989). An 
important subregion is the subgranular zone (SGZ), a two-cell wide germinal layer between the 
hilus and GCL. The SGZ is important as it, along with the subventricular zone, is 1 of only 2 
sites of neurogenesis in the adult brain. The GCL forms the principal cell layer in the DG. It is 
composed of tightly packed excitatory granule neurons which extend processes into the 
molecular layer (ML) and axons back into the hilus. The GCL is approximately 4 to 8 cells thick, 
and estimates place roughly 1.2 million neurons in the GCL of a rat (Rapp & Gallagher, 1996). 
The hilus forms the innermost layer of the DG and contains inhibitory interneurons and 
excitatory mossy cells. The most common inhibitory interneuron type in the hilus is the 
pyramidal basket cell, and these cells form inhibitory synaptic contacts onto the proximal 
dendrites and cell bodies of dentate granule cells (Amaral et al., 2007).  
The stratum moleculare is a cell-free layer at the outermost region of the DG and is 
composed of an inner, middle, and outer subregions. Importantly, it is the recipient of the 
dendrites of granule cells, pyramidal basket cells, and polymorphic layer cells (Amaral et al., 
2007). The projections of the performant path terminate in the middle and outer layer of the 
stratum moleculare, forming excitatory connections.  
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1.7.3.  The prefrontal cortex 
One of the most famous subjects in the annals of psychology is Phineas Cage. Cage was a 
railway worker who, as a result of an accident, had a tamping iron impaled through his frontal 
lobes. The consequences of this insult on his behaviour were immediate. Cage became 
impulsive, did not follow social cues, could not manage money, and became aggressive. It was 
later that this set of behaviours came to be attributed to the frontal lobes, and fell under the 
domain of executive functions. While the role and function of the frontal lobes is relatively clear 
in humans, the question of do rodents possess a prefrontal cortex (PFC) has long been a 
contentious issue in the field of neuroscience. There are 2 opposing camps in this issue. The first 
group says that the rodent does not possess a PFC as this structure is uniquely human in its  
function. For example, they argue that tasks such as reasoning and planning are not ones that a 
rodent performs. The other group argues that indeed the rodent does have a PFC. Their argument 
is based off of lesion studies which indicate that lesioning the area of the PFC in the rodent 
produces behavioural effects similar to those seen in humans. For the purposes of this 
dissertation, it will be assumed that the rodent does possess an analogous PFC to that seen in 
humans. The rodent PFC is divided into 2 regions: the lateral and medial PFC (mPFC). The 
mPFC is further divided into dorsal, medial, and ventral regions. The dorsal mPFC comprises the 
anterior cingulate cortex, medial the prelimbic cortex, and ventral the infralimbic cortex 
(Seamans, Lapish, & Durstewitz, 2008). The PFC shares cortical connections with a large 
number of regions, including the hippocampus, amygdala, entorhinal cortex, perrirhinal cortex, 
and with premotor and somatosensory cortices. Furthermore, the PFC receives input from the 
ventral tagmental area and substantia niagra (Seamans, 2008). The mPFC is the only region that 
possesses direct projections to cholinergic basal forebrain and brainstem nuclei (Seamans). It is 
with this complex pattern of connections that the PFC is able to modulate many aspects of 
complex cognitive behaviours. It is therefore perhaps no surprise that Gages’ behaviours were so 
profoundly disrupted.  
1.8. The Neurobiology of Depression 
Although depression is a complex, heterogeneous disorder, there tend to be clusters of 
neurobiological alterations observed in both post-mortem and non-invasive imaging studies of 
depressed patients. The brain structures most commonly implicated in depression include those 
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involved in emotional behaviours, such as the hippocampus, amygdala, and PFC. Magnetic 
resonance imaging studies reveal reduced volumes of the anterior cingulate and orbitofrontal 
 
Fig 1-3. Schematic of the rodent mPFC. The anterior cingulate cortex, prelimnic cortex, and 
infralimbic cortex are all illustrated. Adapted from (Stern, Gazarini, Vanvossen, & Bertoglio, 
2013).  
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cortex of depressed patients (Koolschijin, van Haren, Lensvelt-Mulders, & Kahn, 2009) 
compared to controls. The dorsolateral PFC shows decreased regional cerebral blood flow and 
glucose metabolism in depressed patients, which is associated with psychomotor retardation and 
anhedonia (Drevets, 1998). Moreover, reductions in neuronal and glial density have been 
observed in the orbitofrontal and dorsolateral PFC of depressed patients during live imaging 
(Raikowska, Miguel-Hidalgo, & Wei, 1999). Finally, reduced dendritic branching in the PFC is 
observed in animal models of depression (Lucassen et al., 2014).  
Similar to the PFC, the hippocampus shows decreased volume, dendritic retraction, and 
decreased hippocampal neurogenesis (see section on neurogenesis for a detailed description of 
this contentious issue in the context of depression; Palazidou, 2012). In contrast to the PFC and 
hippocampus, which tends to show reductions in volume and activity, the amygdala has been 
reported to be enlarged in depression, and animal studies show amygdalar dendritic outgrowth 
(Palazidou). This would indicate that the amygdala is more active in depression, and is therefore 
most likely contributing to anxiety-like behaviour, which is frequently comorbid with 
depression. In addition to structural changes observed in depression, there are also changes in 
brain neurochemistry. Perhaps the most replicated finding in the literature across both preclinical 
and clinical studies is that both blood and cerebrospinal fluid concentrations of the monoamines 
are decreased. Post-mortem studies of depressed brains also reveal decreased numbers of the 
monoamine receptors, for example 5-HT1A and 5-HT1B, located in the hippocampus and PFC 
(Nautiyal & Hen, 2017). GABA and glutamate, the main drivers of inhibition and excitation in 
the brain, respectively, have also been implicated in the pathophysiology of depression. Post-
mortem depressed brains show deregulated GABA and glutamate homeostasis, in particular 
alterations to the function and structure of glutamatergic neurons, the dendrites of GABA 
targeting neurons, astrocytes, and oligodendrocytes (Pabba & Sibille, 2016). Work in our lab has 
shown that rats subjected to repeated CORT injections show an increase in vesicular glutamate 
transporter (VGLUT)-2 and a decrease in GABA receptors in the hippocampus (Lussier et al., 
2013b), adding further evidence to the idea that depression involves a dysregulation of the 
balance between GABA and glutamate. 
Alterations in neurotropic factors are also seen in depression. Reductions in BDNF are 
consistently observed in both preclinical and clinical studies. BDNF is widely distributed  
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Fig 1-4. Schematic of the proposed neurobiology of depression. Adapted from (Palazidou, 2012).  
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throughout the hippocampus, and plays important roles in neuronal growth, survival and 
maturation, and arborisation and synaptic plasticity in the adult brain (Palazidou, 2012). Stress 
has been shown to suppress BDNF synthesis in the hippocampus, with antidepressant drugs and 
electroconvulsive therapy increasing BDNF synthesis and signalling in the hippocampus. A 
negative correlation exists between levels of BDNF and depression symptom severity, with 
reduced levels of BDNF being associated with increased severity (Palazidou). Therefore, the 
neurobiology of depression comprises complex patterns of changes in brain structure, at the level 
of both gross morphology and at the level of proteins and receptors. Given the roles of the 
hippocampus and prefrontal cortex in cognitive processes, it can be expected that impairments in 
cognition are a component of depressive symptoms, and this is exactly the case. 
1.9. Memory Impairments in Depression 
While not consistently recognized as a feature of depression, included in the DSM-V and 
patient self-reporting are problems in memory and thinking. Cognitive impairment is associated 
with poor response to treatment, and is observed in over two-thirds of the depressed population 
(Rock, Rosier, Riedel, & Blackwell, 2014). The most commonly observed deficits in cognition 
involve alterations in explicitly verbal and visual memory, while performance on implicit 
memory tasks are spared (Austin, Mitchell, & Goodwin, 2001). A meta-analysis of commonly 
reported cognitive deficits in depressed patients revealed impairments in executive functioning, 
memory, and attention. Specifically, in terms of executive function, depressed patients tended to 
exhibit deficits on spatial working memory tasks, where participants search for tokens while 
keeping in mind previous token locations (Rock, 2014). In terms of memory, depressed patients 
exhibited deficits in delayed matching to sample tasks, where participants must remember the 
visual features of a complex stimulus and select the stimulus they encountered previously from 4 
similar targets (Rock). Depressed patients also show deficits in pattern recognition memory, 
where participants have to correctly identify from 2 choices a previously encountered abstract 
pattern (Rock). Finally, depressed patients also show deficits in tasks of sustained attention and 
signal detection. (Rock). Kizilbash, Vanderploeg, and Curtiss (2002) showed significant 
impairments of immediate recall of new information on the California Verbal Learning Test in 
depressed veterans. This pattern of cognitive deficits present in depressed patients implicates 
dysfunction within the hippocampus and PFC broadly.  
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Several researchers in the depression field argue that it is not cognitive processes impaired 
in depression, but rather motivational processes that are impaired. They argue that depressed 
patients lack motivation, and it is this lack of motivation that skews the pattern of cognitive 
alterations observed in the depression literature. For example, Scheurich et al (2008) showed that 
when controlling for motivation, depressed patients performed at equal or slightly below levels 
of control patients on several tasks of neurocognitive functioning. This in turn could be 
correlated with anhedonia/lethargy, as depressed patients might say what is the point of even 
trying? However, evidence to counter this argument is presented below, and again shifts the 
focus back to cognitive impairment originating from altered brain function. 
An interesting question is what happens to the cognitive performance of depressed patients 
who are successfully treated and experience remission? Interestingly, Paridiso, Lamberty, 
Garvey, and Robinson (1997) addressed this question and found that formerly depressed patients 
still exhibited deficits on set-shifting tasks. In a similar vein, Marcos et al. (1994) showed that 
recovered depressed patients continue to present with deficits in both immediate memory and 
delayed recall of visual and verbal material. This is an interesting finding, as it would be 
expected according to the neuroplasticity hypothesis that once the depressed patient is recovered, 
impaired plasticity in the brain should be restored. What this suggests is that it is more than 
likely that most of the cognitive deficits observed in depression are a result of altered brain 
structure and function (i.e., changes in morphology) rather than simply a lack of motivation. 
However, more research is required to fully elucidate the mechanism maintaining cognitive 
dysfunction in depressed patients in remission.  
Preclinical models of depression consistently indicate that chronic stress results in 
impairments in tasks that require functioning of the hippocampus and PFC. For example, deficits 
in spatial learning and memory are well-validated (Conrad, Galea, Kuroda, & McEwen, 1996; 
Goodman & McIntyre, 2017; Kleen, Sitomer, Kileen, & Conrad, 2006; Lin et al., 2016; Park et 
al., 2015). In regards to the PFC, consistent impairments in working memory are observed as a 
consequence of chronic stress (Diamond, Park, Heman, & rose, 1999; Lee & Goto, 2015; Mika 
et al., 2012; Mizoguchi et al., 2000). However, it has to be acknowledged that while chronic 
stress impairs performance on the above measures, acute stress serves to enhance both spatial 
and working memory, likely a result of enhanced physiological arousal.  
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1.10. Adult Neurogenesis  
It was a long-held belief in the neuroscience community that adult neurogenesis, or the 
birth of new neurons throughout the lifespan, did not occur. Instead, it was believed that the 
brain was unchanging, and the cyroarchitecture from birth did not alter. This is best illustrated by 
one of the pioneers of modern neuroanatomy, Santiago Ramon y Cajal: 
“Once development was ended, the fonts of growth and regeneration of the axons and 
dendrites dried up irrevocably. In the adult centers, the nerve paths are something fixed, 
and immutable: everything may die, nothing may be regenerated” (Lie, Song, 
Colamarino, Ming, & Gage, 2004).  
This view of the brain persisted for decades, however it was with a series of pioneering 
studies that this view came to be challenged. For example, Joseph Altman described 
neurogenesis occurring in the adult DG and olfactory bulb of adult rats (Altman & Das, 1965). 
This work was furthered by Michael Kaplan, who demonstrated that the presence of complex 
environments, such as running wheels and toys, increased the numbers of [3H]-thymidine 
labelled cells in layer IV of the rat visual cortex (Kaplan, 2001). Lastly, a major change in the 
acceptance of adult neurogenesis was spearheaded by the development of 5- bromo-3’-
deoxyuridine (BrdU). The advantage of BrdU is that it allows for researchers to conduct 
investigations of neuronal fate, allowing for an age-old debate as to what happens to adult 
generated neurons to be settled. The advent of new immunohistochemical techniques to detect 
newly generating neurons lead to the discovery of 2 neurogenic niches in the adult brain: the 
subventricular zone of the lateral ventricles and the SGZ of the DG. This discovery led the way 
to important advances in the fields of disease and cognition.  
1.10.1. Stages of Neurogenesis 
 Neurogenesis is more than simply the birth of new neurons. Rather, it is a complex 
process made up of many different stages that depend on the interplay of intrinsic and extrinsic 
factors. Adult neurogenesis comprises 5 different stages: 1. Proliferation. 2. Differentiation, 3. 
Migration, 4. Maturation, and 5. Integration (Kemperman & Gage, 2000). Adult neural stem 
cells originate from the entire dentate neuroepithilium, and the descendants of these cells relocate 
to the dorsal hippocampus (Goncalves, Schafer, & Gage, 2016). Within the hippocampal DG, 
radial glia-like cells represent the pool of neural progenitor cells (NPCs), and these cells occupy 
the SGZ (Seri, Garcia-Verdugo, McEwen, & Alvarez-Buylla, 2001). Radial glial-like cells 
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express glial fibrillary acidic protein (GFAP), nestin, and brain lipid binding protein (BLBP) 
(Ming & Song, 2011). These radial glial-like cells divide asymmetrically to produce transiently 
amplifying progenitor type 2 cells. Type 2 cells are said to represent the transition from glial to a 
neuronal lineage (Steiner et al., 2006). Type 2 cells can be divided into type 2A and type 2B 
cells, which differ in their expression of certain biomarkers. For example, type 2A cells express 
GFAP, nestin, and BLBP, while type 2B cells express nestin, doublecortin (DCX), and PSA-
NCAM. Overall, type 2 cells represent cells that have committed to a neuronal fate. 
Type 2 cells next give rise to type 3 migratory neuroblasts, representing the population of 
immature postmitotic neurons that mature into the population of resident granule neurons over 
the course of weeks to months. Type 3 neuroblasts maintain their expression of DCX while also 
expressing calretinin. However, as they mature, the expression of DCX and calretinin shifts to a 
pattern of calbindin and NeuN (Kempermann, Jessberger, Steiner, & Kronenberg, 2004).  
1.10.2.   Morphological Characteristics of Adult Generated Granule Neurons 
It takes approximately 7 weeks for adult generated neurons to reach their final 
morphological maturity (Kempermann, Song, & Gage, 2015). Immature neurons begin to 
migrate radially and integrate into the local DG circuitry 1 week after their birth, following an 
inside-out pattern that is dependent on disrupted in schizophrenia 1 (DISC1) and reelin signalling 
(Mao et al., 2009). As adult generated granule neurons mature, they begin to extend their apical 
dendrites first through the GCL and then into the ML. Tracing studies have demonstrated that the 
first dendrites from these sprouting immature granule cells are detected 16 days post-division 
(Zhao, Teng, Summers, Ming, & Gage, 2006). Furthermore, approximately 4-10 days post-
division these immature granule neurons send axonal projections to pyramidal cells in the CA3 
(Zhao, Teng, Summers, Ming, & Gage, 2006). These immature granule cells contain functional 
GABA and glutamate receptors located on their plasma membrane 4 days post-division. GABA 
continues to depolarize the cell for 2-3 weeks until the immature granule cells become 
responsive to glutamate (Kempermann, 2015). After becoming responsive to glutamate, the 
threshold to induce long-term potentiation (LTP) is decreased in these immature granule cells, 
biasing input to these new neurons (Marin-Burgin, Mongiat, Pardi, & Schinder, 2012). Finally, 
as immature granule cells begin to reach a mature stage, their mossy fibers begin to form 
connections with interneurons dispersed throughout the GCL, hilus, and CA3 (Toni et al., 2008). 
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1.10.3.  Regulation of neurogenesis 
As mentioned earlier, hippocampal neurogenesis is a dynamic process regulated by a 
combination of intrinsic and extrinsic factors. One of the best studied regulators of hippocampal 
neurogenesis is Notch. Notch is a single-pass transmembrane protein, and is involved in a variety 
of signalling cascades (Goncalves, Schafer, & Gage, 2016). Inactivation of the Notch pathway 
component results in an initial increase in hippocampal neurogenesis by causing a premature 
differentiation of progenitor cells, which eventually leads to a depletion of the progenitor cell 
pool and a decrease in hippocampal neurogenesis (Ehm et al., 2010).  Furthermore, conditional 
knockout or overexpression of Notch has contrasting effects on dendritic morphology: knockout 
significantly decreases dendritic arborisation, while overexpression increases dendritic 
complexity (Breunig, Silbereis, Vaccarino, Sestan, & Rakic, 2007). Hedgehog signalling has also 
been implicated in the regulation of postnatal hippocampal neurogenesis. Hedgehog signalling is 
initiated in the brain by sonic hedgehog (Shh) (Goncalves, 2016). Support for the role of Shh in 
postnatal hippocampal neurogenesis has come from both in vitro and in vivo studies. For 
example, application of exogenous Shh to cultured neurons promotes progenitor proliferation, 
while Shh overexpression within the DG increases hippocampal progenitor cell proliferation. 
Moreover, pharmacological inhibition of Shh in the hippocampus reduces hippocampal cell 
proliferation (Lai et al., 2003).  
Secreted growth factors dynamically regulate postnatal hippocampal neurogenesis. Of 
these, BDNF is the most widely studied. BDNF expression is highest within the hippocampus, 
especially in dentate granule cells (Katoh-Semba, Takeuchi, Semba, & Kato, 1997). The 
regulatory effects of BDNF on hippocampal neurogenesis are best illustrated by studies showing 
that BDNF infusion into the hippocampus significantly increases neural progenitor proliferation 
(Scharfman et al., 2005), and others showing heterozygous BDNF mice have reduced survival of 
neural progenitor cells (Rossi et al., 2006). Furthermore, deletion of the BDNF receptor tyrosine 
receptor kinase B (TrkB) located on neural progenitor cells reduces hippocampal neurogenesis 
(Li et al., 2008). It is interesting that antidepressant drugs consistently elevate BDNF expression 
in the hippocampus, which suggests that a component of antidepressant action involves 
hippocampal neurogenesis (Zhao, Deng, & Gage, 2008). Extracellular matrix proteins also 
regulate neurogenesis. Perhaps the best studied of these is reelin. Reelin is expressed in the 
hippocampus and cerebellum, where it is released by a subset of GABAergic interneurons.  
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Fig 1-4. The stage of developmental courses in adult hippocampal neurogenesis. Within the 
hippocampal DG, radial glia-like cells represent the pool of neural progenitor cells (NPCs), and 
these cells occupy the SGZ (Seri, Garcia-Verdugo, McEwen, & Alvarez-Buylla, 2001). Radial 
glial-like cells express glial fibrillary acidic protein (GFAP), nestin, and brain lipid binding 
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protein (BLBP) (Ming & Song, 2011). These radial glial-like cells divide asymmetrically to 
produce transiently amplifying progenitor type 2 cells. Type 2 cells are said to represent the 
transition from glial to a neuronal lineage (Steiner et al., 2006). Type 2 cells can be divided into 
type 2A and type 2B cells, which differ in their expression of certain biomarkers. For example, 
type 2A cells express GFAP, nestin, and BLBP, while type 2B cells express nestin, doublecortin 
(DCX), and PSA-NCAM. Overall, type 2 cells represent cells that have committed to a neuronal 
fate.Type 2 cells next give rise to type 3 migratory neuroblasts, representing the population of 
immature postmitotic neurons that mature into the population of resident granule neurons over 
the course of weeks to months. Type 3 neuroblasts maintain their expression of DCX while also 
expressing calretinin. However, as they mature, the expression of DCX and calretinin shifts to a 
pattern of calbindin and NeuN. Adapted from (Kempermann, Song, & Gage, 2015). 
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During neonatal development reelin plays a critical role in cortical lamination, however in the 
postnatal period its role shifts to one involved in mediating a variety of mechanisms involved in 
synaptic plasticity. One such role is in the regulation of hippocampal neurogenesis. Pujadas et al. 
(2010) found that mice overexpressing reelin have a significant increase in DCX-ir granule cells, 
accompanied by increased complexity in their dendrites. Won et al. (2006) demonstrated that 
heterozygous reeler mice show a significant reduction in newborn neurons in the DG.  
In addition to intrinsic factors, extrinsic factors also play a role in the regulation of 
neurogenesis. One of the most consistent findings is that environmental enrichment increases the 
proliferation of neural progenitor cells. Complex environments (access to toys and other 
interactable objects), and social housing all increase hippocampal neurogenesis (Kempermann, 
Kuhn, & Gage, 1997). Voluntary running, such as wheel running, is also reported to increase 
hippocampal neurogenesis (van Praag, Shubert, & Gage, 1999). Finally, antidepressant 
medication is demonstrated to increase the proliferation of neural progenitor cells. Specifically, 
tranylcypromine, reboxetine, fluoxetine, and haloperidol have been shown to increase the 
number of BrdU-labelled progenitor cells in the hippocampus (Malberg, Eisch, Nestler, & 
Duman, 2000). However, the role of hippocampal neurogenesis in depression and antidepressant 
action is far from clear, and this issue will be discussed in further detail below. 
1.10.4. Neurogenesis in Depression 
Animal models of depression repeatedly show that neurogenesis is decreased by exposure 
to chronic stress (Brummelte & Galea, 2010; David et al., 2009: Nestler et al., 2002; Pham, 
Nacher, Hof, & McEwen, 2003; Mayer et al., 2006; Murray, Smith, & Hutson, 2008) and that 
antidepressants and electroconvulsive shock therapy treatment restores this (Czeh et al, 2001; 
Malberg & Duman, 2003; Mayer, 2006; Murray, 2008; Scott, Wojtowicz, & Burnham, 2000). 
Work in our lab has shown that the tricyclic antidepressant imipramine and the tumor necrosis 
factor alpha (TNF-α) inhibitor etanercept restore CORT-induced reductions in hippocampal 
neurogenesis (Brymer et al., 2018; Fenton et al., 2015). The finding that animal models of 
depression decrease hippocampal neurogenesis fits nicely with the well-documented 
hippocampal volume reductions and loss of grey matter seen in depression (Bremner et al., 2000; 
Grieve, Korganokar, Koslow, Gordon, & Williams, 2013). These findings have led to the 
proposal of the neurogenesis hypothesis of depression. This hypothesis posits that depression 
results from a reduction in hippocampal neurogenesis, and that antidepressant medications at 
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least partially work though an increase in hippocampal neurogenesis. However, this hypothesis 
has garnered intense criticism from the field, the most vocal being that to date has been little 
evidence of reductions in hippocampal neurogenesis in post mortem depressed patients. 
Moreover, there are currently no ways to causally test if neurogenesis is involved in depression 
in human patients.  
Müller et al. (2001) and Reif et al. (2006) both failed to find reductions in proliferating 
progenitor cells in the hippocampus. Furthermore, it has been demonstrated that antidepressant 
effects can be achieved without increases in neurogenesis, and ablation of neurogenesis is not 
sufficient to create a depression-like phenotype (Hanson, Owens, & Nemeroff, 2011; Zhao, 
Deng, & Gage, 2008). Recently, Sorrels et al. (2018) found that human hippocampal 
neurogenesis sharply drops from childhood into near undetectable levels in adulthood, boldly 
suggesting that hippocampal neurogenesis does not occur past childhood. One must approach 
these findings with caution, as the samples used in the Sorrels et al. study were obtained from 
epileptic post-mortem tissue. However, counter to this report, Boldrini et al. (2018) report that 
human hippocampal neurogenesis persists throughout aging, even into the 70th year of life. 
Moreover, recent reports have found reductions in hippocampal neurogenesis in post-mortem 
depressed tissue (Boldrini et al., 2012). In an elegant study, Hill et al. (2015) showed that 
increasing hippocampal neurogenesis through transgenic methods alone is sufficient to create an 
antidepressant phenotype. Therefore, a complicated picture of the role of hippocampal 
neurogenesis in depression emerges. It is highly unlikely that hippocampal neurogenesis is 
absent in humans as Sorrels et al. would suggest, however it is also a possibility that 
neurogenesis is not as important in humans as it is in rodents. The development of better imaging 
and staining techniques will inevitably solve the debate as to the true role of hippocampal 
neurogenesis in the pathogenesis of depression.    
1.11. Inflammation and Depression 
The notion that inflammation is a contributing factor in the pathogenesis of depression is 
not a new one. Work in the 1980s’s first revealed that some patients with heightened immune 
activity (e.g., a patient with an intense cold) displayed the hallmark features of depression (i.e., 
lethargy, depressed mood, anhedonia) (Miller and Raison, 2016). This in turn led to the cytokine 
sickness hypothesis of depression, which posits that sustained increases in circulating levels of 
pro-inflammatory cytokines can produce depressive symptoms (Dantzer, 2009). Interestingly, 
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high circulating levels of the pro-inflammatory cytokine IL-6 are strongly associated with 
feelings of guilt and suicidal ideation (O’Donovan et al., 2013). If the cytokine sickness 
hypothesis of depression is correct, then one would expect that disorders characterized by high 
circulating levels of cytokines would share a high comorbidity with depression, and this turns out 
to be the case. For example, rheumatoid arthritis, a disorder in which the immune system targets 
bodily tissues and instigates widespread inflammation, shares a 13-42% comorbidity rate with 
depression (Margaretten et al., 2011). Furthermore, cancer patients treated with cytokines 
experience a significant reduction in plasma tryptophan levels that coincides with depression 
(Capuron et al., 2002). This tryptophan reduction reduces the bioavailability of serotonin, which 
is a known risk factor for the development of depression according to the monoamine 
hypothesis. It was later discovered that the culprit for this decrease in plasma tryptophan levels in 
cancer patients receiving immunotherapy is indoleamine 2,3-dioxygenase (IDO). Activation of 
IDO decreases tryptophan bioavailability, creating a net decrease in monoamines (Danzter, 
2009). Immuno-activation in healthy control subjects creates depression-like behaviour and 
impairments in cognition (Reichenberg et al., 2001), and serum concentrations of interleukin-6 at 
9 years of age is positively correlated with depressive symptomology at 18 years of age 
(Khandaker et al., 2014). Finally, high circulating levels of cytokines are associated with 
treatment-resistant depression (Carvalho et al., 2013).     
Stress is also known to transiently elevate the expression of pro-inflammatory cytokines. 
Unsurprisingly, pro-inflammatory cytokines are efficient activators of the hypothalamic-
pituitary-adrenal (HPA) axis (Kenis & Maes, 2002), which often becomes dysregulated in 
depression. However, as not all depressed patients display a dysregulated HPA axis, it is 
tempting to speculate that elevated levels of pro-inflammatory cytokines occur in a subset of 
depression patients, possibly those patients who develop symptoms after a period of major life 
stressors leading to HPA dysfunction.  
1.11.1.  The role of TNF-α in Depression 
TNF-α is a protein that is initially released as a soluble cytokine (sTNF-α) after being 
enzymatically cleaved by its cell surface bound precursor (tmTNF-α) by TNF-α converting 
enzyme (TACE) (Bortolato, Carvalho, Soczynska, Perini, & McIntyre, 2015) and is therefore 
expressed as a transmembrane protein. TNF-α binds to one of two receptors: TNF receptor 1 
(TNFR1) and TNF receptor 2 (TNFR2). TNFR1 is activated by soluble and transmembrane 
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TNF-α, and promotes inflammation and tissue degeneration (Kalliolias & Ivashkiv, 2016). 
TNFR2’s expression is restricted to neurons, endothelial cells, and immune cells, and is involved 
in mediating cell survival and tissue regeneration (Kalliolias, 2016). sTNF-α possesses a higher 
affinity for binding with TNFR1. When TNF-α binds to TNFRs, complex 1 is assembled at the 
plasma membrane and includes the TNF-α associated death domain protein (TRADD) among 
other complexes resulting in the creation of a scaffolding ubiquitin network (Kalliolias). This 
scaffolding ubiquitin creates the recruitment and activation of 2 signaling complexes: 
transforming growth factor (TGF)-α activated kinase 1 (TAK1) complex and the inhibitor of kB 
(Ikkα) kinase complex (Kalliolias). Activation of TAK1 results in the recruitment of mitogen 
activated kinase (MAPK) signaling cascades resulting in activation of downstream JUN N-
terminal kinase and P38 (Kalliolias). Ikkα activates the canonical nuclear factor KB (NFKB) 
pathway (Kalliolias). Therefore, the pattern of activation that emerges from induction of complex 
1 signaling is one of NFKB and JUN N-terminal kinase and P38 target genes that are responsible 
for inflammation, cell proliferation and survival, and host defense. In contrast, complex II 
signaling results in the activation of necroptosis effector mixed lineage kinase domain like 
protein (MLKL) (Kalliolias) by a RIPK3-dependent mechanism, responsible for TNF-α induced 
cell death via apoptosis. It is currently unclear what factors lead to the activation of complex I 
and resultant inflammatory processes or complex II leading to cell death (Kalliolias).  
 One of the main roles of TNF-α is in maintaining inflammation during times of 
proinflammatory conditions. During proinflammatory events, TNF-α production is induced by 
other cytokines (IL-1) and microglia. Once released, TNF-α stimulates the production of other 
proinflammatory cytokines, including IL-1 and 6, as well as increasing the production of reactive 
oxygen intermediates, including nitric oxide, which in turn creates a feedback loop of enhanced 
inflammation (Bortolato, Carvalho, Soczynska, Perrini, & McIntyre, 2015). It is not surprising 
that increased inflammation as a result of increased TNF-α production results in altered 
glutamatergic signaling and ecotoxicity. TNF-α upregulates glutaminase in astrocytes, decreases 
the conversion from glutamate to glutamine, increases the trafficking of NMDA receptors, and 
promotes long-term depression (LTD) (Bortolato, 2015). Furthermore, TNF-α signaling results 
in the endocytosis of GABAA receptors, resulting in an altered balance between inhibition and 
excitation (Bortolato). Preclinical studies corroborate the role of TNF-α in depression-like  
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Fig 1-4. Induction of complex 1 signaling is one of NFKB and JUN N-terminal kinase and 
P38 target genes that are responsible for inflammation, cell proliferation and survival, and 
host defense. Complex II signaling results in the activation of necroptosis effector mixed 
lineage kinase domain like protein (MLKL) (Kalliolias) by a RIPK3-dependent mechanism, 
responsible for TNF-α induced cell death. Adapted from (Kalliolias & Ivashkiv, 2016) 
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behaviour. Peripheral administration of TNF-α can produce anhedonic behaviour in rodents (van 
Heesch et al., 2013).  Likewise, deletion of TNFR1 or TNFR2 creates an antidepressant 
phenotype on measures of depression-like behaviour (Simen et al., 2006). Yamada, Iida, and 
Miyamoto (2000) showed that TNF-α knockout mice display a mild antidepressant phenotype. 
Along these same lines, administration of the TNF-α inhibitor infliximab during chronic mild 
stress significantly decreased immobility time in the forced swim test, increased sucrose 
consumption during the sucrose preference test, and decreased anxiety-like behaviour in the 
elevated plus maze (Karson et al., 2013).  
Given that pro-inflammatory cytokine treatment produces depression-like behaviour and 
reducing pro-inflammatory cytokine levels alleviates this, the question that arises is whether or 
not antidepressants can influence inflammation. Interestingly, SSRIs and tricyclic 
antidepressants are known to reduce levels of TNF-α and other proinflammatory cytokines and 
increase anti-inflammatory cytokines, including IL-10 (Song et al., 1994). Two potential 
explanations for how antidepressant drugs might reduce pro-inflammatory cytokine levels have 
been offered. The first explanation posits that higher levels of activation of serotonergic 
receptors located on immune cells dynamically regulate the production of pro-and anti-
inflammatory cytokines, and this could be influenced by a higher availability of serotonin upon 
antidepressant treatment, although the pro- or anti- inflammatory effects of peripheral serotonin 
is still under debate (recently reviewed in Herr et al., 2017; see also Kenis & Maes, 2002). The 
second explanation sees the increased production of cyclic adenosine monophosphate (cAMP) 
by antidepressants as a mechanism by which antidepressants might reduce cytokine levels. 
Specifically, cAMP activates protein kinase A (PKA), increasing the production of cAMP 
responsive element binding protein (CREB), both of which act to decrease pro-inflammatory 
cytokine production (Kenis & Maes, 2002). Considerable attention 
has been dedicated to the antidepressant potential of ketamine. Ketamine rapidly reverses 
depression-like behaviour in both clinical and preclinical subjects, in a timeframe of hours 
(Cusin et al., 2012; Yoshi & Constantine-Paton, 2010). An important question asked within the 
literature is whether ketamine is altering neuroinflammation? Although this question is relatively 
recent, it does appear to be the case that at least a component of the antidepressant properties of 
ketamine involve reductions in neuroinflammation, in particular TNF-α. For example, Wang et 
al. (2015) have shown that in chronically-stressed rats, the rapid antidepressant effects of 
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ketamine are accompanied by a reduction of hippocampal TNF-α levels. Moreover, a reduction 
in depressive symptoms 40 minutes post ketamine infusion in depressed patients has been shown 
to be correlated with reductions in serum TNF-α levels (Chen et al., 2018). These findings 
suggest that rapid changes in neuroinflammation, in particular TNF-α, are perhaps one of the 
mechanisms underlying the antidepressant actions of ketamine.  
 In terms of clinical studies, a large body of evidence supports the role of TNF-α in 
depression. Endotoxin administration in control subjects produces an increase in TNF-α in 
addition to depressed mood and cognitive impairment (Della and Hannestad, 2010). Microarray 
mRNA studies demonstrate increased expression of tmTNF-α in the prefrontal cortex (PFC) of 
suicide victims (Pandey et al., 2012). In fact, higher suicidal ideation itself is associated with an 
increased cytokine profile, including elevated TNF-α (O’Donnovan et al., 2013), and high 
circulating levels of TNF-α are found in peripheral tissues of suicide victims (Lindqvist et al., 
2009). Several lines of evidence support the efficacy of TNF-α inhibitors in the treatment of 
depression. Patients with rheumatoid arthritis and plaque psoriasis taking prescribed etanercept, 
which is a TNF-α antagonist, reported significant reductions in depressive symptoms (Kekow et 
al., 2011; Gelfand et al., 2008). Similarly, patients with Crohns Disease receiving infusions of 
infliximab experienced significant reductions in depressive symptoms and this decrease was 
associated with corresponding reductions in proinflammatory cytokines (Guloksuz et al., 2013). 
Finally, psoriasis patients with comorbid psychiatric conditions report improvement in mood and 
overall well-being when taking infliximab (Bassukas et al., 2008). Interestingly, inflammation 
itself is associated with anhedonia, and one of the first symptoms to be alleviated in depressed 
patients receiving anti-inflammatory compounds is anhedonia (Felger et al., 2016).  
Some interesting extensions of these clinical studies have been observed in patients with 
treatment-resistant depression. Raison et al. (2013) reported that patients with treatment -
resistant depression with a high baseline level of inflammation as indicated by elevated high 
sensitivity C-reactive protein expression responded favorably to infusions of the TNF-α inhibitor 
infliximab. However, in patients with a low baseline level of high sensitivity C-reactive protein 
infliximab was not more effective than placebo. This pattern of results suggests that subsets of 
treatment-resistant patients experience high levels of inflammation, and therapies aimed at 
reducing inflammation might be particularly effective in these patients. However, other patients 
may have a different physiological profile such that factors other than inflammation are at play. 
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This conclusion is consistent with the observation that two depressed patients can present with a 
different cluster of symptoms. For example, patient A could present with agitation, weight loss, 
an inability to sleep, and lowered mood, whereas patient B presents with weight gain, excess 
sleep, psychomotor retardation, and anhedonia. This raises the question (asked elsewhere; see 
Nestler, 2010) of whether depression is actually part of a constellation of different disorders. It is 
tempting to suggest that depressed patients with inflammation might represent a subset of 
depressed patients who require a different course of treatment compared to their non-inflamed 
counterparts. Kappelmann et al. (2016) conducted a meta-analysis of the effectiveness of anti-
cytokine treatments in depression. They found that across 7 double-blind clinical trials involving 
1309 subjects, anti-cytokine treatment was generally more efficacious than treatment with 
placebo. Of interest is the fact that several research groups have reported that currently available 
non-cytokine antidepressant medications are not more effective than placebo, at least in the 
treatment of non-severe depression (Fournier et al., 2010; Garland, 2004; Kirsch et al., 2008). 
Therefore, treatments that target inflammation might represent a more viable approach to the 
treatment of depression, as the monoamine hypothesis of depression largely does not align with 
what is currently known about the biological causes of depression. Of the anti-cytokine 
treatments analyzed, Kapplemann et al. (2016) reported that anti-TNF-α drugs were the most 
commonly used option. The picture that emerges is that depression is associated with elevations 
in TNF-α, and treatments aimed at reducing circulating TNF-α produce significant normalization 
of depressive symptoms. In the next section, we elaborate on some putative mechanisms 
underlying the antidepressant effect of TNF-α antagonists. 
Peripheral injection of TNF-α antagonists (i.e., etanercept) causes a functional decrease 
in peripheral TNF-α with only an indirect effect on central TNF-α expression, as drugs like 
etanercept cannot cross the blood brain barrier (Boado et al., 2010). Therefore, it has been 
assumed that drugs like etanercept are only able to indirectly reduce central inflammation as a 
consequence of reduced peripheral TNF-α activity (Kerfoot et al., 2006). However, TNF-α per se 
can cross the blood brain barrier by a receptor mediated mechanism (Pan & Kastin., 2001, 2002; 
Pan et al., 2006), and when this occurs, it instigates an increase of both TNF-α protein and 
mRNA by stimulating central expression of TNF-α by microglial cells (Qin et al., 2007; McCoy 
and Tansey., 2008). Peripheral TNF-α also can stimulate secretion of TNF-α from 
circumventricular organs and choroid plexus, and TNF-α secreted by these organs can then 
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induce the activation of microglia and a subsequent increase in TNF-α secretion by microglial 
cells (Qin et al., 2007; McCoy and Tansey., 2008). As stated, etanercept does not cross the blood 
brain barrier but it binds peripheral TNF-α, and in doing so, it reduces the effect of peripheral 
TNF-α in promoting the activation of microglia, which results in decreased secretion of central 
TNF-α.  
 High circulating levels of TNF-α are associated with significant reductions in cognitive 
functioning. Hennesey et al. (2017) showed that systemic TNF-α injections produced deficits on 
the Morris Water maze and T-maze. High circulating levels of TNF-α were found to be 
negatively correlated with delayed performance on the Rey Auditory Verbal Learning Test in 
bipolar patients (Doganavsargil-Baysal et al., 2013). In older adults, post-operative cognitive 
decline following surgery is common. Terrando et al. (2010) showed that post-operative 
cognitive decline is accompanied by an increased peripheral production of TNF-α and a 
subsequent increased production of other proinflammatory cytokines. Sahin et al. (2015), using 
the chronic mild stress paradigm, investigated the effects of TNF-α inhibition on cognitive 
functioning and hippocampal BDNF levels. Infliximab administration reversed stress-induced 
deficits on the Morris water maze and passive avoidance test, and this was accompanied by an 
increase in hippocampal BDNF levels. Importantly, work in our lab has demonstrated that TNF-
α is critically involved in hippocampal dependent memory. Repeated CORT injections impair 
hippocampal-dependent object-location memory and produce depression-like behaviour, and 
peripheral etanercept injections restore object-location memory performance to control levels 
and reverse depression-like behaviour. These results will be discussed in further detail in Chapter 
3. From the research described above it is clear that TNF-α is involved in the regulation of 
cognitive functioning, in particular hippocampal dependent memory. It is currently unclear as to 
how high circulating levels of TNF-α are impacting cognitive functioning. An interesting 
hypothesis (and one further detailed in chapter 3) is that repeated corticosterone injections 
increase TNF-α levels in the periphery, which in turn increases central TNF-α expression. This 
increased expression of TNF-α reduces hippocampal reelin expression which contributes to 
cognitive dysfunction. A rescuing of reelin expression by the TNF-α inhibitor etanercept then 
restores cognitive performance.  
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1.11.  Reelin and its role in Depression 
Reelin is an extracellular matrix protein involved in the development of the nervous system 
and in functions that promote synaptic plasticity. During development, reelin is secreted by cajal 
retzius cells and cerebellar granule cells, however in the postnatal brain reelin is released by 
GABAergic interneurons located in the hippocampus and cortex. Reelin is cleaved by 
metalloproteases at two specific sites, which leads to the generation of 3 large fragments, 
composed of a N-terminal, central fragment, and a C-terminal. The C terminal by itself can 
initiate intracellular signaling (Lee & D’Arcangelo, 2016). Reelin is approximately 385 kDA, 
and is composed of a single peptide, a N-terminal sequence, and a hinge region of 8 reelin 
repeats containing 350-390 amino acids (Fatemi, 2005). Each of these reelin repeats is itself 
composed of 2 sub repeats separated by an EGF motif. This reelin protein structure ends with a 
C-terminus that is composed of 33 amino acids (Fatemi).  
Reelin binds to 2 receptors, apolipoportein E receptor 2 (ApoER2), and very-low density 
lipoprotein receptor (VLDL-R), which belong to the low-density lipoprotein receptor (LDLR) 
family (Lee & D’Arcangelo, 2016). Reelin binding to these 2 receptors results in their clustering, 
which itself leads to the dimerization/oligomerization of the adapter protein disabled-1 (Dab-1) 
through tyrosine phosphorylation. Dab-1 is critical for the transduction of reelin signaling, and it 
binds to the cytoplasmic tail of both ApoER2 and VLDR-R (Lee, 2016). Once Dab-1 becomes 
activated the recruitment of SRC family tyrosine kinases (SFKs) to Dab-1 begins. The resulting 
high concentration of SFKs then triggers a cytosolic kinase cascade (Lee), which includes 
phosphatidylinositol-3-kinase (PI3K) and the inhibition of glycogen synthase kinase 3α (GSK3α) 
(Lee). Finally, the recruitment of ubiquitin ligases to now phosphorylated Dab-1 
polyubiquitylationates Dab-1, leading to the termination of the signal and both ApoER2 and 
VLDL-R are recycled back to the membrane (Lee).  
The best known functions of reelin are perhaps its role in cortical lamination and brain 
development. This is best illustrated by the reeler mouse, where a mutation during development 
leads to decreased levels of reelin in the cerebellum and hippocampus. The brains of these mice 
fail to display a granule cell layer in the dentate gyrus, have dispersed neurons in multiple 
cortical layers, have impaired dendrite outgrowth, and have a decreased cerebellar size (Fatemi, 
2005). While reelin was initially investigated for its role in development, the finding that reelin is 
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preferentially expressed by GABAergic interneurons in the adult cortex and hippocampus led to 
investigations into the role of reelin in postnatal development. These investigations revealed that  
 
Fig 1-5. Reelin has differential effects on synaptic function and neural development 
depending on the time in development it is released. During neonatal development, reelin is 
involved in neuronal migration and lamination. However, after development reelin switches 
roles to one focused on promoting dendrite and spine development and synaptic function. 
Adapted from (Lee & D’Arcangelo, 2016) 
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reelin is critically involved in the control of dendrite and spine development, and synaptic 
function. It is likely that P13K and akt are the main contributors to the effects of reelin on 
dendrite development, which are activated by reelin’s effects on Dab-1 activity, which in turn 
activates SFKs. The downstream targets of akt include mammalian target of rampomycin 
(mTOR), which is shown to be activated by reelin treatment in neuronal cultures and is also 
involved in reelin’s effects on dendrite development (Lee & D’Arcangelo, 2016). This is best 
illustrated by a report from Jaworski, Spangler, Seeburg, Hoogenraad, and Sheng (2005) which 
showed that inactivation of either PI3K or mTOR reduced dendritic complexity in neuronal 
cultures. Moreover, Lim and Walikonis (2008) showed that hepatocyte growth factor increased 
neurite length and this outgrowth was accompanied by akt activation. Blockade of the PI3K/akt 
signalling pathway inhibited the hepatocyte growth factor induced increase in neurite outgrowth. 
These results suggest that the downstream targets of reelin, the PI3K/akt and mTOR pathways, 
are critically involved in promoting dendritic outgrowth and inhibitors of these pathways impairs 
this process.  
In addition to promoting dendritic outgrowth, reelin is also involved in key aspects of 
synaptic function. For example, reelin is involved in the promotion of hippocampal long-term 
potentiation (LTP). This enhancement of hippocampal LTP requires both the ApoER2 and 
VLDL-R receptors, as ApoER2 and VLDL-R knockout mice display reduced hippocampal LTP 
(Weeber et al., 2002). These ApoER2 and VLDL-R knockout mice also display deficits in 
contextual fear conditioning. One way that reelin and its receptor ApoER2 act to enhance LTP is 
through ApoER2’s interaction with NDMAR and PSD-95, which mediates a reelin induced 
calcium++ influx through NMDAR’s (Lee & D’Arcangelo, 2016). Reelin also requires the 
presence of phosphorylated Dab-1 for its enhancement of LTP. For example, Trotter et al. (2013) 
showed that Dab-1 knockout mice display deficits in LTP and spatial memory, as well as 
reductions in dendritic spine size. Finally, Rogers et al. (2011) have shown that reelin 
supplementation enhances hippocampal LTP and learning and memory in naïve mice.  
Preclinical studies have implicated deficits in reelin signalling in the pathogenesis of 
psychiatric disorders, in particular depression. For example, work in our lab has shown that 
repeated CORT injections significantly reduced the number of reelin positive cells in the SGZ of 
the hippocampus, while restraint stress had no effect (Lussier et al., 2009). In another study, we 
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showed that the onset of depression-like behaviour in CORT-treated rats is paralleled by a 
reduction in reelin positive cells in the SGZ (Lussier et al., 2013a). This suggests that a loss of 
reelin expression in the hippocampus contributes to depression-like behaviour, and we would 
expect that animals lacking reelin would show depression-like behaviour. Heterozygous reeler 
mice, which express 50% of the normal levels of reelin, provide a way to approach this question. 
Our lab has shown that heterozygous reeler mice, while not spontaneously displaying 
depression-like behaviour, are in fact more susceptible to the depressogenic effects of CORT 
injections than are wild type mice. If loss of reelin is a risk factor for the development of 
depression in animal models, then it might be expected that one mechanism of antidepressants is 
to enhance hippocampal reelin expression. Work in our lab has shown that the tricyclic 
antidepressant imipramine restores CORT-induced reductions in hippocampal reelin expression 
(Fenton et al., 2015). Furthermore, we have shown that the TNF-α inhibitor etanercept can also 
alleviate CORT-induced reductions in hippocampal reelin expression (Brymer et al., 2018). This 
finding that etanercept restores reelin expression will be discussed more in Chapter 3. Teixeira et 
al. (2011) showed through overexpression that reelin prevents the behavioural manifestation of 
both bipolar disorder and schizophrenia. In terms of clinical studies, Fatemi et al. (2000) found 
that reelin expression was decreased in the CA4 region of the hippocampus in post-mortem 
depressed brains. Furthermore, a decrease in reelin and glutamic acid decarboxylase67 (GAD67) 
was found in the brains of post-mortem schizophrenia and bipolar disorder patients (Guidotti et 
al., 2000).  
A question that remains to be answered is can reelin supplementation reverse the 
depression-like behaviour induced by repeated CORT treatment? Given that CORT treatment 
reduces hippocampal reelin expression, it would be hypothesized that reelin supplementation 
would reverse depression-like behaviour. This question will be addressed in Chapter 4 and 5 of 
the current dissertation. 
In addition to reelin’s role in depression-like behaviour, reelin also plays significant roles 
in learning and memory. For example, as noted above reelin supplementation in naïve mice 
enhances learning and memory (Rogers et al., 2011). Reelin has been demonstrated to recover 
synaptic function and spatial learning and memory in a mouse model of Angelman syndrome 
(Hethorn et al., 2015). Pujadas et al (2014) reported that overexpression of reelin delayed the 
formation of amyloid beta fibrils and rescued deficits of recognition memory in a mouse model 
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of Alzheimer’s disease. Heterozygous reeler mice display a deficit in contextual fear 
conditioning as well as LTP (Qiu et al., 2006). Importantly, reelin supplementation in 
heterozygous reeler mice was shown to recover contextual fear conditioning deficits, suggesting 
that reelin is critically involved in learning and memory (Rogers et al., 2013). It is likely that the 
mechanism behind reelin effects on enhancing learning and memory lies in reelin’s robust ability 
to restore hippocampal LTP, as disrupting the reelin signaling pathway disrupts LTP and 
produces corresponding hippocampal dependent memory deficits. Chapter 4 will explore the 
ability of reelin supplementation to restore CORT-induced deficits in object location memory, a 
hippocampal dependent form of memory.  
1.13.   Glutamate and its role in Depression 
Glutamate is the primary excitatory neurotransmitter present in vertebrate nervous systems. 
While the importance of glutamate was recognized for decades, it was not until the 1970s that 
glutamate was acknowledged as a neurotransmitter. Glutamate is distributed throughout the 
central nervous system and spinal cord where it acts to promote rapid neurotransmission. 
Glutamate is released from vesicles in presynaptic terminals through a CA++ mechanism (Hackett 
& Ueda, 2015). Glutamate plays major roles in brain development, neuronal survival, and axon 
genesis (Dang & Hashimoto, 2014). Once released, glutamate acts on both ionotropic and 
metabotropic glutamate receptors. The ionotropic glutamate receptors include a-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), N-Methyl-d-asparate (NMDA), kainate, 
and d receptors. Metabotropic glutamate receptors are G protein linked and have seven trans-
membrane domains including an extracellular N-terminal and an intracellular COOH terminal 
(Meldrum, 2000). They are composed of 7 subunits, mGluR1-mGluR7. In contrast to the fast-
acting actions of ionotropic receptors, metabotropic glutamate receptors are involved in complex, 
longer-acting signaling cascades.  
AMPA receptors are composed of 4 subunits, including GluA1, GluA2, GluA3, and 
GluA4. All of the GluA1-4 subunits form both homo and heteromers (Traynelis et al., 2010). 
Kainate subunits include GluK1, GluK2, GluK3, GluK4, and GluK5, and the subunits GluK1-
GluK3 form both homo and heteromers (Traynelis, 2010). The NMDA subunits are composed of 
GluN1, GluN2A-GluN2D, GluN3A, and GluN3B. NMDA receptors are characterized by a 
voltage sensitive block by magnesium, which is removed upon depolarization (Traynelis). d 
subunits include GluD1 and GluD2.  
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Both AMPA and NMDA receptors are particularly pertinent to the study of depression, due 
to their well-established roles in learning and memory, stress, and neurotoxicity. AMPARs are 
responsible for the majority of fast excitatory synaptic transmission in the central nervous system 
(Krugers, Hoogenraad, & Groc, 2010). AMPARs are first synthesized in the neuronal cell body, 
and eventually reach their synaptic targets through the motor protein dynein, which aids in the 
sorting of AMPA into dendrites (Krugers, 2010). Once inside dendrites, AMPARs are trafficked 
to and from the synapse by exocytotic and endocytic recycling through both intracellular and 
extracellular receptor pools, and surface diffusion between extrasynaptic and synaptic receptor 
pools (Krugers).  
Contextual learning, where animals learn information regarding a specific context, 
increases the number GluA subunits in the synapses of hippocampal neurons (Krugers, 
Hoogenraad, & Groc, 2010), suggesting that learning in the hippocampus is accompanied by 
corresponding changes in AMAPR trafficking. AMPARs are especially involved in the 
regulation of spatial learning and memory. For example, GluA1-knockout mice display profound 
deficits on the Morris water maze task (Sanderson et al., 2010). Interestingly, these same animals 
display normal acquisition of spatial reference memory tasks. Sanderson et al. (2009) further 
explored this relationship, showing that GluA1 knockout mice display degraded performance on 
the novelty preference test if the interval between training and testing was short (< 1 hour) but 
enhanced performance if the interval was long (<24 hours). To examine the specificity of this 
spatial memory deficit, Sanderson et al. (2011) examined the ability of GluA1 knockout mice to 
learn spatial discrimination tasks. Surprisingly, GluA1 knockout mice performed like controls on 
spatial discrimination tasks, however deficits emerged in purely spatial memory tasks. This 
pattern of results suggests that perhaps the role of AMPARs in spatial memory is more related to 
spatial working memory, which does not appear to be affected, and the deficit lies in spatial 
long-term memory. Given the roles of AMPARs in learning and memory, it is not surprising that 
disruptions to AMPARs produce alterations in LTP. For example, Selcher, Xu, Hanson, 
Melenka, and Madison (2012) showed that GluA1 knockout mice displayed reductions in 
hippocampal LTP in the CA1 region.  
Animal models demonstrate that exposure to stress results in alterations in the expression 
of AMPARs. Caudal et al. (2010) showed that inescapable stress decreases phosphorylation of 
the AMPA receptor Ser831-GluA1 within both the prefrontal cortex (PFC) and hippocampus, 
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and decreases phosphorylation in the amygdala (Caudal et al., 2010). Furthermore, stress induces 
a selective decrease in AMPA receptor mediated synaptic excitation at hippocampal CA1 
synapses (Kallarackal et al., 2013). Interestingly, in a recent study by Zanos et al. (2016), the 
fast-acting antidepressant effects of the ketamine metabolite (2R, 6R) – HNK were associated 
with increased phosphorylation of AMPARs (α-amino-3-hydroxy-5-methyl-4-isoxazole 
propionic acid receptors). Along these same lines, Chourbaji et al. (2008) showed that targeted 
deletion of the GluA1 subunit in mice creates a depression-like phenotype. This pattern of results 
suggests that ionotropic glutamate receptors are critically involved in the pathogenesis of 
depression, and inactivation of these receptors results in depression-like behaviour per se. The 
idea of glutamate receptors playing contributive roles in depression will be explored in greater 
detail in Chapter 5.  
NMDA receptors are heterotetramers that contain two GluN1 subunits and two GluN2 or 
GluN3 subunits, which forms a CA++ ion channel. (Vyklicky et al., 2014). NMDA receptor 
activation requires two molecules of glycine and glutamate (Vyklicky, 2014). The different 
NMDA subunits are each composed of 4 functional domains: an amino-terminal extracellular 
domain, a ligand-binding domain, a carboxyl tail domain in the intracellular region, and a 
transmembrane region (Flores-Soto et al., 2012). Both in vitro and in vivo work show that 
chronic NMDA receptor activation leads to excitotoxic cell death. Therefore, physiological 
regulation of NMDA receptor activation is a tightly controlled process.  
NMDA receptors are critically involved in the regulation of learning and memory. 
Constantine-Paton (1994) suggest that the NMDA system is important for the induction of 
memory formation, but not maintenance. This is best exemplified in studies of learning and 
memory in humans, where NMDA receptor blockade before learning a task resulted in impaired 
memory, but NMDA receptor blockade after learning a task had no effect (Hadj Tahar, Blanchet, 
& Doyon, 2004). Systemic NMDA administration in rats has been shown to have a potentiating 
effect on cognitive functions, in particular spatial learning (Hlinak & Krejci, 2002), and genetic 
overexpression achieves the same effect. Along the same lines, mice lacking the NMDA receptor 
subunit GLUN2A have reduced hippocampal LTP and impaired spatial learning (Sakimura et al., 
1995), and mice without NMDA receptors in the hippocampal CA1 present with deficient LTP 
and profound deficits in both spatial and non-spatial learning (Shimizu, Tang, Rampon, & Tsien,  
2000). Unsurprisingly, systemic administration of NMDA receptor antagonists has been shown 
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to impair performance on tasks reliant on the amygdala and hippocampus, for example 
acquisition of the Morris water maze (Heale & Harley, 1990). Finally, either controlled or 
recreational use of the NMDA receptor antagonist ketamine produces cognitive deficits similar 
to those observed in schizophrenia (Honey et al., 2005). Given that NMDA receptors are 
involved in learning and memory, it is not surprising that NMDA receptors are also implicated in 
the pathogenesis of depression.  
NMDA receptor systems are increasingly being recognized as a potential therapeutic target 
in the treatment of depressive symptomology. Olfactory bulbectomy in rodents leads to 
depression-like behaviour, and this is paralleled by decreased NMDA receptor density in the 
cerebral cortex and amygdala (Ho et al., 2001). The Flinders Sensitive Line rats, which develop 
depression spontaneously, exhibit reduced expression of the NMDA receptor GLUN2A subunit 
in addition to BDNF within the hippocampus (Ryan et al., 2009). Stress is also concomitant with 
an upregulation of hippocampal GLUN2B expression within the molecular layer (Calabrese et 
al., 2012; Ciu et al., 2012; Kreutz & Sala, 2012). Importantly, prolonged elevated GLUN2B 
expression drives excitotoxicity: in vitro work demonstrates that elevated GLUN2B leads to a 
rapid influx of calcium ions into the cell, trigging an excitotoxic event (Von Engelhardt et al., 
2007). This in turn can lead to inflammation or atrophy of the hippocampus, paralleling the 
reductions in hippocampal volume observed in depressed patients (Bremner et al., 2000). The 
important distinction here is that while transiently elevated levels of GLUN2B might confer 
beneficial effects in the nervous system, prolonged elevation of GLUN2B has deleterious 
consequences on the healthy functioning of the organism. Clinical studies report higher serum 
levels of glutamate in the blood and cerebrospinal fluid of patients with depression. Interestingly, 
there is a positive correlation between glutamate levels and the severity of depression, such that 
increased levels of glutamate correspond with increased depression symptomology (Mitani et al., 
2006). Furthermore, the brains of depressed patients reveal increased glutamate levels in the 
frontal cortex (Hashimoto, Sawa, & Iyo, 2007). 
If depression is associated with elevated levels of glutamate, in particular the NMDA 
receptor, which could correspond to increased excitotoxity, then it would be expected that 
compounds that reduce glutamate levels would have antidepressant properties. Ketamine, a 
NMDA receptor antagonist, decreases immobility time in the FST and tail suspension test (Silva, 
et al., 2010). In humans, a single sub-anesthetic dose of ketamine can result in depression 
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symptom remission in as little as 2 hours, and the effects persist for as long as 7 days 
(Diazgranados et al., 2010). AZD6765 and memantine, both members of the NMDA receptor 
antagonist family, achieve similar antidepressant effects in animal models of depression. 
However, a problem facing these compounds is that their administration can result in acute 
effects similar to the symptoms of schizophrenia. Ro25-6891, a compound specific for the 
GluN2B subunit, significantly decreases immobility time in the FST without producing the 
unwanted side effects observed with ketamine (Maeng et al., 2008). Therefore, what emerges is 
that the NMDA receptor and its subunits are consistently elevated in depression, and compounds 
that act to reduce these levels confer antidepressant effects. The role of NMDA receptors in the 
CORT model of depression and the impact of reelin on these will be explored in Chapter 4.  
1.14.   Specific aims and goals 
The goal of the research presented in this dissertation was to investigate the antidepressant 
potential of TNF-α receptor inhibition and reelin on neurobiological and behavioural markers 
using the CORT model of depression. In order to address these issues, I conducted a series of 
experiments: 
Experiment 1: Repeated CORT administration reliably increases depression-like 
behaviour on the FST. However, the majority of previous research conducted using the CORT 
model of depression has either examined changes in depression-like behaviour or on 
neurobiological markers (e.g., reelin). What has been missing from the literature is an 
examination of the effects of CORT administration on tests of cognitive functioning. As over 
two-thirds of depressed patients experience cognitive dysfunction, this is an important gap to be 
addressed using this model. To examine this issue, I examined the effects of repeated CORT 
injections (21 days, 40 mg/kg) in male rats on the FST. I then investigated potential alterations in 
memory performance as a result of CORT exposure, specifically by using the object-recognition, 
object-location, and object-in-place memory tests. Finally, I also investigated the effects of 
CORT treatment on the acoustic startle response using prepulse inhibition testing.  
Hypothesis: I predicted that repeated CORT injections would increase depression-like 
behaviour on the FST. I also expected that CORT treatment would impair performance on both 
the object-location and object-in-place memory tests, but not on the object-recognition test. The 
rationale for these predictions was that the object-location and object-in-place memory tests are 
reliant on the hippocampus and PFC, respectively, which show alterations in structural plasticity 
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in response to stress. However, the perirhinal cortex, which is implicated in performance on the 
object-recognition memory test, is less involved in depression. Finally, I predicted that repeated 
CORT injections would produce impairments on prepulse inhibition test, specifically through a 
reduction in startle response.  
Experiment 2: Chronic stress leads to a significant increase in the expression of cytokines 
in the peripheral and central nervous system. Unsurprisingly, depression is frequently comorbid 
with autoimmune disorders, for example rheumatoid arthritis (Margaretten et al., 2011). The 
expression of pro-inflammatory cytokines, which promote inflammation, are increased after 
chronic stress, whereas the expression of anti-inflammatory cytokines, which act to decrease 
inflammation, are decreased. In particular, the pro-inflammatory cytokine TNF-α is consistently 
elevated after chronic stress. Within the nervous system, TNF-α has a variety of functions, 
including modulating cell recruitment and proliferation, and cell death. Under conditions of 
stress, TNF-α participates in promoting inflammation through stimulating the production of other 
pro-inflammatory cytokines, including IL-1 and IL-6. Elevated levels of TNF-α produce a wide 
range of deleterious effects on physiology, emotional behaviour, and cognition (Bortolato et al., 
2015). Inflammation also serves to decrease reelin expression, which is involved in promoting 
synaptic plasticity and learning and memory. Rats received 21 days of CORT (40 mg/kg) or 
vehicle injections and half the rats in each group also received semi-weekly injection of the 
TNF-α inhibitor etanercept (0.8 mg/kg) (Inglis et al., 2005). We then assessed depression-like 
behaviour using the forced-swim test (FST), cognition using the novel object-location and 
object- in-place tests, and alterations in hippocampal neurogenesis, reelin, and GABAA β2/3 
receptors using immunohistochemistry. 
Hypothesis: I expected that repeated CORT injections would increase depression-like 
behaviour on the FST, impair both object-location and object-in-place memory, and decrease 
hippocampal neurogenesis, reelin expression, and GABAA-ir cell numbers. Furthermore, I 
predicted that etanercept administration would act to reverse the above changes, through an 
increase in hippocampal reelin expression.  
Experiment 3: Repeated CORT injections have been shown to reduce hippocampal reelin 
expression (Lussier et al., 2013a). Furthermore, post-mortem investigations of depressed brains 
have shown reduced reelin expression in the CA4 (Fatemi et al., 2000). The antidepressant 
imipramine has been shown to recover CORT-induced reductions in hippocampal reelin 
 54 
expression (Fenton et al., 2015). Reelin is an extracellular matrix protein involved in 
synaptogenesis, promoting contacts onto dendritic spines, neurogenesis, and learning and 
memory. Therefore, I examined the antidepressant potential of intrahippocampal infusion of 
exogenous reelin. To address this question, I conducted stereotaxic surgery to implant an 
indwelling cannula into the dorsal hippocampus of male rats. Rodents then received 21 days of 
repeated CORT (40 mg/kg) or vehicle injections. A subset of rats received an intrahippocampal 
reelin infusion (1 µg/µl) on days 7, 14, and 21 of CORT injections, or only on day 21. Rodents 
then underwent the FST on day 22. A subset of rats were immediately sacrificed after completing 
the FST, while another subset went on to complete the object-location memory test. We then 
assessed changes in hippocampal neurogenesis, GluA1 cell counts in the SGZ, GluN2B 
expression throughout the major subfields of the DG, and changes in GABAA β2/3 ir cells in the 
SGZ. 
Hypothesis: I predicted that repeated CORT treatment would increase depression-like 
behaviour on the FST. As reelin expression is decreased by repeated CORT treatment and this 
change parallels the development of depression-like behaviour, I expected that reelin infusions 
would significantly reverse depression-like behaviour in the FST. I also predicted that CORT 
would impair performance on the object-location memory test, and that reelin would rescue this. 
I expected that CORT would decrease hippocampal neurogenesis, the number of GluA1-ir cells 
in the SGZ, increase the expression of GluN2B throughout the DG, and decrease the number of 
GABAA β2/3-ir cells in the SGZ. As reelin is involved in the regulation of neurogenesis and 
participates in glutamatergic neurotransmission, I expected that reelin would reverse the above 
described changes.  
 Experiment 4: As my previous study (Chapter 4) indicated that reelin has fast-acting 
antidepressant effects that are accompanied by an increase in the number of GluA1-ir cells in the 
SGZ, I was interested in examining if the antidepressant effect of reelin requires a contribution of 
AMPA signaling. To address this question, I conducted stereotaxic surgery to implant an 
indwelling cannula into the dorsal hippocampus of male rats. Rodents then received 21 days of 
either repeated CORT (40 mg/kg) or vehicle injections. A subset of rats received a single 
intrahippocampal reelin infusion (1 µg/µl) on day 21 of injections. Another subset of rats that 
received reelin also received an intrahippocampal CNQX (AMPA antagonist) infusion (1.25 
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µg/µl) immediately before the FST. Post-mortem investigation of hippocampal neurogenesis, 
fos, and microglia morphology was then conducted.  
 Hypothesis: As intrahippocampal reelin infusions produce a fast-acting antidepressant 
effect that is accompanied by an increase of GluA1-ir cells in the SGZ, I predicted that infusion 
of CNQX in reelin-treated animals would abolish reelin’s effects on the FST. I further predicted 
that CNQX would not alter reelin’s effects on hippocampal neurogenesis, as not enough time 
will have elapsed between the reelin and CNQX infusion to produce an effect. In terms of Fos, I  
predicted that reelin would increase the number of Fos + cells in the SGZ active during the FST, 
and CNQX would decrease this. Finally, I predicted that reelin would shift the morphology of 
microglia away from an active phenotype into a more ramified phenotype, with CNQX then 
reversing this effect. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 56 
CHAPTER 2 
 
SELECTIVE DEFICITS IN OBJECT RECOGNITION MEMORY AND PREPULSE 
INHIBITION PRODUCED BY REPEATED CORTICOSTERONE IN RATS 
 
Kyle J Brymer1, Erin Y Fenton2, John G Howland3, Hector J Caruncho4 & Lisa E Kalynchuk4 
1 Department of Psychology, University of Saskatchewan, Saskatoon, SK S7N 5A5, Canada  
2 College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK S7N 5A5 
3 Department of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5A5, Canada  
4 Division of Medical Sciences, University of Victoria, Victoria, BC, Canada 
 
 
 
Kyle J Brymer was involved in the design of the experiment, conducting all aspects of the experiment, analyzing the 
data, and writing up the manuscript. Erin Y Fenton was involved in assisting in conducting the experiment. John G 
Howland was involved in planning the experimental design as well as lending the use of several materials necessary 
to conduct the experiments listed. Hector J Caruncho and Lisa E Kalynchuk were involved in planning the 
experimental design and formulating the manuscript. The current chapter was included in the dissertation as the 
behavioural tests described here (in particular the object-location memory tests) make up key components of the 
experiments of subsequent chapters in this dissertation. 
 
 
 
 
 
 
 57 
Abstract 
The symptoms of human depression often include cognitive deficits. However, cognitive 
behaviour is not typically included in the behavioural assessments conducted in preclinical 
models of depression. For example, it is well known that repeated corticosterone injections in 
rodents produce depression-like behaviour as measured by the forced swim test, sucrose 
preference test, and tail suspension tests, but the cognitive impairments produced by 
corticosterone have not been thoroughly examined. The purpose of this experiment was to assess 
the effect of repeated corticosterone injections on several versions of object recognition memory 
and prepulse inhibition, along with the more traditional assessment of depression-like behaviour 
using the forced swim test. Rats received 21 days of corticosterone (40 mg/kg) or vehicle 
injections followed by a battery of behavioural tests. Corticosterone decreased body weight and 
increased immobility in the forced swim test and lowered startle amplitudes and prepulse-
facilitation to 30-ms prepulse-pulse intervals. Corticosterone also impaired both object location 
and object-in-place recognition memory, while sparing performance on object recognition 
memory. Collectively, our data suggest that CORT produces selective disruptions in prepulse 
inhibition, object location, and object-in-place recognition memory, and that these cognitive 
impairments should be taken into account as part of the depressive phenotype produced by 
chronic stress. 
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1. Introduction  
 Depression is a debilitating psychiatric disorder estimated to be the leading cause of 
disease burden worldwide by 2030 (Willner, Scheel-Kruger, & Belzung, 2013). (Kendler & 
Gardner, 2010). Exposure to chronic stress is a significant risk factor in the development of 
depression (Kendler & Gardner, 2010). To better understand the neurobiological bases of 
depression, preclinical animal models have been developed that expose rodents to extended 
periods of chronic stress or glucocorticoid exposure followed by an assessment of the resulting 
changes in behaviour and neurobiology. These models provide the opportunity to relate specific 
aspects of a depressive phenotype to distinct neurobiological changes, which informs our 
understanding of the neurobiological consequences of stress and also our insight about the 
fundamental biological causes of depressive disorders.  
Experiments using animal models of depression have demonstrated robust changes in the 
brain cytoarchitecture in response to stress that mirror some aspects of human depression. For 
example, both human patients and rodents from preclinical models of depression display reduced 
hippocampal volume, dendritic atrophy in the hippocampus and prefrontal cortex, and decreased 
hippocampal neurogenesis manifested as reduced cell proliferation and survival (Jacobs, Praag, 
& Gage, 2000; Lussuer et al., 2013a; Sahay & Hen, 2007; Synder, Soumier, Brewer, Pickel, & 
Cameron, 2011). Paralleling the stress-induced alterations in brain structure and function are 
deficits in cognition. In the clinical literature, depressed patients often show impaired working 
memory and attention, executive dysfunction, and dampened processing speed and recall of new 
information(Kizilbash, Vanderploeg, & Curtiss, 2002; Papazacharias & Nardini, 2012). This has 
not been fully examined in preclinical models, but there is evidence that deficits in the Morris 
water maze (Warner et al., 2013) and context-object discrimination (Czerniawski, Miyashita, 
Lewandowski, & Guzowski, 2015) are produced in response to chronic, but not acute, stress. 
Many of the tasks described above rely on the integrity of the hippocampus, which 
unsurprisingly is particularly sensitive to the deleterious effects of chronic stress in both humans 
and rodents (Conrad, 2008).  
Work in our lab utilizes the repeated corticosterone (CORT) model of depression to 
investigate the effects of stress on the hippocampus. The repeated CORT paradigm is a well-
validated model of depression involving 21 days of repeated subcutaneous CORT injections (40 
mg/kg), which reliably increase depression-like behaviour on the forced swim test (FST) and 
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sucrose preference test (Fenton et al., 2015; Gregus, Wintink, Davis, & Kalynchuk, 2005; Marks, 
Fournier, & Kalynchuk, 2009; Sterner & Kalynchuk, 2010), decrease markers of hippocampal 
plasticity (Lussier et al., 2013a; Fenton et al., 2015), and disrupt the balance between GABA and 
glutamate within the hippocampus (Lussier, Romay-Tallon, Caruncho, & Kalynchuk, 2013b). 
However, little is known about the effects of CORT injections on cognitive functioning. The 
sparse work on this topic has focused on low doses of CORT (5 mg/kg CORT; Darcet et al., 
2014], CORT given after adrenalectomy [Spanswick & Sutherland, 2010], CORT given acutely 
[Vargas-Lopez et al., 2015], or after mineralocorticoid overexpression [Ferguson & Sapolsky, 
2007], or CORT given via an intrahippocampal infusion [Kelemen, Bahrendt, Born, & Inostroza, 
2014]. Therefore, to our knowledge, the effects of repeated (21 days) systemic CORT injections 
on object memory has not been investigated at a dose (40 mg/kg) that induces depression-like 
behaviour. Similarly, the effects on prepulse inhibition using the above CORT model have not 
been investigated. In order to characterize cognitive deficits in the CORT model of depression, 
we included two well-established behavioural paradigms - prepulse inhibition (PPI) of the 
acoustic startle response (Geyer, Krebs-Thomson, Braff, & Swerdlow, 2001; Koch, 1999) and 
three types of object memory testing (Howland, Cazakoff, & Zhang, 2012). Prepulse inhibition is 
the reduction in acoustic startle response observed when a brief, low intensity stimulus is 
presented 30-500 ms prior to the presentation of the startle-evoking stimulus (Geyer, Krebs-
Thomson, Braff, & Swerdlow, 2001; Koch, 1999). Object-memory tasks involve the rodent 
encountering a set of objects in a training phase, and then a subsequent testing phase with the 
objects manipulated in some way (e.g., new location, new object introduced). These tasks were 
chosen due to their known neurobiological substrates. For example, object location is reliant on 
the hippocampus (Vogel-Ciemia & Wood, 2014) whereas object-in-place depends on the 
prefrontal cortex (Barker & Warburton, 2015). In contrast, object recognition memory depends 
on the perirhinal cortex (Barker & Warburton, 2015). Although deficits in object memory and 
PPI are well documented in animal models of schizophrenia (Bitanihirwe, Weber, Feldon, & 
Meyer, 2010b; Howland, Cazakoff, & Zhang, 2012; Ibi et al., 2009; Meyer, Spoerri, Yee, 
Schwarz, & Feldon, 2008c; Ozawa et al., 2006; Shi, Fatemi, Sidwell, & Patterson, 2003) to our 
knowledge, this is the first study to systematically investigate the effects of repeated (21 days) 
CORT injections on rodent performance in object memory and PPI. Given that CORT is known 
to dampen hippocampal plasticity, we hypothesized that CORT would produce deficits in the 
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hippocampal version of object memory. We also hypothesized that CORT would produce 
impairments in the PPI due to the requirement of the hippocampus in this task.  
2. Materials and Methods 
2.1. Animals 
We used 25 male Long-Evans rats purchased from a commercial supplier (Charles River 
Laboratories, Canada). Rats weighed 225-250g upon arrival and were individually housed in 
polypropylene cages with the colony room maintained at an ambient temperature of 21 ± 1°C. 
Both food and water were available ad libitum. All experimental procedures took place during 
the light phase of the 12:12 light/dark cycle (lights on at 0700). All animals were treated in 
accordance with an animal use protocol approved by the University of Saskatchewan’s Animal 
Research Ethics Board. Efforts were made to minimize the number of animals used in the study. 
2.2. Experimental Procedures 
Rats were handled briefly once per day for 7 days prior to the CORT or vehicle 
injections. Following this acclimatization period, rats were weight-matched into two groups that 
received either 21 days of CORT injections (CORT group: n = 13) or 21 days of vehicle 
injections (vehicle group: n = 12). All injections were administered subcutaneously once per day 
(between 9:00-2:00 pm). CORT (Steraloids) was suspended in 0.9% (w/v) physiological saline 
with 2% (v/v) Tween-80 and given at a dose of 40 mg/kg in a volume of 1 ml/kg. Previous work 
in our laboratory and others has demonstrated that the dose of 40 mg/kg of CORT reliably 
increases depression-like behaviour in rats  (Lussier et al., 2013a; Kalynchuk, Gregus, Boudreau, 
& Perrot-Sinal, 2004; Johnson, Fournier, & Kalynchuk, 2008; Lebedeva, Caruncho, & 
Kalynchuk, 2017; Workman et al., 2016; Kott, Mooney-Leber, Shoubah, & Brummelte. 2016; Li 
et al., 2017). 
2.3. Behavioural Testing 
   All behavioural testing was conducted in a procedures room that was not used for 
housing the rats or for delivering the CORT/vehicle injections. Behaviour was video-recorded 
for the FST and object memory tests for offline scoring at a later date. The FST and PPI test were 
conducted on the 22nd and 23rd day of the experiment, respectively. After the PPI test, the rats 
received 3 days of CORT or vehicle top up injections, and then three versions of object 
recognition memory were assessed with 3-day injection intervals in between each test. This was 
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done to ensure that the effects of CORT on behaviour did not dissipate over time. The 
experimental design is shown in Figure 1.  
2.3.1. FST 
  The FST was conducted the day after the 21st injection. The FST was modified from the 
Porsolt Test [3]. Rats were individually placed into a Plexiglas swim tank (25 cm wide x 25 cm 
long x 60 cm high, 27 ± °C water, 30 cm deep) for 10 minutes. We measured the duration of 
time each rat spent immobile, struggling, and swimming. An increase in immobility is typically 
inferred to indicate the presence of a depressive phenotype in rodents (Cryan, Valentino, & 
Lucki, 2005; Lussier et al., 2013a; Sterner and Kalynchuk, 2010). 
2.3.2. PPI 
 PPI was assessed two days after the final CORT or vehicle injection. We used a protocol 
that was very similar to previously published methods (Howland, Cazakoff, & Zhang, 2012]). 
Rats were tested in two standard SR-LAB startle boxes (San Diego Instruments, CA, USA). The 
startle boxes were washed with 40% EtOH between each set of animals. The PPI session began 
with a 5-minute acclimatization period, during which a 70-dB background noise was presented, 
which remained constant for the remainder of the testing. Immediately following the 
acclimatization period, six pulse alone trials were presented (120 dB, 40ms), which allowed for a 
baseline startle amplitude to be established before the presentation of the prepulse + pulse trials. 
Following the pulse-alone trails, 84 trials of three different types were presented in pseudo-
random order: pulse-alone (6 trials: 120 dB, 40 ms), prepulse + pulse (6 trials X 3 prepulse 
intensities X 4 prepulse intervals- discussed below), or no stimulus (6 trials). Prepulse + pulse 
trials began with the presentation of a 20-ms prepulse of 3, 6, or 12 dB above background noise. 
Prepulse-pulse time intervals were 30, 50, 80, or 140 milliseconds between the onset of the 
prepulse and onset of the pulse. Each session concluded with six pulse-alone trials. The intertrial 
interval randomly varied from 3 to 14 seconds (average 7.5 seconds).  
Two measures were calculated for each rat. The first measure, startle amplitude, 
represents the mean startle response amplitude for each of the six pulse-alone trials, which were 
presented after the six habituation trials. The second measure, PPI, was calculated by averaging 
the startle amplitudes for each trial type, and the percent PPI for each prepulse intensity was 
calculated using the formula: (100-(100xstartle amplitude on prepulse + pulse trials)/ (startle 
amplitude on pulse alone trials). The average startle amplitude elicited during three blocks of six 
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pulse alone trails (before, during, and after PPI trails) was compared to measure habituation 
[Howland, Cazakoff, & Zhang, 2012; Howland, Hannesson, Barnes, & Phillips, 2007; Howland, 
Hannesson, & Phillips, 2004; Howland, MacKenzie, Yim, Taepavarapruk, & Phillips, 2004b).  
2.3.3. Recognition Memory 
The recognition memory test procedures were similar to previously published protocols 
(Howland, Cazakoff, & Zhang, 2012). Testing was conducted in a square open field 
(60x60x60cm) constructed of white corrugated plastic. One overhead light provided 
illumination. The object-in-place trials had a black cardboard insert on the northern wall of the 
arena. Rats received 3 habituation sessions before the first recognition test (object location). 
The last habitation session occurred 24-48 hours before the first test session. For the remaining 
tests (object-in-place and object recognition), rats received one habituation session (in pairs) 24-
48 hours before the new test. Objects used in all tests were made of porcelain, plastic, or glass 
and did not exceed 10 cm in height or length. Duplicate copies of objects were used when the 
same objects were required for both sample and testing phases. Object locations were 
counterbalanced to eliminate potential side preferences in all tests. In both sample and test 
phases, objects were placed in the corners of the arena 10 cm from each of the nearest walls and 
rats were placed in the center of the arena facing the wall opposite the objects. Both the open 
field and the objects were wiped with 40% EtOH after each session (Howland, Cazakoff, & 
Zhang, 2012). 
2.3.3.1. Object Location Recognition 
Three days following PPI testing, rats explored two identical objects for 4 minutes during 
the sample phase (C1 and C2). The test phase occurred one day later, during which rats explored 
2 copies of the sample objects (C3 and C4) for 4 minutes, but with one object moved to a corner 
location at the front of the box while the other remained in its original position (Fig. 4). Object 
location memory was inferred when rats spent more time exploring the object in the new location 
than the one in the original location.  
2.3.3.2. Object-in-Place Recognition  
Three days following the object location testing, rats were tested in the object-in-place 
paradigm. During the sample phase, rats explored 4 different objects (D1, E1, F1, G1) located in 
the four corners of the arena for 5 minutes. Following a 1-hour delay, rats were placed back in  
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Fig 1. Schematic representation of experimental design used for study. All animals received 
identical amounts of handling, injections, and behavioural testing. Forced swim test: Rats were 
placed in a plexiglass swim tank for 10 minutes. Object memory. During object memory testing 
all animals were placed in a testing chamber made of white corrugated plastic. Object location: 
Rats explored 2 identical objects during a sample phase followed 24 h later by a testing phase 
with 2 identical objects but with 1 moved to a new location. Object-in-place: Rats explored 4 
different objects in the corners of the box during a sample phase with a black insert on the front 
wall. 1 h later rats explored 4 of the same objects but with 2 objects in new positions in a test 
phase. Object recognition: Rats explored 2 duplicate objects during a sample phase. 24 h later 
rats explored 1 duplicate object and 1 new object during a testing phase. 
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the arena for the test phase. In the test phase, rats explored 4 identical copies of the objects (D2, 
E2, F2, G2), however the exploration time was reduced to 3 minutes and the position of 2 of the 
objects on the same side was switched (i.e., front object became back object and vice-versa), 
whereas the 2 objects on the other side remained in their original positions. Object-in-place 
memory was inferred when rats spent more time exploring the pair of objects that switched 
positions than the objects that remained in their original positions. 
2.3.3.3. Novel Object Recognition 
Three days following the object-in-place testing, rats were tested for novel object 
recognition. During the sample phase, rats explored 2 identical objects (A1 and A2) for 4 
minutes. The next day, recognition memory for the previously encountered objects was tested 
during a 4 minute test phase in which subjects explored a copy of the sample object (A3) and a 
novel object (B1). Object recognition memory was inferred when rats spent more time exploring 
the novel object.  
2.4. Data Analyses 
 All analyses were conducted using the Statistical Package for Social Sciences (SPSS), 
version 21 (IBM). Separate one-way ANOVA’s were used to test for group differences in body 
weight and FST behaviour. Corrections for sphericity (Mauchly’s Test) were utilized in all 
repeated measures of variance (ANOVA). Statistical tests were considered significant at p < .05. 
Error bars on all graphs represent the standard error of the mean (SEM).  
 Prepulse facilitation was observed for the 30-ms interval, whereas prepulse inhibition was 
observed for the 50, 80, and 140-ms intervals as observed previously (Howland, Cazakoff, & 
Zhang, 2012). Therefore, data from the 30 millisecond interval were analyzed separately. Startle 
amplitudes were analyzed with a one-way between-within repeated measures ANOVA 
(treatment as between-subjects factor; pulse block as repeated measures factor). PPI data were 
analyzed with a three-way between-within repeated measures ANOVA (treatment as between 
subjects factor; prepulse intensity and prepulse-pulse interval as repeated measures factor).  
 Data from the recognition memory tests were scored by an individual blind to treatment 
according to previously published measures (Howland & Cazakoff, 2010; Howland, Cazakoff, & 
Zhang, 2012). Briefly, a rat was defined to be actively exploring an object when its nose was 
directed within 2 cm of an object and either its head or vibrissae were moving, but not when it 
was standing on top of an object and not directing attention to it. Rats must explore objects for at 
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least 15 seconds in both the sample and test phases to have reliable recognition memory; 
therefore, rats with less than 15 seconds of exploration time in either the sample or test phase 
were eliminated from the study (Bitanihirwe, Weber, Feldon, & Meyer, 2010b). The 
discrimination ratio (DR) was calculated for the first 2 minutes of the test phase for each rat, as 
previous reports have reliably demonstrated that the recognition memory tests are most sensitive 
in the first 1-2 minutes of the test (Bitanihirwe, Weber, Feldon, & Meyer, 2010b; Howland, 
Cazakoff, & Zhang, 2012). Both total exploration times and the discrimination ratio [(DR)time 
exploring novel object/location- time exploring familiar object/location/time exploring both 
objects] were computed for each rat. Any rat with a DR greater than 2 standard deviations above 
the group mean were removed from the study. Total exploration times during the training and 
testing phase were analyzed with separate one-way ANOVA’s with treatment as a between 
subject’s factor. For test-phase data, the DR was analyzed for each group using separate one-
sample t-tests (a comparison value of 0 indicates equal exploration of each object (Bitanihirwe, 
Weber, Feldon, & Meyer, 2010b; Howland & Cazakoff, 2010). Between-group comparisons 
were made using a one-way ANOVAs. 
3. Results 
 3.1. CORT Decreases body weight 
Figure 2 shows the effect of CORT on body weight. Consistent with previous research, 
CORT had significant effects on body weight. A main effect of both time (F (6, 138) = 165.739, 
p < .001) and treatment was observed (F (1, 23) = 37.81, p < .001), with the CORT rats weighing 
significantly less than the vehicle rats beginning on day 7 and continuing throughout the 
experiment. 
3.2.  CORT Increases Immobility in the FST 
Figure 2 shows the effect of CORT on FST behaviour. CORT produced clear changes in 
this test. Specifically, the CORT rats spent significantly more time immobile (F (1, 23) = 67.95, 
p < .001), less time struggling (F (1, 23) = 50.09, p < .001), and less time swimming (F (1, 23) = 
13.22, p < .001) than did the vehicle rats.  
3.3.  CORT Alters Startle Amplitudes and the 30-ms Prepulse Interval  
Figure 3 shows the results of the PPI testing. Panel A focuses on startle amplitudes during 
the different blocks of pulses. The vehicle rats displayed higher startle amplitudes relative to the 
CORT rats at all times. This was confirmed by the statistical analyses. A repeated measures 
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ANOVA revealed a significant main effect of pulse block (F (2, 46) = 34.73, p < .001) and 
treatment (F (1, 23) = 5.21, p < .05), with no significant pulse block by treatment interaction (F 
(2, 46) = 1.44, p = .24; Fig. 3).  
   Next, we then examined the average percent PPI by prepulse-pulse interval (50, 80, and 
140 ms) and by prepulse intensity (3, 6, and 12 dB). Both vehicle and CORT-treated rats 
displayed PPI that depended on intensity (F (2, 46) = 111.65, p < .001) but not interval (F (2, 46) 
= 1.74, p = .19) or treatment (F (1, 23) = .80, p = .37). The treatment by prepulse interaction was 
not statistically significant (F (2, 46) = 1.81, p = .17). Data from the 30 millisecon interval 
revealed a significant main effect of prepulse interval (F (2, 46) = 9.56, p < .001) and treatment 
(F (1, 23) = 5.55, p < .05), with no significant prepulse interval by treatment interaction (F (2, 
46) = 1.48, p = 23; Fig. 3). 
3.4.       CORT Impairs Object Location Recognition, Object-in-Place Recognition, but not Novel 
Object Recognition 
Figure 4 shows the discrimination ratios for rats in both groups on all three memory tests. 
Panel A shows the object location testing, panel B shows the object-in-place testing, and panel C 
shows the object recognition testing. 
Analysis of the discrimination ratios during the object location test phase revealed a 
significant difference between the CORT and vehicle rats. Although the vehicle rats displayed 
memory that was significantly different from zero (t(11) = 2.57, p  = .026), the CORT rats failed 
to show memory significantly different from zero (t(12) = -1.95, p = .075). Analysis with a one-
way ANOVA revealed a significant effect of treatment (F (1, 23) = 10.64, p < .01), with vehicle 
rats spending significantly more time exploring the object in the novel location than the CORT 
rats (Fig. 4). 
Analysis of the discrimination ratios during the object-in-place recognition memory task 
revealed a significant difference between the vehicle and CORT rats. Specifically, although the 
vehicle rats displayed memory significantly different from zero (t(11) = 5.70, p < .001), the 
CORT rats failed to show memory significantly different from zero (t(12) = -1.49, p = .16). 
Analysis with a one-way ANOVA revealed a significant effect of treatment, F (1, 23) = 25,42, 
p<.001, with the vehicle rats spending significantly more time exploring the objects that 
switched places than the CORT rats (Fig. 4). 
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Fig 2. CORT had significant effects on both body weight and depression-like behaviour. Panel A 
shows the body weight data. CORT-treated rats weighed significantly less than vehicle-treated 
rats on days 7, 14, 21, 28, 35, and 42 (all p values < .05). Panels B, C, D, and E show the FST 
behaviour. CORT-treated rats had significantly higher immobility times than vehicle-treated rats 
(p < .05). CORT-treated rats had significantly lower swimming times than vehicle-treated rats (p 
< .05). CORT-treated rats had a significantly shorter latency to immobility than vehicle-treated 
rats (p < .05). CORT-treated rats had significantly lower struggling times than vehicle-treated 
rats  (p < .05). All data are represented as means ± standard error of the mean. 
 
 
 
 
 68 
 
 
Fig 3. Effects of CORT-treatment on startle amplitudes and prepulse inhibition (PPI) in vehicle 
and CORT-treated rats. Prepulse-pulse intervals of 50, 80, and 140 ms are shown. Panel A 
represents the startle amplitudes (arbitrary units) of rats for the pulse-alone trials before, during, 
and after the PPI trials. Panel B shows percent PPI for each prepulse-pulse interval (50, 80, and 
140 ms) for the vehicle and CORT-treated rats. Panel C shows percent PPI for each prepulse 
intensity (3, 6, and 12 dB above background) averaged for trials with 50, 80, and 140 ms 
prepulse-pulse intervals. Panel D shows percent PPI for trials with a 30-ms prepulse-pulse 
interval. Note that a negative PPI score represents an increase in startle responding on trials with 
a prepulse (3, 6, or 12 dB above background). There was an overall effect of treatment on the 30-
ms prepulse-pulse interval. All data are represented as means ± standard  
error of the mean. 
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Table 1. Object recognition, object location, and object-in-place exploration times for vehicle 
and CORT-treated rats. Total exploration time of objects (seconds ± standard error of the mean) 
during the sample and test phases of the object recognition, object location, and object-in-place 
paradigms. The total time for the sample phase is presented, whereas the times for the first 2 
minutes is presented for the test phases 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Treatment Object Location Object-in-Place Novel Object Recognition
Sample Test Sample Test Sample Test 
Phase Phase Phase Phase Phase Phase
Vehicle 42.52±3.11 33.31±2.19 88.48±4.82 44.02±3.91 54.05±23.34 38.43±13.38
CORT 41.19±2.99 28.61±1.72 79.89±3.74 39.65±2.80 46.59±16.80 30.59±11.45
 70 
Analysis of the discrimination ratios during the object recognition test revealed that both vehicle 
(t(11) = 6.30, p <.001) and CORT rats (t(12) = 6.29, p < .001) displayed memory that was 
significantly different from zero. Analysis with a one-way ANOVA revealed no effect of 
treatment (F (1, 23) = .01, p = .92; Fig. 4). 
4. Discussion 
The results of this experiment make three main points. First, they reveal that CORT has 
selective effects on object recognition memory. The CORT rats showed impairments on both 
object location and object-in-place recognition memory, but they had normal performance with 
object recognition memory. Second, the results showed that prepulse inhibition is selectively 
effected by CORT. Finally, they confirm that repeated injections of CORT reliably increase 
depression-like behaviour as measured by the FST (Johnson et al. 2006). This is consistent with 
previous findings from a number of different labs showing that CORT produces clearly stratified 
behaviours on the FST.  
 Work in our lab has demonstrated that the CORT model reliably increases depression-
like behaviour on the FST. For example, we have shown that repeated CORT treatment increases 
time spent immobile and decreases time spent struggling and swimming (Fenton et al., 2015; 
Lussiet et al., 2013a; Lussier, Romay-Tallon, Kalynchuk, & Caruncho, 2011). Moreover, we 
have shown that the effects of CORT treatment on depression-like behaviour depend on both the 
dosage and time. For example, while 7 days of CORT treatment begins to alter FST behaviour, 
the largest effects are seen with 14 and 21 days of CORT treatment (Lussier et al., 2013a), and in 
heterozygous reeler mice, 20 mg/kg, but not 5 or 10 mg/kg of CORT, significantly increases 
depression-like behaviour in the FST (Lussier, Romay-Tallon, Kalynchuk, & Caruncho, 2011). 
Importantly, these CORT-induced alterations in FST behaviour are not the result of non-specific 
changes in muscle tone (Marks, Fournier, & Kalynchuk, 2009). Recently, we have also shown 
that repeating cycles of CORT treatment produces graded effects on FST behaviour (Lebedeva, 
Caruncho, & Kalynchuk, 2017). Importantly, work in other labs has also shown that CORT 
treatment produces depression-like behaviour in the FST (Kott, Mooney-Leber, Shoubah, & 
Brummelte, 2016; Zhao et al., 2008). Therefore, while not a main focus of the current paper, the 
results from the FST add to the current body of literature and help further establish the validity of 
the CORT model.  
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The present study provides the first evidence of selective deficits in object-memory in 
CORT-treated rats. Specifically, although both vehicle and CORT rats displayed novel object 
recognition memory, the CORT rats failed to show intact object location recognition and object-
in-place recognition. This is evidenced by a negative discrimination ratio during the two tests in 
the CORT rats. A negative discrimination ratio indicates that a greater time is being spent 
exploring the familiar objects rather than the novel objects. This points to an inability of CORT 
rats to recognize new objects in their environment and reference this back to previously 
encountered information. However, this deficit is specific to location, as novel object recognition 
memory is still functional in the CORT rats. The argument could be made that the CORT rats 
were sick, explaining their poor performance on object location recognition and object-in-place 
recognition. However, as mentioned previously, both the vehicle and CORT rats displayed equal 
levels of intact novel object recognition memory. Additionally, no significant differences 
between groups were observed in exploration times during the training and testing phases of the 
different tasks. Therefore, the CORT rats are still capable of learning, and do not display an 
inability to explore objects. This points to a fundamental neurobiological underpinning to the 
results observed.  
The neurobiological bases of the object memory tests are well-established. As mentioned 
previously, the object location memory test typically relies on an intact hippocampus, whereas 
the object-in-place memory test relies on the prefrontal cortex. In contrast, the novel object 
recognition memory test relies on the integrity of the perirhinal cortex (Vogel-Ciernia & Wood, 
2014). Furthermore, a study by Albasser and colleagues (2011) showed that perirhinal cortex 
lesions did impair performance on the novel object recognition memory test. However, this 
deficit was only present with no training trial before the testing phase and with less than a 90- 
minute delay between the two trials. The protocol used here for the novel object recognition 
memory test employed both a training phase before the testing and a 24-hour delay between the 
trials. Winters, Forwood, Cowell, Saksida, and Bussey (2004) reported a double dissociation 
between the hippocampus and perirhinal cortex in tests of object memory. Specifically, they 
found that animals with a perirhinal cortex lesion were impaired on the novel object recognition 
memory task but were spared on the object location memory task, whereas the 
reverse was found for animals with hippocampal lesions. This suggests that performance on the 
novel object recognition memory task will be impaired if the perirhinal cortex is damaged due to  
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Fig 4. Effects of CORT treatment on the discrimination ratio in the object recognition, object 
location, and object-in-place recognition memory paradigms. Panel A- CORT-treatment had no 
effect on novel-object recognition memory. Panel B- CORT-treatment significantly impaired 
object location recognition memory (p < .05).  Panel C – CORT-treatment significantly impaired 
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object-in-place recognition memory (p < .05). All data are represented as means ± standard error 
of the mean. 
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insult. As the CORT rats in this experiment were not impaired on the object recognition memory 
task, it appears that the CORT treatment did not damage the perirhinal cortex. However, it 
cannot be ruled out that the spared performance observed here did not result from our use of a 
training phase and a 24-hour delay between the training and testing (as was not done in the 
Albasser and Winters) phases.  
 The startle amplitudes recorded in this experiment revealed a normal pattern of response, 
where high startle is observed during the start of PPI, followed by a gradual decline. 
Additionally, the vehicle rats displayed significantly higher overall startle amplitudes (combined 
PPI before, during, and after) than did the CORT rats, suggesting that CORT treatment may 
dampen overall startle amplitudes. However, an alternative explanation for the observed effect is 
that CORT treatment significantly decreased body weight – the CORT rats weighed significantly 
less than did the vehicle rats. Therefore, the CORT rats may have startled less simply because 
they weigh less than the vehicle rats. We observed prepulse facilitation for vehicle, but not 
CORT rats, for intensities of 3 dB, whereas prepulse inhibition was observed for 6 and 12 dB 
trials when only considering prepulse intervals of 50, 80, and 140 ms for both groups. However, 
prepulse intensities of 30 ms resulted in prepulse facilitation in the vehicle rats for 3, 6, and 12 
dB intensites, whereas the CORT rats displayed prepulse facilitation for 3 and 6 dB, but not 12 
dB (Floresco, Geyer, Gold, & Grace, 2005; Mansbach & Geyer, 1991; Young, Powell, 
Risbrough, Marston, & Geyer, 2009). In conclusion, CORT treatment altered prepulse inhibition 
in male rats, however additional work is needed with this model to further validate the effects 
observed here. 
5. Conclusion 
 In conclusion, the results of this experiment reveal that repeated CORT injections induce 
a depressive phenotype, with deficits extending to selective impairments in object location 
recognition, object-in-place recognition, but not novel object recognition. This pattern of results 
suggests that the normal functioning of the hippocampus and prefrontal cortex is impaired by 
CORT treatment, however the perrihinal cortex is spared. Although the CORT rats had overall 
lower startle amplitudes and less pre-pulse facilitation for 30-ms prepulse-pulse intervals than 
did the vehicle rats, further research is required to validate this finding. The current study adds to 
the existing literature on depression and extends the CORT model to include memory deficits. 
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Future studies could examine the ability of antidepressants to reverse the object memory deficits 
observed here. 
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Abstract 
Depression is a serious psychiatric disorder frequently comorbid with autoimmune disorders. 
Previous work in our lab has demonstrated that repeated corticosterone (CORT) injections in rats 
reliably increase depression-like behaviour, impair hippocampal- dependent memory, reduce the 
number and complexity of adult-generated neurons in the dentate gyrus, decrease hippocampal 
reelin expression, and alter markers of GABAergic function. We hypothesized that peripheral 
injections of the TNF-α inhibitor etanercept could exert antidepressant effects through a 
restoration of many of these neurobiological changes. To test this hypothesis, we examined the 
effect of repeated CORT injections and concurrent injections of etanercept on measures of 
object-location and object-in-place memory, forced-swim test behaviour, hippocampal 
neurogenesis, and reelin and GABA β2/3 immunohistochemistry. CORT increased immobility 
behaviour in the forced swim test and impaired both object-location and object-in-place memory, 
and these effects were reversed by etanercept. CORT also decreased both the number and 
complexity of adult-generated neurons, but etanercept restored these measures back to control 
levels. Finally, CORT decreased the number of reelin and GABA β2/3- ir cells within the 
subgranular zone of the dentate gyrus, and etanercept restored these to control levels. These 
novel results demonstrate that peripheral etanercept has antidepressant effects that are 
accompanied by a restoration of cognitive function, hippocampal neurogenesis, and GABAergic 
plasticity, and suggest that a normalization of reelin expression in the dentate gyrus could be a 
key component underlying these novel antidepressant effects.  
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1. Introduction  
There is a strong connection between the immune system and the brain in the context of 
major depression. Chronic stress induces an inflammatory response, which in the central nervous 
system includes an increase in pro-inflammatory and a decrease in anti-inflammatory cytokines, 
in addition to the recruitment of microglia (Campbell, Marriott, Nahmias, & MacQueen, 2004; 
Dantzer, O’Connor, Freund, Johnson, & Kelley, 2008). Exposure to chronic stress is a significant 
risk factor for the development of depression. One of the earliest links between stress and 
depression was the observation that stressful life events frequently precede the onset of 
depression in human populations (reviewed in Sterner and Kalynchuk, 2010). Half of depressed 
patients display the hallmarks of a deregulated stress response, hypercortisolemia (Sachar and 
Baron, 1979). Moreover, these high circulating levels of cortisol have pathological consequences 
for healthy brain functioning (Kendler and Gardner, 2010). Studies of post-mortem tissue from 
patients with depression have revealed dendritic atrophy in the hippocampus and prefrontal 
cortex, in addition to reductions in hippocampal volume (Bansar, Dwyer, & Duman, 2011; 
Campbell, Marriott, Nahmias, & MacQueen, 2004). Research using preclinical animal models of 
depression further corroborate the link between stress and depression. For example, stress 
significantly increases depression-like and anhedonia behaviour (Sterner, 2010). Stress also 
produces similar neurobiological alterations as those seen in humans, along waith decreases in 
hippocampal cell proliferation, survival, and the rate of neuronal maturation (Lussier et al., 
2013a). Clinically, patients with autoimmune disorders frequently present with comorbid 
depression (Andersson et al., 2015) – for example, rheumatoid arthritis patients have a lifetime 
prevalence rate of 13–42% of developing depression (Margaretten, Julian, Katz, & Yelin, 2011) 
– and there seems to be a clear bidirectional relationship between depression and autoimmune 
disorders (Euesden, Danese, Lewis, & Maughan, 2017). Moreover, subsets of depressed patients 
exhibit the cardinal features of an inflammatory response, most notably an increased expression 
of pro-inflammatory cytokines in blood and cerebrospinal fluid (Miller, Maletic, & Raison, 
2009). Some of the most frequently reported elevated pro-inflammatory cytokines include IL-1, 
IL-6, and TNF-α (Dowlati et al.,2010), and general alterations in neuroimmune systems 
represent a key component underlying the neurobiology of both mood and psychotic disorders 
(Calcia et al., 2016; Rodrigues-Amorim et al., 2017; Wohleb, Franklin, Iwata, & Duman, 2016).  
TNF-α is a soluble cytokine with two receptors, the TNF-α receptor 1 and TNF-α 
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receptor 2. Produced peripherally, TNF-α also acts centrally through activation of toll-like 
receptor 4 on circumventricular organs and choroid plexus, which in turn activates microglia that 
then release TNF-α within the brain, with the hippocampus being a key region of expression 
(McCoy and Tansey, 2008). Within the nervous system, TNF-α has a variety of functions, 
including modulating cell recruitment and proliferation, and cell death. Under conditions of 
stress, TNF-α participates in promoting inflammation through stimulating the production of other 
pro-inflammatory cytokines, including IL-1 and IL-6. Elevated levels of TNF-α produce a wide 
range of deleterious effects on physiology, emotional behaviour, and cognition (Bortolato, 
Carvalho, Soczynska, Perini, & McIntyre, 2015). TNF-α also increases excitatory synaptic 
strength by promoting AMPA receptor expression, while concomitantly decreasing inhibitory 
synaptic strength by inducing internalization of GABAA receptors (Stellwagen, Beattie, Seo, & 
Malenka, 2005). Work in preclinical animal models demonstrates that peripheral administration 
of TNF-α produces deficits in learning and memory (particularly spatial memory) in addition to 
anhedonia (Dunn & Swiergiel, 2005; van Heesch, Prins, & Korte-Bouws, 2013). Furthermore, 
TNF-α knockout mice display an antidepressant-like phenotype (Yamanda, Iida, & Miyamoto, 
2000). In an elegant study, Klaus et al. (2016) injected TNF-α peripherally or achieved 
expression in the hippocampus using viral vectors. Peripheral TNF-α produced anhedonia 
behaviour and increased fear memory, while brain expression increased anxious behaviour. 
Increased expression of TNF-α results in a decrease in neurogenesis through apoptotic neuronal 
death, whereas low levels of TNF-α promote neurogenesis through increased proliferation of 
neural precursor cells (Fan, Tien, & Zhang, 2011). Finally, peripheral administration of the TNF-
α inhibitor etanercept decreases depression-like behaviour in rats subjected to stress paradigms 
(Bayramgurler, Karson, Ozer, & Utkan, 2013; Krugel, Fischer, Radicke, Sack, & Himmerich, 
2013; Sahin et al., 2015). In fact, a recent systematic review and meta-analysis validated the 
effect of anti –TNF-α drugs in improving depression symptoms, and associated the 
antidepressant effect with baseline symptom severity (Kappelmann et al., 2016).  
In spite of the clinical studies showing antidepressant actions of etanercept, little is 
known about the mechanisms by which anti –TNF-α drugs exert their antidepressant effects. 
Thereby, considering that administration of peripheral TNF-α produces anhedonia behaviour and 
deficits in spatial memory, we were interested in examining if TNF-α inhibition could alleviate 
stress- induced deficits in depression-like behaviour and measures of cognition.  
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Work in our lab has demonstrated that prolonged exposure to stress hormones decreases 
reelin expressing cells in the dentate subgranular zone, and treatment with the tricyclic 
antidepressant imipramine reverses this effect (Lussier, Caruncho, & Kalynchuk, 2009; Fenton et 
al., 2015). Reelin is a large extracellular matrix protein primarily expressed by cortical and 
hippocampal subpopulations of GABAergic interneurons and by cerebellar granule cells (Pesold 
et al., 1998; Rogers and Weeber, 2008). Within the hippocampus, reelin is involved in a variety 
of functions, including dendritic spine development and maturation (Niu, Yabut, & D’Arcangelo, 
2008; Chameau et al., 2009; Hethorn et al., 2015), hippocampal neurogenesis (Teixeira et al., 
2011), promoting and modulating maturation and synaptic plasticity of newborn granule cells 
(Bosch et al., 2016a), and learning and memory (Beffert et al., 2005). Importantly, there is also 
evidence of decreased reelin expression in the dentate gyrus in postmortem samples from 
patients with depression (Fatemi, Earle, & McMenomy, 2000). Interestingly, in a mouse model 
of aging, a viral-induced infection increased inflammation and reduced the number of reelin 
expressing interneurons (Doehner and Knuesel, 2010). This suggests that the pattern of 
behaviours (e.g., depression-like behaviour, impaired cognition) observed under times of 
increased inflammatory signaling in chronic stress might be related to a loss of hippocampal 
reelin expression (Caruncho et al., 2016). Therefore, we hypothesized that reducing chronic 
stress- induced increases in TNF-α would increase reelin expression and normalize behaviour 
and neurobiological markers. To test this hypothesis, we utilized a repeated corticosterone 
(CORT) injection model of depression that we and others have shown can produce a robust 
depressive phenotype (Sterner and Kalynchuk, 2010). Rats received 21 days of CORT or vehicle 
injections and half the rats in each group also received semi-weekly injection of the TNF-α 
inhibitor etanercept (Inglis et al., 2005). We then assessed depression-like behaviour using the 
forced-swim test (FST), cognition using the novel object-location and object- in-place tests, and 
alterations in hippocampal neurogenesis, reelin, and GABAA receptors using 
immunohistochemistry. Our results support our hypothesis and suggest that peripheral 
administration of a TNF-α antagonist increases hippocampal reelin expression and corresponding 
neurobiological markers, and normalizes the behavioural phenotype.  
2. Materials and Methods  
2.1.   Animals  
We used 24 male adult Long-Evans rats purchased from Charles River (QC, Canada). 
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The rats were reared in standard conditions by the breeder and weighed 200–250 g at the time of 
arrival in our lab. Rats were 9 weeks old at the start of the experiment. It is generally accepted 
that at 9 weeks old rats are in the young adult to adulthood stage (Sengupta, 2013). Rats were 
individually housed in rectangular polypropylene cages containing standard laboratory bedding 
with access to food and water ad libitum. The rodent colony room was maintained at an ambient 
temperature of 20 ± 1◦C on a 12:12 light-dark cycle (lights on at 7 am). All experimental 
procedures were in accordance with the guidelines of the Canadian Council and Animal Care and 
an animal care protocol approved by the University of Saskatchewan Committee on Animal Care 
and Supply. All efforts were made to minimize the number of rats used in the present study.  
2.2.    Experimental Procedures  
Rat were handled briefly once per day for 7 days prior to the start of experimental 
manipulations. We weight-matched the rats and randomly assigned them to one of the following 
four treatment groups: CORT + saline (n = 6), CORT + etanercept (n = 6), vehicle + saline (n = 
6), or vehicle + etanercept (n = 6) injections. All CORT and vehicle injections were administered 
subcutaneously once per day (between 9:00 and 10:00 am) for 21 consecutive days. Etanercept 
and saline injections were given subcutaneously twice per week (between 2:00 and 3:00 pm) 
during the 21-day CORT/vehicle injection period. Rats also received 3 days of CORT or vehicle 
injections and 1 day of etanercept or saline injections in between each behavioural test (forced-
swim test, object-location, object-in-place) to maintain the effects of CORT throughout the 
behavioural testing period. The experimental design is shown in Figure 1.  
CORT (Steraloids, Newport, RI, United States) was suspended in 0.9% (w/v) 
physiological saline with 2% (v/v) Tween-80 (Sigma–Aldrich) and given at a dose of 40 mg/kg 
at a volume of 1 ml/kg. This dose produces reliable and robust increases in depression-like 
behaviour (Gregus, Wintink, Davis, & Kalynchuk, 2005; Johnson, Fournier, & Kalynchuk, 
2006). Etanercept (Immunex, Thousand Oaks, CA, United States) was suspended in 0.9% (w/v) 
physiological saline with 2% (v/v) Tween-80 and given at a dose of 0.8 mg/kg in a volume of 1 
ml/kg. This dose was chosen based on previous studies showing that etanercept can normalize 
depression-like behaviour in rats (Bayramgurler et al., 2013). Body weight was recorded for each 
rat during the injection phase of the experiment. 
2.3.    Behavioural Testing  
Behavioural testing was conducted in a procedures room that was not used for any other 
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aspect of the study. All behaviours were recorded with a digital video camera and stored for 
offline analyses by researchers blind to the treatment conditions. The FST assessed depression-
like behaviour, whereas the novel object location and object-in-place tests assessed recognition 
memory.  
2.3.1.   Forced Swim Test  
The FST was conducted the day after the final CORT injection. We used a modified 
version of the Porsolt test, as previously described (Marks et al., 2009). Each rat was individually 
placed in a Plexiglas swim tank (25 cm diameter × 60 cm high, 27 ± 2◦C water, 30 cm deep) for 
10 minutes. We measured the duration of time each rat spent immobile, struggling, and 
swimming.  
2.3.2.  Object Recognition Memory  
Recognition memory was assessed according to previously published protocols (Howland 
and Cazakoff, 2010; Howland et al., 2012). Object-location (OBL) memory testing took place in 
a square open-field area (60 × 60 × 60 cm) constructed of white corrugated plastic. Rats received 
three habituation sessions before the training session. During the first two habituation sessions, 
rats were brought in pairs and placed in separate arenas for 10 minutes. During the last 
habituation session, rats were brought in individually and placed in the arena for 10 minutes. 
Rats were immediately returned to the colony room after each habituation session. The last 
habitation session occurred 24–48 hours before the first testing session. The objects used in this 
test were made of porcelain and did not exceed 10 cm in height or length. Duplicate copies of 
objects were used when the same objects were required for both training and testing phases. 
Object locations were counterbalanced to eliminate potential side preferences in all tests. In both 
sample and test phases, objects were placed in the corners of the arena 10 cm from each of the 
nearest walls and rats were placed in the center of the arena facing the wall opposite the objects. 
Both the arena and the objects were wiped with 40% EtOH after each session.  
The rats were allowed to explore two identical objects for 4 minutes during the sample 
phase (C1 and C2). Twenty-four hours later, the rats underwent a testing phase, during which 
they explored two copies of the sample objects (C3 and C4) for 4 minutes, but with one object 
moved to a corner location at the front of the box while the other maintained its original position. 
The amount of time each rat spent actively exploring the objects was recorded. A rat received 
credit for active exploration when its nose was directed within 2 cm of an object and either its  
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Fig 1. Schematic representation of the experimental design used for the study. All rats received 
the same amount of handling, injections, and behavioural testing. The injection top up periods in 
between each behavioural test were implemented to ensure that the effects of CORT did not 
wane over time.  
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head or vibrissae were moving, but not when it was standing on top of an object and looking 
away. Rats were required to explore objects for at least 15 seconds in both the sample and test 
phases to have reliable recognition memory. A discrimination ratio (DR) was calculated as the 
time the rat spent exploring the novel orientation subtracted by the time the rat spent exploring 
the familiar orientation during the first two minutes of the test phase and dividing by two. A 
positive discrimination ratio indicates intact OBL memory (Howland and Cazakoff, 2010; 
Howland, Cazakoff, & Zhang, 2012). Three days following object location testing, rats were 
tested in the object-in-place (OBIP) paradigm. During the sample phase, rats explored 4 different 
objects (D1, E1, F1, G1) located in the four corners of the arena for 5 minutes. Following a 1-
hour delay, rats were placed back in the arena for the test phase. During the test phase, rats again 
explored 4 identical copies of the objects (D2, E2, F2, G2) for 3 minutes, but in this case the 
position of 2 of the objects on the same side was switched (i.e., front object becomes the back 
object and vice-versa). Object-in-place memory is inferred when animals spend more time 
exploring the pair of objects that switched positions than the objects that remained in their 
original positions (Howland, 2012). Here a discrimination ratio was again calculated to 
determine the degree to which rats explored the novel objects. A positive discrimination ratio 
indicates intact OBIP memory.  
2.4.   Histology  
Rats were sacrificed 3 days after the OBIP memory task. Each rat was deeply 
anesthetized with 5% isoflurane and then transcardially perfused using physiological saline, 
followed by ice-cold 4% (w/v) formaldehyde fixative (pH = 7.4). The brains were extracted from 
the cranial vault and immersed in the same formaldehyde fixative for 48 hours at 4◦C. The brains 
were then sectioned in the coronal plane at 30 µm on a vibrating microtome (VT1200s, Leica 
Biosystems). Sections were collected and stored at −20◦C in a cryoprotectant solution containing 
30% (w/v) sucrose, 1% (w/v) polyvinylpyrrolidone, and 30% (v/v) ethylene glycol in 0.1 M PBS 
(pH = 7.4).  
2.4.1. Immunohistochemistry  
We used a standard immunohistochemistry technique with commercially available 
antibodies for all of our experiments. Immunostaining was done on free-floating sections in six-
well tissue culture plates under gentle agitation. To ensure consistent immunohistochemical 
processing, we processed all sections for each assay (i.e., DCX, reelin, GABAA 
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β2/3receptorsubunit) in unison with treatment groups counterbalanced across all tissue plates. To 
confirm the specificity of our antibodies, we omitted the primary antibody from an additional 
well of free-floating sections. In the absence of the primary antibody, we were unable to detect 
any immunoreactive cells. We used doublecortin (DCX) to label immature dentate granule cells, 
as previously described (Botterill et al., 2015). Brain sections underwent heat-induced epitope 
retrieval in sodium citrate buffer (pH = 6.0) at 85◦C for 30 minutes. The sections were then 
blocked in 5% (v/v) normal goat serum (NGS), 1% (w/v) bovine serum albumin (BSA), and 
0.5% (v/v) Triton X-100 in 0.1 M TBS (pH = 7.4), followed by incubation in a rabbit anti-DCX 
polyclonal primary antibody (1:1000, Cell Signaling Technology) diluted in blocking solution 
for 24 hours at room temperature. The next day, the sections were treated with 5% (v/v) H2O2 in 
0.1 M TBS for 30 minutes to block endogenous peroxidase activity. The sections were then 
incubated for 1 hour in biotinylated goat anti-rabbit secondary antibody (1:500, Vector 
Laboratories) diluted in 5% (v/v) NGS, 1% (w/v) BSA, and 0.5% (v/v) Triton X-100 in 0.1 M 
TBS, followed by avidin-biotin peroxidase complex (1:500, Vector Laboratories) for 1 hour. 
Sections were then rinsed with 0.175 M sodium acetate (pH = 6.8) and visualized with 0.025% 
(w/v) DAB, 4.167% NiSO4, and 0.002% (v/v) H2 O2.  
Reelin immunohistochemistry was conducted as previously described (Lussier et al., 
2013a). Sections were treated with 0.3% H2O2 in 0.1 M PBS for 30 minutes to block 
endogenous peroxidase activity. The sections were then blocked in 5% normal horse serum 
(NHS), 1% (w/v) BSA, and 0.3% (v/v) Triton X-100 in 0.1 M PBS (pH = 7.4), followed by 
incubation in a mouse anti-reelin primary antibody (1:2000, Vector Labs) diluted in blocking 
solution for 48 hours at room temperature. Following primary antibody, the sections were then 
incubated for 2 hours in biotinylated horse anti-mouse secondary antibody (1:500, Vector Labs) 
diluted in 5% (v/v) NHS, 1% (w/v) BSA, and 0.3% (v/v) Triton X-100 in 0.1 M PBS, followed 
by avidin-biotin peroxidase complex (1:500, Vector Laboratories) for 1 h. Sections were then 
rinsed with 0.175 M sodium acetate (pH = 6.8) and visualized with 0.033% (w/v) DAB and 
0.007% (v/v) H2O2.  
GABAA β2/3 receptor subunit immunohistochemistry was conducted as follows. 
Sections first underwent heat-induced epitope retrieval in sodium citrate buffer (pH = 6.0) at 
85◦C for 30 minutes. Next, the sections were placed into a blocking solution containing 5% (v/v) 
NHS, 1% (w/v) BSA, and 0.5% (v/v) Triton X-100 in 0.1 M TBS for 30 min, and were then 
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exposed to a monoclonal mouse anti-GABAA β2/3 receptor primary antibody (clone bd17, 
1:1000, Millipore/Sigma) diluted in blocking solution for 48 hours at 4◦C. Following this, the 
sections were treated with 5% (v/v) H2O2 in 0.1 M TBS for 30 minutes to block endogenous 
peroxidase activity. Next, the sections were incubated for 2 hours in biotinylated horse anti-
mouse secondary antibody (1:500, Vector Laboratories) diluted in 5% (v/v) NHS, 1% (w/v) 
BSA, and 0.5% (v/v) Triton X-100 in 0.1 M TBS, followed by avidin-biotin peroxidase complex 
(1:500, Vector Laboratories) for 1 hour. The sections were then rinsed with 0.175 M sodium 
acetate (pH = 6.8) and visualized with 4.167% NiSO4 and 0.05% (w/v) glucose oxidase DAB. 
At the end of each immunohistochemical run, all sections were mounted onto glass slides using 
0.2 M PB (pH = 7.4), air dried overnight, dehydrated using a series of graded alcohols, cleared in 
xylene, and cover slipped with Permount mounting medium (Fisher Scientific).  
2.4.3.  Cell Counting  
Immunohistochemical results were quantified as previously described (Lussier et al., 
2013a; Botterill et al., 2015). All analyses were conducted by researchers blind to the treatment 
conditions. Immunostained sections were examined using a Nikon Eclipse E800 microscope with 
a motorized stage and digital camera (MicroFire, Optronics) connected to a dedicated stereology 
computer. The dentate SGZ (defined as a two-cell width zone in between the inner granule cell 
layer and the hilus) and granule cell layer (GCL) were traced at 4 X magnification using a 
computerized stereology program for DCX-ir cells. However, only the SGZ was traced for reelin 
and GABAA β2/3-ir cells (StereoInvestigator, MicroBrightfield, Williston, VT, United States). 
DCX, reelin, and GABAA β2/3-ir cells were counted in both the ipsilateral and contralateral 
hemispheres at 40 x magnification. All counts utilized unbiased stereology using a modified 
optical fractionator method that excludes cells in focus at the uppermost focal plane to reduce 
oversampling (Lussier et al., 2013a). The total number of cells was estimated using the following 
formula: Ntotal = Q− × 1/ssf × A(x, y step) / a(frame) × t/h. Q− represents the number of 
counted cells, ssf is the section sampling fraction (1 in 12), A(x, y step) is the area associated 
with each x, y movement (10,000 µm2), a(frame) is the area of the counting frame (3600 µm2), t 
is the weighted average section thickness, and h is the height of the dissector (12 µm) (Lussier et 
al., 2013a; Botterill et al., 2015). To avoid counting sectioning artifacts, we used a guard zone of 
2 µm.  
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2.4.2.1. Characterization of Immature DCX-ir Neurons  
We utilized a dendritic categorization method (Lussier et al., 2013a; Botterill, Brymer, 
Caruncho, & Kalynchuk, 2015) to determine whether CORT or etanercept altered the dendritic 
morphology of immature DCX- ir neurons. A meander scan method was used to randomly select 
100 DCX-ir cells from each rat. A researcher blind to experimental conditions then assigned the 
cell to one of six categories of dendritic complexity based on both the presence and extent of 
apical dendrites (see Figures 5C,D). The proliferative stage encompassed categories one (no 
process) or two (one small process). Category three (medium process reaching the granule cell 
layer) and category four (process reaching the molecular layer) comprised the intermediate stage 
of development. Finally, category five (one major process extending into the molecular layer) 
and category six (defined dendritic tree with delicate dendritic branching in the granule cell 
layer) represented mature cell development. Data are presented as the percentage of DCX-ir cells 
in each of the six categories.  
2.5.  Statistical Analyses  
All statistical analyses were done using IBM’s Statistical Package for Social Sciences 
v24. We used separate one- way ANOVA’s to assess the statistical significance of group 
differences in each measure (i.e., body weight, FST behaviour, OBL, OBIP, DCX, reelin, 
GABAA β2/3), and significant main effects were followed by post hoc comparisons using 
Tukey’s HSD. The criterion for statistical significance was p < 0.05. All graphs depict the mean 
± standard error of the mean.  
3.    Results 
3.1  CORT had Significant Effects on body weight 	
Figure 2 shows fluctuations in body weight in each group during the CORT injections. 
CORT had significant effects on body weight, consistent with previous findings from our lab 
(Lussier et al., 2013a,b). We found significant group differences on days 14 [F(3,23) = 7.414, p 
< 0.01] and 21 [F(3,23) = 7.295, p < 0.01]. Post hoc analyses revealed that the CORT-treated 
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Fig 2. Effect of CORT and etanercept on body weight. The CORT rats weighed significantly less 
than the vehicle and etanercept rats on days 14 (p < 0.05) and days 21 (p < 0.05). In addition, the 
CORT + etanercept rats weighed significantly less than the vehicle or etanercept rats on days 14 
(p < 0.05) and 21 (p < 0.05). All data are represented as means ± standard error of the mean.  
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Fig 3. Effect of CORT and etanercept on FST behaviour. (A) Shows the effect of treatment on 
time spent immobile. The CORT rats spent significantly more time immobile than did the 
vehicle, CORT + etanercept, and etanercept rats (p < 0.05). (B) Shows the effect of treatment on 
time spent struggling. The CORT rats spent significantly less time struggling compared to the 
vehicle, CORT + etanercept, and etanercept rats (p < 0.05). (C) Shows the effect of treatment on 
time spent swimming. The CORT rats spent significantly less time swimming than did the 
vehicle, CORT + etanercept, and etanercept rats (p < 0.05). All data are represented as means ± 
standard error of the mean.  
 
 
 
 
 
 90 
rats weighed significantly less than the vehicle and etanercept rats on day 14 (p-values < 0.05) 
and day 21 (p-values < 0.05). We also found that the CORT + etanercept rats weighed 
significantly less than the vehicle and etanercept rats on day 14 (p-values < 0.05) and 
significantly less than the etanercept rats on day 21 (p = 0.021). 
3.2.   Etanercept Normalizes CORT-Induced Changes in Behaviour on the FST  
Figure 3 shows the results of the FST in each group. We found significant group  
differences in immobility [F(3,23) = 34.96, p < 0.001], struggling [F(3,23) = 10.39, p < 0.001], 
and swimming [F(3,23) = 7.57, p < 0.001] during the FST. Post hoc analyses indicated that the 
CORT rats spent significantly more time immobile, less time struggling, and less time swimming 
than the rats in all other groups (p values < 0.05). No other group differences were significant. 
3.3.   Etanercept Normalizes CORT-Induced Deficits in OBL and OPIP Memory  
Figure 4 shows the results of the OBL and OBIP testing in each of the groups. We found 
significant group differences in both the OBL [F(3,23) = 5.858, p < 0.01] and OBIP [F(3,23) = 
5.088, p < 0.01] memory tests. Post hoc analyses of these main effects revealed that the CORT 
rats had a lower discrimination ratio than all other groups in the OBL test (p-values < 0.05) and 
OBIP test (p-values < 0.05). No other group differences were significant.  
3.4.   Etanercept Restores CORT-Induced Reductions in Hippocampal Neurogenesis  
Figure 5 shows the results of our DCX analyses. Figure 5A provides photomicrographs of 
DCX immunoreactivity in each of the four groups and Figures 5B,D show quantified differences 
among the groups. Consistent with previous results from our lab (Lussier et al., 2013a; Fenton et 
al., 2015), we found a significant main effect of group on the total number of DCX- ir cells 
[F(3,23) = 20.180, p < 0.001]. Post hoc analyses of this main effect revealed that the CORT rats 
had significantly fewer DCX-ir neurons compared to the vehicle, CORT-etanercept, and 
etanercept rats (p-values < 0.001). No other group differences were significant. In relation to 
dendritic complexity, we also found a number of significant group differences. There were 
significant group differences in the % of neurons in category 1 [F(3,23) = 7.760, p < 0.01], 
category 2 [F(3,23) = 49.504, p < 0.001], category 4 [F(3,23) = 4.673, p < 0.05], category 5  
[F(3,23) = 16.329, p < 0.001], and category 6 [F(3,23) = 21.852, p < 0.001]. Post hoc analyses 
showed that the CORT rats had a greater percentage of category 1 cells than did the vehicle (p = 
0.002) and etanercept rats (p = 0.003). The CORT rats also had a greater % of category 2 cells 
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Fig 4. Effect of CORT and etanercept on cognition. (A) Shows a schematic of the object location 
memory test. (B) Shows the discrimination ratio in this test for the rats in each group. The CORT 
rats had a significantly lower discrimination ratio than did the vehicle, CORT + etanercept, and 
etanercept rats (p < 0.05). (C) Shows a schematic of the object-in-place memory test. (D) Shows 
the discrimination ratio in this test displayed by the rats in each group. The CORT rats had a 
significantly lower discrimination ratio than did the vehicle, CORT + etanercept, and etanercept 
rats (p < 0.05). All data are represented as means ± standard error of the mean.  
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than all other groups (p-values < 0.001), while CORT etanercept animals had a greater % of 
category 2 cells than vehicle rats (p = 0.042). CORT rats had a smaller % of category 4 cells than 
the vehicle rats (p = 0.009), and a smaller % of category 5 and category 6 cells than all other  
groups (p-values < 0.001). In summary, the CORT rats had more DCX-ir cells with less complex 
dendrites but the CORT + etanercept rats did not differ from vehicle rats in this respect.  
3.5 Etanercept Restores CORT-Induced Reductions in Hippocampal Reelin-ir cells  
Figure 6 shows the results of the reelin immunohistochemistry. Figure 6A shows the 
distribution of reelin-ir neurons in the SGZ across the groups and Figure 6B shows the actual 
reelin- ir cell counts. Our stereological analyses revealed a significant effect of group on the 
number of reelin-ir cells in the SGZ [F(3,23) = 14.256, p < 0.001]. Post hoc analyses further 
revealed that the CORT rats had significantly fewer reelin-ir cells than the rats in all other groups 
(p-values < 0.001). No other group differences were significant.  
3.6 Etanercept Restores CORT-Induced Reductions in GABAA β2/3-ir cells in the SGZ  
            Figure 7 shows the results of the GABAA β2/3 immunohistochemistry. Figure 7A 
provides photomicrographs of GABAA β2/3 immunoreactivity in each group and Figure 7B 
provides the results of our stereological cell counts. We found a significant main effect of group 
on the number of GABAA β2/3ir cells in the SGZ [F(3,23) = 4.530, p < 0.05]. Post hoc analyses 
revealed that the CORT rats had significantly fewer GABAA β2/3-ir cells than the vehicle rats (p 
= 0.022) and CORT + etanercept rats (p = 0.022), but not the etanercept only rats (p = 0.129). 
CORT induces internalization of GABAA receptors in the SGZ (see arrows in Figure 7A) 
andthis effect was also partially rescued by etanercept. 
4. Discussion 
The results of this experiment show that prolonged exposure to the stress hormone CORT 
produces a cluster of effects characterized by increased immobility in the FST, impaired spatial 
memory on the OBL and OBIP tests, reduced hippocampal neurogenesis, fewer SGZ reelin-ir 
cells, and dampened GABAA β2/3 expression levels. Importantly, semi- weekly etanercept given  
along with CORT prevented all these effects, suggesting that anti-TNF-α drugs could exert their 
antidepressant effects by facilitating key aspects of hippocampal plasticity. The current 
experimental paradigm employed the use of individual housing along with CORT injections in 
adult rats, a protocol that we and others have extensively used in the past to analyze depression-
like behaviour (see Sterner and Kalynchuk, 2010, for a review; Gregus, Wintink,  
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Fig 5. Effect of CORT and etanercept on DCX-ir and dendritic complexity. CORT treatment 
significantly impaired hippocampal neurogenesis, and etanercept treatment restored this. (A) 
Shows representitive photomicrographs of DCX expression in the dentate gyrus (scale bar = 200 
µm). A higher magnification image is pictured in the insets (Scale bar = 50 µm). (B) Shows the 
effect of treatment on the number of DCx-ir cells in the subgranular zone. CORT-treated rats had 
significantly fewer DCX-ir cells than did the vehicle, CORT + etanercept, and etanercept rats (p 
< 0.05). (C) Shows representative photomicrographs of the six categories of dendritic 
complexity. (D) Shows the quantified categorization of dendritic complexity after analysis of a 
subset of DCX-ir cells. In general, the CORT rats had a higher percentage of cells in category 1 
and category 2 and lower percentage of cells in categories 5 and 6, demonstrating that DCX-ir 
neurons are less well developed after CORT treatment. All data are represented as means ± 
standard error of the mean.  
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Davis, & Kalynchuk, 2005; Johnson, Fournier, & Kalynchuk, 2006; Lussier et al., 2009, 
2013a,b; Brummelte and Galea, 2010a,b; Fenton et al., 2015). While it has been noted that social 
isolation can increase depression-like behaviour in rodents and disrupt the neuroendocrine 
profile, during postnatal development and weaning period (Lapiz et al., 2003; Leng, Feldon, & 
Ferger, 2004; Weiss, Pryce, Jongen-Relo, Nan-Bahr, & Feldon, 2004; Shetty and Sadananda, 
2017), behavioural alterations related to social isolation in adult rats have been reported only 
after longer isolation periods than those used in the present study (see Murinova et al., 2017). 
Furthermore, group housing adult rats can lead to increased cortisol levels, indicative of an 
increased stress response (Kamakura, Kovalainen, Leppaluoto, Herzig, & Makela, 2016).  
Prolonged exposure to CORT in rodents is known to produce a clear behavioural 
phenotype of depression, characterized by increased immobility in a FST and tail suspension 
test, decreased preference for sucrose, and decreased interest in sexual behaviour (Marks, 
Fournier, & Kalynchuk, 2009; Sterner and Kalynchuk, 2010; Lussier et al., 2013a; Fenton et al., 
2015). Our FST results are consistent with these previous findings, in that the CORT rats 
displayed increased immobility and decreased swimming and struggling compared to control 
rats. Importantly, etanercept reversed the effects of CORT on FST behaviour. The CORT + 
etanercept displayed significantly less immobility than the CORT rats and in fact, they looked 
very much like control rats in this test. This was expected, because there have been previous 
studies that assessed the antidepressant effects of etanercept in the FST. For example, Krugel, 
Fishcer, Radicke, Sack, and Himmerich (2013) reported that intraperitoneal injections of 
etanercept can reverse the effects of chronic restraint stress on FST immobility. Adding 
translational validity to the preclinical observations that TNF-α blockade has antidepressant 
effects, Raison et al. (2013) observed antidepressant effects of infliximab (a TNF-α inhibitor) in 
a clinical sample. Specifically, their work demonstrated that infusion of infliximab reduced 
scores on the Hamilton scale in patients with a high baseline level of inflammation. Furthermore, 
a recent systematic review and meta-analysis of seven randomized clinical trials demonstrated 
the antidepressant effectivity of several anti-TNF-α drugs (i.e., adalimumab, etanercept, 
infliximab, and tocilizumab) (Kappelmann, Lewis, Dantzer, Jones, & Khandaker, 2016). 
Therefore, our findings and the literature presented here suggest that TNF-α – induced 
inflammation is critically involved in the pathogenesis of depression, and therapies targeting this 
inflammation can produce therapeutic benefits. However, the mechanisms by which TNF-α  
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Fig 6. Effect of CORT and etanercept on the number of reelin-ir neurons. (A) Shows 
representative photomicographs of reelin-ir neurons in the dentate gyrus (scale bar = 200 µm). 
We focused our attention on reelin-ir cells in the proliferative subgranular zone. (B) Shows 
quantified values of reelin-ir neurons. The CORT rats had significantly fewer reelin-ir cells 
compared to the vehicle, CORT + etanercept, and etanercept rats (p < 0.05). All data are 
represented as means ± standard error of the mean.  
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Fig 7. Effect of CORT and etanercept on the number of GABAA b2/3-ir cells. (A) Shows 
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representative photomicrographs of GABAA b2/3 expression along the subgranular zone (scale 
bar = 200 µm). Arrows point to cell bodies showing GABAA b2/3-ir. Note that in the vehicle 
rats, GABAA b2/3 immunostaining appears to be concentrated on the plasma membrane of the 
cell bodies, whereas after CORT treatment the labeling is more diffuse and can be observed 
along the cytoplasm indicating receptor internalization. Etanercept partially rescues this effect. 
(B) Shows the quantified number of GABAA b2/3-ir cells in each group. The CORT rats had 
significantly fewer GABAA b2/3-ir cells compared to the vehicle and CORT + etanercept rats (p 
< 0.05). All data are represented as means ± standard error of the mean.  
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antagonism can produce antidepressant effects are completely unknown.  
Chronic stress is known to impair aspects of cognition, particularly hippocampal-
mediated spatial memory. For example, deficits in Morris Water maze performance (Warner et 
al., 2013), fear conditioning (Hoffman, Lorson, Sanabria, Olive, & Conrad, 2014), and OBL 
memory (Hattiangady et al., 2014) have all been observed after exposure to chronic stress. 
Inflammation can also impair performance on hippocampal-dependent forms of memory. This 
has been seen through studies using lipopolysaccharide, where impairments on context-object 
location discrimination were associated with high levels of proinflammatory cytokines, such as 
TNF-α (Czerniawski, Miyashita, Lewandowski, & Guzowski, 2015). Chronic restraint stress can 
also elevate hippocampal TNF-α levels, and this has been linked to impairments in a passive 
avoidance learning test (Azadbakht, Radahmadi, Jevanmard, & Reisi, 2015). Furthermore, 
studies of breast-cancer survivors reveal reduced hippocampal volumes and deficits in verbal 
memory performance that are associated with elevated circulating levels of TNF-α (Kesler et al., 
2013). Here, in line with previous research, we report that CORT impairs both OBL and OBIP 
memory, and that etanercept restores memory performance to control levels. The CORT rats 
were not able to discriminate the novel object location in either test, whereas rats in all other 
groups, including the CORT + etanercept rats, performed normally. These findings reinforce the 
idea that TNF-α plays an important role in hippocampal-dependent memory because the OBL is 
a hippocampal dependent task, but interestingly, OBIP relies not only on the hippocampus, but 
also on functional connections between the hippocampus, perirhinal cortex, and medial 
prefrontal cortex (Barker and Warburton, 2015). These connections require intact NMDA 
receptor synaptic plasticity (Barker and Warburton, 2008) and it is notable that one action of 
hippocampal reelin (also restored by etanercept in this experiment) is to regulate the composition 
and trafficking of NMDA receptor subunits (Bosch et al., 2016b). Therefore, the restoration of 
reelin –ir cells by etanercept in this experiment could have played a role in the normalization of 
cognitive behaviour.  
One should consider that etanercept is a large molecule that is unable to cross the blood-
brain barrier (Boado, Hui, Lu, Zhou, & Pardridge, 2010). Peripheral etanercept seems to be able 
to indirectly reduce CNS inflammation as a consequence of decreased peripheral inflammatory 
signals (Kerfoot et al., 2006). A particularly novel finding from this experiment was that 
peripheral administration of etanercept restored CORT-induced deficits in hippocampal 
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neurogenesis. Reductions in hippocampal neurogenesis are a well-documented finding in the 
preclinical stress literature (Sliwowska et al., 2010; Lussier et al., 2013a; Fenton et al., 2015; 
Levone, Cryan, & O’Leary, 2014). However, the role of hippocampal neurogenesis in depression 
is a contentious issue, as ablation of hippocampal neurogenesis does not always induce 
depression- like behaviour (Bessa et al., 2009), and antidepressant effects can be achieved 
without increases in neurogenesis (Hanson, Owens, & Nemeroff, 2011). Furthermore, studies of 
post-mortem tissue from depressed patients previously failed to find reductions in hippocampal 
neurogenesis (Reif et al., 2006); although more recent papers seem to refute that (Boldrini et al., 
2012). Interestingly, Hill, Sahay, and Hen (2015) convincingly demonstrated that increasing 
hippocampal neurogenesis through a transgenic mouse line reversed a CORT- induced 
depressive phenotype, suggesting that neurogenesis per se does play a contributing role in 
antidepressant responses. Moreover, when considering neurogenesis, one should focus not only 
on the number of newborn neurons, but also on the maturation of those neurons, including the 
sprouting of dendritic arborization and integration of new neurons into mature circuits that seem 
to be dampened in depression and rescued by effective antidepressant treatment (Mateus-
Pinherio et al., 2013a,b; Alves et al., 2017; Morais et al., 2017). Importantly, our data indicate 
that peripheral etanercept administration works in rescuing not only the number of new neurons 
but also the maturation rate of hippocampal DCX-ir cells, and this could be one mechanism by 
which etanercept exerts an antidepressant action.  
How might peripheral administration of etanercept be acting to normalize CORT-induced 
deficits in neurogenesis? To our knowledge, this is the first study to report such an effect. It has 
been shown that peripherally produced TNF-α acts on toll-like receptor 4 on circumventricular 
organs and choroid plexus, which in turn stimulates microglia to secrete pro-inflammatory 
cytokines (among them TNF- α), resulting in neurodegenerative events and an increase of 
apoptotic neuronal death (Bortolato, Carvalho, Soczynska, Perini, & McIntyre, 2015). On the 
other hand, low levels of TNF-α are known to produce the opposite effect, promoting 
hippocampal neurogenesis through increased proliferation of neural precursor cells (Fan, Tien, & 
Zhang, 2011). Therefore, peripheral administration of etanercept likely decreases the expression 
of peripheral pro-inflammatory cytokines, which indirectly protects against the deleterious 
effects of CORT. This idea should be further examined in future studies.  
Another novel finding from this experiment is that peripheral injections of etanercept 
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normalize CORT-induced deficits in hippocampal reelin expression. Previous work in our lab 
has shown that CORT decreases the number of reelin-positive cells in the hippocampus (Lussier 
et al., 2009, 2013a; Fenton et al., 2015). We believe that the behavioural and neurobiological 
effects of etanercept observed here are secondary to an increase in hippocampal reelin 
expression: this idea is supported by our previous observation that heterozygous reeler mice, 
which express 50% of the normal levels of reelin, are more susceptible to the depressogenic 
effects of CORT (Lussier, Romay-Tallon, Caruncho, & Kalynchuk, 2011), by previous findings 
showing that the time course for the development of depressive-behaviour in rats coincides with 
the time course for decreased reelin expression (Lussier, 2013a), that the tricyclic antidepressant 
imipramine rescues hippocampal reelin levels in a dose-dependent manner (Fenton, 2015), and 
that oxidative events may be operative in CORT- induced deficits on reelin-ir cells in the dentate 
subgranular zone (Romay-Tallon et al., 2010, 2015). This leads to the idea that blocking 
peripheral TNF-α through the administration of etanercept will decrease excitotoxic insults 
affecting reelin-ir cells in the dentate SGZ, thus restoring the normal release of reelin alongside 
proliferating neurons in the SGZ, which will facilitate the maturation and integration of 
immature neurons and rescue the behavioural phenotype (for a more detailed explanation of this 
hypothesis see Caruncho et al., 2016). Direct support for this idea comes from observations that 
reelin overexpressing mice have increased neurogenesis (Pujadas et al., 2010) and that 
exogenous reelin can recover cognitive deficits in mouse models of both Angelman syndrome 
and Alzheimers Disease (Pujadas et al., 2014; Hethorn et al., 2015). This also dovetails nicely 
with our finding of that etanercept restores both OBL and OBIP memory, as discussed above.  
Finally, we have previously shown that repeated CORT injections reduce GABAA 
receptor expression in the hippocampus (Lussier et al., 2013b). Here, we found that CORT 
decreased the number of GABAA β2/3-ir cells within the subgranular zone, and induced 
GABAA receptor internalization, and etanercept restored this to control levels. TNF-α alters the 
surface expression of AMPA and GABAA receptors by increasing AMPA receptor expression 
and decreasing GABAA receptors (Stellwagen, Beattie, Seo, & Malenka, 2005), which may 
contribute to the excitotoxic effects of upregulated TNF-α in a chronic stress paradigm 
(Bortolato et al., 2015). The normalization of GABAA receptor expression in SGZ cells by 
peripheral etanercept may represent a neuroprotective mechanism that is necessary to facilitate 
SGZ plasticity and restore hippocampal neurogenesis. Indeed, much like reelin, GABA released 
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from local interneurons exerts a depolarizing effect on immature neurons during the time when 
they express DCX, promoting neuronal differentiation and maturation (Song, Killeen, & 
Leonard, 2013). In the absence of GABA, neuronal survival is jeopardized. Therefore, the 
influence of etanercept on GABA function is likely quite important for its antidepressant effects.  
It should also be considered that etanercept is also affecting other body organs: For 
example, clinical studies in rheumatoid arthritis have indicated that etanercept -prescribed 
because of its anti-inflammatory activity-, can increase the risk of developing inflammatory 
bowel disease, lung infections, and pancytopenia (Thavaranjah, Wu, Rhew, Yeldandi, & Kamp, 
2009; Santana et al., 2012; O’Toole, Lucci, & Korzenik, 2016), but these side effects of 
etanercept are not frequently reported and the medication is generally well tolerated. 
5.     Conclusion 
We have shown that peripheral injections of the TNF-α inhibitor etanercept normalize the 
depressogenic effects of repeated CORT administration, possibly through a restoration of 
hippocampal reelin expression, hippocampal neurogenesis, and GABAA β2/3-ir cells in the 
dentate subgranular zone. These results add to the body of literature suggesting that 
inflammatory events are a critical component of the pathogenesis of depression and suggest that 
reelin may be a key link in the relationship between the immune system and brain. Future work 
should examine whether blocking reelin or its signaling mechanisms can abolish the 
antidepressant effect of etanercept. 
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Abstract 
We examined the effects of intrahippocampal reelin infusions on measures of depression-like 
behaviour, cognition, hippocampal neurogenesis, and markers of GABA and glutamate 
neurotransmission. Stereotaxic surgery was conducted and an indwelling cannula was implanted 
into the left dorsal hippocampus. Rodents were then administered 21 days of either 40 mg/kg 
CORT injections or vehicle injections.  Reelin was then infused on days 7, 14, and 21(repeated) 
or only on day 21(single) of corticosterone (CORT) injections. As expected, CORT increased 
depression-like behaviour in the forced swim test and impaired object-location memory. 
Notably, these effects were reversed in rats that received a single reelin infusion before 
behavioural testing. CORT decreased both the number and complexity of adult-generated 
neurons, and a single reelin infusion increased the number but not complexity of adult-generated 
neurons, whereas repeated reelin infusions restored both. CORT increased GluN2B 
immunoreactivity and decreased GluA1-ir cells. Reelin infusions decreased GLUN2B 
immunoreactivity and increased the number of GLUA1-ir cells to control levels. Finally, CORT 
decreased the number of GABAA b2/3-ir cells, and reelin infusions restored this to control levels. 
These novel results demonstrate that a single intrahippocampal reelin infusion into the dorsal 
hippocampus has fast acting antidepressant effects, and is accompanied by a restoration of 
cognitive function, hippocampal neurogenesis, and markers of glutamatergic and GABAergic 
neurotransmission.   
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1. Introduction 
Depression is a debilitating psychiatric disorder estimated to be the leading cause of 
disease burden worldwide by 2030 (Willner, Scheel-Jruger, & Belzung, 2013). The majority of 
antidepressant medications target the monoamine system, however a third of patients do not 
respond to conventional antidepressant treatment (Raison et al., 2013). Further compounding this 
issue is that antidepressants take weeks to achieve their therapeutic effects, which presents a 
problem for depressed patients with suicidal thoughts. In light of this dilemma, novel 
antidepressants with fast-acting properties are required. 
In rodents and humans, chronic stress leads to a significant reduction in reelin-expressing 
cells in the hippocampus (Lussier et al., 2013a; Fatemi, 2005). For example, work in our lab has 
demonstrated that repeated corticosterone (CORT) injections reliably reduce the number of 
reelin-immunoreactive (IR) cells in the subgranular zone (SGZ) of the dentate gyrus (DG). 
Furthermore, the reduction of reelin cell number becomes more exaggerated with increased 
doses of CORT (e.g., 20 vs 40 mg/kg) and longer durations of CORT injections (e.g., 14 vs 21 
days). (Lussier et al., 2013a; Johnson, Fournier, & Kalynchuk, 2006). Heterozygous reeler mice, 
which express 50% of the normal levels of reelin, support this observation. In particular, we have 
shown in a dose-dependent manner that heterozygous reeler mice are more susceptible to 
repeated CORT injections than wild-type controls. Along the same lines, we recently reported 
that the tricyclic antidepressant imipramine restored hippocampal reelin levels and reversed 
depression-like behaviour after CORT treatment, which indicates that restoration of reelin 
expression coincides with an antidepressant response (Fenton et al., 2015). This led us to 
hypothesize that reelin could have antidepressant effects in rats subjected to CORT injections.  
Alterations or impairments of reelin signaling has been implicated in several psychiatric 
conditions, including major depression. Importantly, the therapeutic potential of reelin 
supplementation through genetic overexpression or infusions has been demonstrated across 
several studies. For example, mesial temporal lobe epilepsy is accompanied by granule cell 
dispersion and a loss of reelin in the hilus. Remarkably, application of recombinant reelin to 
hippocampal slice cultures restored the granule cell dispersion to control levels induced by 
kainite (Orcinha et al, 2016). In line with this, intraventricular injections of exogenous reelin has 
been shown to recover synaptic function and cognitive deficits in a mouse model of Angelman 
syndrome (Hethorn et al., 2015). A single intraventricular injection of exogenous reelin was 
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reported to increase hippocampal CA1 long-term potentiation, dendritic spine density, and 
spatial learning and memory in otherwise experimentally naïve mice (Rogers et al., 2011). 
Finally, overexpression of reelin has been found to prevent the behavioural phenotypes of both 
schizophrenia and bipolar disorder (Teixeira et al, 2011). Taken together, these results 
demonstrate that reelin has broad effects on cognitive function and can ameliorate many of the 
structural and functional changes associated with several brain disorders. 
In the current study, we were interested in determining whether intrahippocampal  reelin 
infusions produce an antidepressant response -- a question that has yet to be addressed in the 
literature. To investigate this issue, we used 2 different reelin infusion paradigms across 2 
different time points to evaluate the effects of reelin on both behavioural assays and 
neurobiological markers known to be effected by stress (Fig. 1). We were particularly interested 
in examining the contribution of GABA and glutamate to the potential antidepressant response of 
reelin, as previous work has demonstrated that heterozygous reeler mice display a significant 
reduction in GLUA1 subunit clustering in cultured hippocampal neurons (Qiu and Weeber, 
2007), and reelin is released by GABAergic interneurons (Caruncho et al., 2016). As discussed 
above, based on the findings that supplementation of reelin recovers cognitive function and 
mood, we tested the hypothesis that intrahippocampal reelin infusions would normalize 
depression-like behaviour and cognitive dysfunction induced by repeated CORT injections. We 
also investigated the potential that these changes are accompanied by alterations in GABA and 
glutamate signaling in the DG, a region we have shown to be susceptible to the depressiogenic 
effects of CORT (Lussier et al., 2013a). 
2. Materials and methods 
2.1. Animals 
We used 60 adult male Long-Evans rats purchased from Charles River (QC, Canada). 
The rats weighed 200-250 g at the time of arrival from the breeder. Rats were individually 
housed in rectangular polypropylene cages containing standard laboratory bedding with access to 
food and water ad libitum. The rodent colony room was maintained at an ambient temperature of 
20 ± 1 °C on a 12:12 light-dark cycle (lights on at 7 am). All experimental procedures were in 
accordance with the guidelines of the Canadian Council and Animal Care and an animal care 
protocol approved by the University of Saskatchewan Committee on Animal Care and Supply. 
All efforts were made to minimize the number of rats used in the present study.  
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2.2. Stereotaxic Surgery 
Surgery was conducted as previously described (Botterill, Nogovitsyn, Caruncho, & 
Kalynchuk, 2016; Botterill, Guskjolen, Marks, Caruncho, & Kalynchuk, 2015b). Briefly, rats 
were deeply anesthetized with isoflurane (5% initial, 2-2.5% maintenance) and secured into a 
stereotaxic apparatus using ear bars. Rats were given ketoprofen (Anafen, ketoprofen, 10 mg/kg 
s.c.) to minimize pain and inflammation. At flat skull position, a single cannula (C313G/spc, 
Plastics 1, Roanoke, VA, USA) was chronically implanted into the left hemisphere of the dorsal 
hippocampus using the following coordinates from the rat brain atlas (relative to bregma): -3.5 
mm anteroposterior, +2.6 mm mediolateral, -3.1 mm dorsoventral (Paxinos and Watson, 1998). 
The cannula was secured to the skull with 4 jeweler screws and dental acrylic. We then inserted a 
dummy cannula into the guide cannula to prevent debris from entering the site during the course 
of the study. To minimize the risk of post-surgical infection, we administered the antibacterial-
antifungal ointment Hibitane (Chlorhedixine acetate B.P. 1% [w/w]) daily around the incision 
site for at least one week after the surgery.  
2.3. Experimental Procedures 
2.3.1. CORT and Vehicle Injections 
 All rats were briefly handled once per day for seven days prior to the start of CORT 
injections. We then weight-matched the rats and randomly assigned them to one of the following 
six treatment groups: 21 days of vehicle injections (vehicle, n = 10); 21 days of CORT injections 
(CORT, n = 10); vehicle + a single infusion of reelin on day 21 (vehicle reelin single, n = 10);  
CORT + a single infusion of reelin on day 21 (CORT reelin single, n = 10);  vehicle + 3 
infusions of reelin on days 7, 14, and 21 of injections (vehicle reelin repeated, n = 10); or CORT 
+ 3 infusions of reelin on days 7, 14, and 21 of injections (CORT reelin repeated, n = 10). These 
two reelin infusion paradigms allowed us to compare and contrast the antidepressant effects of 
reelin both acutely and repeatedly (Fig. 1). 
 All CORT and vehicle injections were administered subcutaneously once per day 
(between 9:00 and 10:00 am). CORT (Steraloids, Newport, RI, USA) was suspended in 0.9% 
(w/v) physiological saline with 2% (v/v) Tween-80 (Sigma-Aldrich) and given at a dose of 40 
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Fig 1. Schematic representation of the experimental design used for the study. Stereotaxic 
surgery was performed and a chronic indwelling cannula was inserted into the left dorsal 
hippocampus. Animals were weight-matched and received 21 days of 40mg/kg of corticosterone 
(CORT) or vehicle injections. A subset of animals received infusions of 1µg/ µl of reelin either 
on days 7, 14, and 21 of CORT/vehicle injections, or only on day 21. All rats underwent the 
forced-swim test (FST) on day 21, and a subset of rats were immediately sacrificed (time 1). The 
remaining rats then underwent the object-location memory paradigm (OBL) from days 23-28, 
and were then sacrificed (time 2). All experimental groups were evenly distributed throughout 
both times 1 and 2.  
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mg/kg in a volume of 1 ml/kg. Our lab has reported that the 40 mg/kg dose reliably increases 
depression-like behaviour in rats (e.g., Johnson, Fournier, & Kalynchuk, 2006; Lussier et al., 
2013a, Fenton et al., 2015). The body weight of each rat was recorded daily for the entire 21 
days of CORT or vehicle treatments. 
2.3.2. Intrahippocampal Reelin infusions 
Recombinant reelin (3820-MR-025/CR; R & D Systems, Minneapolis, MN, USA) was 
reconstituted immediately prior to infusions to a working concentration of 1 µg per 1µl in 0.1 M 
PBS (pH = 7.4). Intrahippocampal reelin infusions were administered in a dedicated procedures 
room for the duration of the experiments. We used a 2 µl Hamilton syringe secured to an 
infusion pump (PHD 2000; Harvard Apparatus, Holliston, MA, USA). The tip of the Hamilton 
syringe was inserted into PE-50 tubing that was connected to an infusion needle (C313l/spc, 
Plastics 1) that extended 1 mm below the base of the guide cannula. The infusion needle was 
inserted into the guide cannula of each rat and secured to the base of the cannula pedestal. We 
then infused recombinant reelin directly into the dorsal hippocampus at a rate of 0.5 µl per 
minute. The infusion needle was left in place for an additional two mins after the infusion to 
facilitate diffusion. We then slowly removed the infusion needle from the guide cannula. 
2.4. Behavioural Testing 
 The forced-swim test (FST) and object-location (OBL) paradigm were carried out in a 
dedicated procedures room that was not used for any other aspect of the study. All behaviours 
were recorded with a digital video camera and stored for offline analyses. The FST assessed 
depression-like behaviour (Gregus et al., 2005), while the OBL assessed hippocampal-dependent 
memory (Howland, Cazakoff, & Zhang, 2012).  
2.4.1. Forced swim test 
 The FST was conducted on day 22, the day after the final CORT injection and 
intrahippocampal reelin infusion (Fig. 1). All rats at both time 1 and 2 completed the FST. We 
used a modified version of the Porsolt test, as previously described (Lussier et al., 2013a; 
Gregus, Wintink, Davis, & Kalynchuk, 2005). Each rat was individually placed in a Plexiglas 
swim tank (25 cm wide x 25 cm long x 60 cm high, 27 ± 2 °C water, 30 cm deep) for 10 minutes. 
We measured the duration of time each rat spent immobile, struggling, and swimming.  
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2.4.2. Object Location  
Recognition memory test procedures were similar to previously published protocols 
(Howland, Cazakoff, & Zhang, 2012; Howland and Cazakoff, 2010; Fig.1). Object-location 
memory testing took place in a square open-field area (60x60x60cm) constructed of white 
corrugated plastic.  
Rats that were not sacrificed at time 1 went on to complete the OBL for time 2 (Fig. 1). 
Rats received three habituation sessions before the training session. During the first two 
habituation sessions, rats were brought in pairs and placed in separate arenas for 10 mins. During 
the last habituation session, rats were brought in individually and placed in the arena for 10 
minutes. Rats were immediately returned to the colony room after each habituation session. The 
last habitation occurred 24-48 hours before the first testing session. Objects used were made of 
porcelain and did not exceed 10 cm in height or length. Duplicate copies of objects were used 
when the same objects were required for both training and testing phases. Object locations were 
counterbalanced to eliminate potential side preference in all tests. In both the sample and test 
phases, objects were placed in the corners of the arena 10 cm from each of the nearest walls and 
rats were placed in the center of the arena facing the wall opposite the objects. Both the arena 
and the objects were wiped with 40% EtOH after each session (Howland, Cazakoff, & Zhang, 
2012). 
The rats were allowed to explore two identical objects for 4 minutes during the sample 
phase (C1 and C2). Twenty-four hours later, rats underwent a testing phase, during which they 
explored two copies of the sample objects (C3 and C4) for 4 minutes, but with one object moved 
to a corner location at the front of the box while the other maintained its original position. Data 
were scored by a researcher that was blind to treatment conditions, using previously published 
measures (Howland, Cazakoff, & Zhang, 2012; Howland & Cazakoff, 2010). Briefly, a rat was 
defined to be actively exploring an object when its nose was directed within 2 cm of an object 
and either its head or vibrissae were moving, but not when it was standing on top of an object 
and not directing attention to it. Rats were required to explore objects for at least 15 seconds in 
both the sample and test phases to have reliable recognition memory. The discrimination ratio 
(DR), determined by calculating the time the rat spent exploring the novel orientation subtracted 
by the time the rat spends exploring the familiar orientation and divided by the two, was 
calculated for the first 2 min of the test phase for each rat since previous studies have reported 
 112 
this to be the most sensitive and reliable measure (Howland, Cazakoff, & Zhang, 2012).  
2.5. Histology  
2.5.1. Perfusions  
Rats were sacrificed following the FST at time 1, or upon completing the OBL at time 2 
(Fig. 1). Briefly, each rat was deeply anesthetized with 5% isoflurane and then transcardially 
perfused using room-temperature physiological saline, followed by ice-cold 4% (w/v) 
formaldehyde fixative (pH = 7.4). The brains were extracted from the cranial vault and immersed 
in the same formaldehyde fixative for 48 hours at 4 °C. The brains were then sectioned in the 
coronal plane at 30 µm on a vibrating microtome (VT1200s, Leica Biosystems, Nussloch, 
Germany). Sections were collected and stored at −20 °C until use in a cryoprotectant solution 
containing 30% (w/v) sucrose, 1% (w/v) polyvinylpyrrolidone, and 30% (v/v) ethylene glycol in 
0.1 M PBS (pH = 7.4).  
2.5.2 Immunohistochemistry  
 We used a standard immunohistochemistry technique with widely used and commercially 
available antibodies for all of our experiments. Immunostaining was done on free-floating 
sections in six-well tissue culture plates under gentle agitation for every step. To ensure 
consistent immunohistochemical processing, we processed all sections in unison with treatment 
groups counterbalanced across all tissue plates. To confirm the specificity of our antibodies, we 
omitted the primary antibody from an additional well of free-floating sections. In the absence of 
the primary antibody, we were unable to detect any immunoreactive cells.  
 Doublecortin immunohistochemistry was run as previously described (Botterill, Brymer, 
Caruncho, & Kalynchuk, 2015a; Lussier et al., 2013a). Sections underwent heat-induced epitope 
retrieval in sodium citrate buffer (pH = 6.0) at 85 °C for 30 minutes. The sections were then 
blocked in 5% (v/v) normal goat serum (NGS), 1% (w/v) bovine serum albumin (BSA), and 
0.5% (v/v) Triton X-100 in 0.1 M TBS (pH = 7.4), followed by incubation in a rabbit anti-
doublecortin (DCX) polyclonal primary antibody (1:1000, catalog #4604S, RRID: AB_561007; 
Cell Signalling Technologies) diluted in blocking solution for 24 h at room temperature. On the 
following day, the sections were treated with 5% (v/v) H2O2 in 0.1 M TBS for 30 minutes to 
block endogenous peroxidase activity. The sections were then incubated for 1 hour in 
biotinylated goat anti-rabbit secondary antibody (1:500, catalog #BA-1000, RRID: 
AB_2313606; Vector Laboratories) diluted in 5% (v/v) NGS, 1% (w/v) BSA, and 0.5% (v/v) 
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Triton X-100 in 0.1 M TBS, followed by avidin-biotin peroxidase complex (1:500, Vector 
Laboratories) for 1 hour. Sections were then rinsed with 0.175 M sodium acetate (pH = 6.8) and 
visualized with 0.025% (w/v) DAB, 4.167% NiSO4, and 0.002% (v/v) H2O2. The sections were 
then mounted onto glass slides using 0.2 M PB (pH = 7.4), air dried overnight, dehydrated using 
a series of graded alcohols, cleared in xylene, and coverslipped with Permount mounting 
medium (Fisher Scientific, Fair Lawn, NJ, USA).  
 To visualize GLUA1 and GLUN2B staining, sections first underwent heat-induced 
epitope retrieval in sodium citrate buffer (pH = 6.0) at 85 °C for 30 mins. Next, the sections were 
placed into a blocking solution containing 5% (v/v) normal animal serum, 1% (w/v) BSA, and 
0.5% (v/v) Triton X-100 in 0.1 M TBS for 30 minutes, and then exposed to either a polyclonal 
rabbit anti-glutamate receptor 1 (GLUA1; 1:1000, catalog #AB1504, RRID: AB_11212863; 
Millipore) or a monoclonal mouse anti-GLUN2B primary antibody (1:1000, catalog #75-101, 
RRID: AB_2232584; NeuroMab) diluted in blocking solution for 48 hours at 4°C. Following 
this, sections were treated with 5% (v/v) H2O2 in 0.1 M TBS for 30 minutes to block 
endogenous peroxidase activity. Next, the sections were incubated for 2 hours in either a 
biotinylated goat anti-rabbit secondary antibody (1:500, catalog #BA-1000, RRID: 
AB_2313606; Vector Laboratories) or a  horse-anti mouse secondary antibody (1:500, catalog 
#BA-2000. RRID: AB_2313571;Vector Laboratories) diluted in 5% (v/v) normal animal serum, 
1% (w/v) BSA, and 0.5% (v/v) Triton X-100 in 0.1 M TBS, followed by avidin-biotin 
peroxidase complex (1:500, Vector Laboratories) for 1 hour. The sections were then rinsed with 
0.175 M sodium acetate (pH = 6.8) and visualized with 4.167% NiSO4 and 0.05% (w/v) glucose 
oxidase DAB (Shu, Ju, & Fan, 1988; Botterill et al., 2016). Sections were then mounted onto 
glass slides using 0.2 M PB (pH = 7.4), air dried overnight, dehydrated using a series of graded 
alcohols, cleared in xylene, and coverslipped with Permount mounting medium (Fisher 
Scientific).  
 GABAA b2/3 receptor subunit immunohistochemistry was conducted as follows. Sections 
first underwent heat-induced epitope retrieval in sodium citrate buffer (pH = 6.0) at 85 °C for 30 
min. Next, the sections were placed into a blocking solution containing 5% (v/v) NHS, 1% (w/v) 
BSA, and 0.5% (v/v) Triton X-100 in 0.1 M TBS for 30 min, and were then exposed to a 
monoclonal mouse anti-GABAA b2/3 receptor primary antibody (clone bd17, 1:1000, catalog 
#MAB341, RRID: AB_2109419; Millipore) diluted in blocking solution for 48 hours at 4°C. 
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Following this, the sections were treated with 5% (v/v) H2O2 in 0.1 M TBS for 30 minutes to 
block endogenous peroxidase activity. Next, the sections were incubated for 2 hours in 
biotinylated horse anti-mouse secondary antibody (1:500, catalog #BA-2000. RRID: 
AB_2313571;Vector Laboratories) diluted in 5% (v/v) NHS, 1% (w/v) BSA, and 0.5% (v/v) 
Triton X-100 in 0.1 M TBS, followed by avidin-biotin peroxidase complex (1:500, Vector 
Laboratories) for 1 hour. The sections were then rinsed with 0.175 M sodium acetate (pH = 6.8) 
and visualized with 4.167% NiSO4 and 0.05% (w/v) glucose oxidase DAB. Sections were then 
mounted onto glass slides using 0.2 M PB (pH = 7.4), air dried overnight, dehydrated using a 
series of graded alcohols, cleared in xylene, and coverslipped with Permount mounting medium 
(Fisher Scientific). 
2.5.2.1. Quantification of Immunohistochemistry 
2.5.2.1.1. Cell Counting  
 Quantification of immunohistochemistry was conducted as previously described 
(Botterill, Brymer, Caruncho, & Kalynchuk, 2015a; Lussier et al., 2013a). All analyses were 
conducted by researchers blind to the treatment conditions. Immunostained sections were 
examined using a Nikon Eclipse E800 microscope with a motorized stage and digital camera 
(MicroFire, Optronics, Goleta, CA, USA) connected to a dedicated stereology computer. The 
dentate subgranular zone (SGZ: defined as a two-cell width zone in between the inner granule 
cell layer and the hilus) and granule cell layer (GCL) were traced at 4 X magnification using a 
computerized stereology program for DCX-ir cells. However, only the SGZ was traced for 
GLUA1-ir cells and GABAA b2/3-ir cells (StereoInvestigator, MicroBrightfield, Williston, VT, 
USA). DCX, GLUA1, and GABAA b2/3-ir cells were counted in both the ipsilateral and 
contralateral hemispheres at 40 x magnification. All counts utilized unbiased stereology using a 
modified optical fractionator method that excludes cells in focus at the uppermost focal plane to 
reduce oversampling (Lussier et al., 2013a). The total number of DCX, GLUA1, and GABAA b 
2/3-ir cells was estimated using the following formula: Ntotal = ∑Q− × 1 / ssf × A(x, y step) / 
a(frame) × t / h. ∑Q− represents the number of counted cells, ssf is the section sampling fraction 
(1 in 12), A(x, y step) is the area associated with each x, y movement (10,000 µm2), a(frame) is 
the area of the counting frame (3600 µm2), t is the weighted average section thickness, and h is 
the height of the dissector (12 µm) (Botterill 2015a; Fenton et al, 2015; Lussier, 2013a.). To 
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avoid counting sectioning artifacts, we used a guard zone of 2 µm. 
2.5.2.1.2. Characterization of Immature DCX-ir Neurons 
 We utilized a dendritic categorization method that our laboratory has used in the past 
(Botterill, Brymer, Caruncho, & Kalynchuk, 2015a; Lussier et al., 2013a) to determine if our 
intrahippocampal reelin infusions paradigm altered the dendritic morphology of immature DCX-
ir neurons. A meander scan method was used to randomly select 100 DCX-ir cells from each rat. 
A researcher blind to experimental conditions then assigned the cell to one of six complexity 
categories based on both the presence and extent of apical dendrites (Fig. 3). The proliferative 
stage encompassed categories one (no process) or two (one small process). Category three 
(medium process reaching the granule cell layer) and category four (process reaching the 
molecular layer) make up the intermediate stage of development. Finally, category five (one 
major process extending into the molecular layer) and category six (defined dendritic tree with 
delicate dendritic branching in the granule cell layer) represented the postmitotic stage. Data are 
presented as the percentage of DCX-ir cells in each of the six categories.  
2.5.2.1.3. Optical Densitometry  
Semiquantitative optical densitometry of GLUN2B immunoreactivity was run on 3 
sections per brain with 300 µm between sections using methods previously described by our 
laboratory (Botterill, Guskjolen, Marks, Caruncho, & Kalynchuk, 2015b). Briefly, we took 
grayscale photomicrographs on our Nikon E800 microscope with exposure and gain settings held 
constant for every subject. We then used ImageJ software (V1.46R, National Institutes of Health, 
Bethesda, MD, USA) to calculate the mean optical density for each region of interest, which 
calculates the intensity of an immunoreaction product within a traced circle. To control for 
background staining, the mean optical density of the corpus callosum was subtracted from each 
region of interest.  All values were standardized between white (0) and black (255) and 
expressed as percentage change from controls. 
2.6. Statistical Analyses 
 All statistical analyses were carried out using IBM’s Statistical Package for Social 
Sciences v24. We determined statistical significance using one-way analysis of variance 
(ANOVA), and post hoc comparisons were made using Tukey HSD when appropriate. The 
criterion for statistical significance was set at p < 0.05. All graphs depict the mean ± standard 
error of the mean.  
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3. Results 
3.1. CORT had Significant Effects on body Weight with no Supplementary Effects of Reelin 
We first sought to determine if intrahippocampal reelin infusions were ameliorating 
CORT-induced decreases in body weight. We pooled the body weights across both times 1 and 
2, as all experimental groups were evenly distributed through both times. Accounting for rats 
being weight matched to begin the study, significant group differences for body weight were 
found for days 7 (F(5, 59) = 7.870, p < .001),14 (F(5, 59) = 13.778, p < .001), and 21 (F(5, 59) = 
14.436, p < .001). Post hoc analyses revealed that the CORT rats weighed significantly less than 
vehicle and vehicle reelin single rats at day 7 (p values < .05), significantly less than the vehicle, 
vehicle reelin single, and vehicle reelin repeated rats at day 14 (p values < .05), and significantly 
less than the vehicle, vehicle reelin single, and vehicle reelin repeated rats at day 21 (p values < 
.05) (Fig. 2). The CORT reelin single rats weighed significantly less than the vehicle rats on day 
7 (p < .05), significantly less than the vehicle and vehicle reelin single rats on day 14 (p values < 
.05), and significantly less than the vehicle, vehicle reelin single, and vehicle reelin repeated rats 
on day 21 (p values < .05). The CORT reelin repeated rats weighed significantly less than the 
vehicle and vehicle reelin single rats at day 7 (p values < .05), significantly less than the vehicle, 
vehicle reelin single, and vehicle reelin repeated rats at day 14 (p values < .05), and significantly 
less than the vehicle, vehicle reelin single, and vehicle reelin repeated rats at day 21 (p values < 
.05).  
3.2. CORT Increases Depression-like Behaviour on the FST and this is Reversed by Reelin 
It is well established that stress increases depression-like behaviour on the FST. As 
overexpression of reelin has been found to reverse the behavioural phenotypes of bipolar and 
schizophrenia, we were interested in determining if intrahippocampal reelin infusions could 
produce an antidepressant effect on the FST. Here, we pooled the FST analyses across both times 
1 and 2 as all groups were represented at both time points. We found significant group 
differences for immobility (F(5,59) = 18.01, p < .001), struggling (F(5,59) = 3.94, p < .01), and 
swimming (F(5,59) = 9.94, p < .001) (Fig. 1). Post hoc analyses revealed that the CORT rats 
spent significantly more time immobile compared to all other groups (all p values < 0.5), less 
time struggling than vehicle (p values < .05), cort reelin single, and vehicle reelin repeated, but 
not vehicle reelin single (p = .051) or CORT reelin repeated (p = .141), and less time swimming 
than all other groups (p values < .05). No other significant group differences were observed (all p  
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Fig 2. Mean body weight through days 1-21, collapsed across both times 1 and 2. Panel A shows 
that CORT-treated and CORT reelin repeated rats weighed less than vehicle, vehicle reelin 
single, and vehicle reelin repeated rats on day 14 (p < .05) and 21 (p < .05) and significantly less 
than vehicle and vehicle reelin single rats on day 7 (p < .05), and CORT reelin single rats 
weighed significantly less than vehicle and vehicle reelin single rats on days 7 and 14 (p < .05), 
and significantly less than vehicle, vehicle reelin single, and vehicle reelin repeated rats on day 
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21 (p < .05). Panel B-D; CORT had significant effects on depression-like behaviour, and 
treatment with reelin reversed this in a fast-acting manner. Data are collapsed across times 1 and 
2. Panel B shows the effects of treatment on time spent immobile in the FST. CORT-treated rats 
spent significantly more time immobile than all other groups (p < .05). Panel C shows the effects 
of treatment on time spent struggling. CORT-treated rats spent significantly less time struggling 
than all other groups (p < .05). Panel D shows the effects of treatment on time spent swimming. 
The CORT rats spent significantly less time swimming than all other groups (p < .05). CORT 
had significant effects on OBL memory, and reelin restored this. Panel E shows the 
discrimination ratio for the OBL variant. The CORT rats had a significantly lower discrimination 
ratio than all other groups (p < .05). All data are represented as means ± standard error of the 
mean.  
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values > .05) (Fig 2.). 
3.3. CORT Impairs Hippocampal-Dependent Memory and Reelin Reverses this Effect  
 After we demonstrated that intrahippocampal reelin infusions produced an antidepressant 
effect on the FST, we next sought to determine if reelin could also reverse CORT-induced 
deficits in cognition at time 2, a finding that we have shown in the past (Brymer et al., 2018). We 
observed a significant main effect of treatment on object-location performance (F(5,29) = 7.74, p 
< .001) (Fig. 2). Post hoc analyses revealed that the CORT rats had a significantly lower 
discrimination ratio than all other groups (all p values < .01) (Fig. 2). 
3.4. Intrahippocampal Reelin Infusions Protect Against the Deleterious Effects of CORT on 
Hippocampal Neurogenesis 
As treatment with CORT reliably reduces the number and complexity of immature DCX-
ir adult-generated neurons, we were interested in examining if intrahippocampal reelin infusions 
could reverse this deficit. At time 1, stereological analyses revealed significant group differences 
in DCX immunostaining in both the ipsilateral (F(5, 29) = 5.329, p < .01) and contralateral (F(5, 
29) = 4.391, p < .01) SGZ/GCL. Post hoc analyses revealed that the CORT rats had significantly 
fewer DCX-ir cells within the SGZ/GCL in the ipsilateral hemisphere than all other groups (p 
values < .05) except for the vehicle rats (p = .148). Interestingly, post hoc analyses revealed that 
in the contralateral hemisphere, the CORT reelin single rats were not significantly different from 
the CORT rats (p = .317), however the remaining groups were significantly different from CORT 
(p values < .05). Significant group differences were found when combining the ipsilateral and 
contralateral hemisphere, (F(5, 29) = 4.790, p < .01). Post hoc tests revealed that the CORT rats 
had significantly fewer DCX-ir cells than all other groups (p values < .05).  
We next examined dendritic complexity. We found significant group differences for 
categories 1 (F(5, 29) = 3.966, p < .01), 2 (F(5, 29) = 18.377, p < .001), 5 (F(5, 29) = 10.711, p < 
.001), and 6 (F(5, 29) = 4.043, p < .01) (Fig. 7). For DCX-ir cells in the proliferative stages of 
maturation, post hoc analyses revealed that the CORT rats had significantly more category 1 
cells than the vehicle reelin repeated and CORT reelin repeated rats (p values < .05), but not the 
vehicle (p = .187), vehicle reelin single (p =.106), or CORT reelin single rats (p = .123). The 
CORT rats also had significantly more category 2 cells than all other groups (p values < .05) 
except for the CORT reelin single-treated rats (p = .103). For DCX-ir cells in the intermediate 
stages of development, no significant group differences were found (p values > .05). Finally, for 
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DCX-ir cells in the post-mitotic stages of maturation, the CORT rats had significantly fewer 
categories 5 cells than all other groups except for the CORT reelin single rats (p = .205), and 
significantly fewer category 6 cells than the vehicle reelin single, vehicle reelin repeated, and 
CORT reelin repeated rats (p values < .05), but not the vehicle (p = .051) or CORT reelin single 
rats (p = .507) (Fig. 4). 
Overall, we found that at time 1, 24 hours after the last infusion, a single 
intrahippocampal reelin infusion increased the number of DCX cells in the ipsilateral hemisphere 
but did not restore dendritic complexity, while repeated infusions restored both of these 
measures. We next were interested in determining how this changed by time 2. Stereological 
analyses revealed significant group differences in both the ipsilateral (F(5, 29) = 7.958, p < .001) 
and contralateral (F(5, 29) = 5.266, p < .01) SGZ/GCL. Post hoc analyses revealed that the 
CORT rats had significantly fewer DCX-ir cells within the SGZ/GCL across both hemispheres 
than all other groups (all p values < .05). Significant group differences were found when 
combining the ipsilateral and contralateral hemispheres, (F(5, 29) = 7.381, p < .001. Post hoc 
analyses revealed that the CORT rats had significantly fewer DCX-ir cells than all other groups. 
Next, to quantify if intrahippocampal reelin infusions influenced the complexity of immature 
DCX-ir neurons, we examined their dendritic morphology (Fig. 4) We found significant group 
differences for categories 1 (F(5, 29) = 98.072, p < .001), 2 (F(5, 29) = 64.019, p < .001), 4 (F(5, 
29) = 9.359, p < .001), 5 (F(5, 29) = 10.172, p < .001), and 6 (F(5, 29) = 20.731, p < .001). For 
DCX-ir cells in the proliferative stages of maturation, post hoc analyses revealed that the CORT 
rats had significantly more category 1 and 2 cells than all other groups (all p values < .001). For 
DCX-ir cells in the intermediate stages of development, we found that the CORT rats had 
significantly fewer category 4 cells than all other groups (all p values < .05). Finally, for DCX-ir 
cells in the post-mitotic stages of maturation, the CORT rats had significantly fewer category 5 
and 6 cells than all other groups (all p values < .001) (Fig. 4). 
3.5. Treatment with CORT Reduces GLUA1-Positive cells Within the SGZ and Reelin Reverses 
this  
Given that heterozygous reeler mice with only 50% normal levels of reelin have 
significantly reduced expression of GLUA1 subunit clustering, and that heterozygous reeler mice 
are more susceptible to the deleterious effects of CORT (Lussier et al., 2011) we examined the 
number of GLUA1-positive cells in the SGZ. At time 1, stereological analyses revealed  
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Fig. 3 Effects of reelin on hippocampal neurogenesis at time 1. CORT had significant effects on 
hippocampal neurogenesis. Panel A shows representative photomicrographs of doublecortin 
expression in the granule cell/subgranular zone. Panel B and C shows the effects of treatment on 
the number of doublecortin-ir cells in the granule cell/subgranular zone. The CORT rats had 
significantly fewer doublecortin-ir cells in the ipsilateral hemisphere than vehicle reelin single, 
CORT reelin single, vehicle reelin repeated, and CORT reelin repeated animals (p < .05). In the 
contralateral hemisphere, the CORT rats had significantly fewer doublecortin-ir cells than 
vehicle, vehicle reelin single, vehicle reelin repeated, and CORT reelin repeated animals (p < 
.05). When combining the ipsilateral and contralateral hemispheres, the CORT rats had 
significantly fewer DXC-ir cells than all other groups. Panel D shows the quantified 
categorization of dendritic complexity using doublecortin staining. All data are represented as 
means ± standard error of the mean. VRS = vehicle reelin single; CRS = CORT reelin single; 
VRR = vehicle reelin repeated; CRR = CORT reelin repeated. 
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Fig 4. Effects of reelin on hippocampal neurogenesis at time 2. CORT had significant effects on 
hippocampal neurogenesis. Panel A shows representative photomicrographs of doublecortin 
expression in the granule cell/subgranular zone. Panel B and C shows the effects of treatment on 
the number of doublecortin-ir cells in the granule cell/subgranular zone. The CORT rats had 
significantly fewer doublecortin-ir cells in the ipsilateral hemisphere than all other groups (p < 
.05). In the contralateral hemisphere, the CORT rats had significantly fewer doublecortin-ir cells 
than all other groups (p < .05). When combining the ipsilateral and contralateral hemispheres the 
CORT rats had significantly fewer DXC-ir cells than all other groups. Panel D shows the 
quantified categorization of dendritic complexity using doublecortin staining. All data are 
represented as means ± standard error of the mean. VRS = vehicle reelin single; CRS = CORT 
reelin single; VRR = vehicle reelin repeated; CRR = CORT reelin repeated. 
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significant group differences in both the ipsilateral (F(5, 29) = 5.949, p < .001) and contralateral 
hemispheres (F(5, 29) = 7.473, p < .001) SGZ (Fig. 5). Post hoc analyses revealed that the 
CORT rats had significantly fewer GLUA1-ir cells across both hemispheres compared to all 
other groups (all p values < .05). At time 2, stereological analyses revealed significant main 
effects in both the ipsilateral (F(5, 29) = 4.196, p < .01) and contralateral (F(5, 29) = 4.196, p < 
.01) SGZ. Post hoc analyses revealed that the CORT rats had significantly fewer GLUA1-ir cells 
in the ipsilateral hemisphere compared to all other groups (p values < .05), except for the vehicle 
rats (p = .065), and the CORT rats also had significantly fewer GLUA1-ir cells in the 
contralateral hemisphere than all other groups (p values < .05), except for the vehicle reelin 
repeated rats (p = .444) (Fig. 5). 
3.6. GLUN2B 
 To investigate if CORT produces alterations in GLUN2B immunoreactivity and if 
treatment with reelin ameliorates this effect, we conducted semi-quantitative optical 
densitometry of GLUN2B. At time 1, our densitometry analyses revealed significant group 
differences in the ipsilateral GCL (F(5, 29) = 5.436, p < .01), ipsilateral SGZ (F(5, 29) = 5.618, p 
< .001), ipsilateral hilus (F(5, 29) = 4.357, p < .01), ipsilateral molecular layer (F(5, 29) = 
18.430, p < .001), contralateral GCL (F(5, 29) = 4.924, p < .01), contralateral SGZ (F(5, 29) 
=3.087, p < .05), and contralateral molecular layer (F(5, 29) = 9.052, p < .001) (Fig. 6). Post hoc 
analyses revealed that the CORT rats had significantly greater GLUN2B immunoreactivity in the 
ipsilateral GCL than all other groups (p values < .05) except for the CORT reelin repeated rats (p 
= .152). The CORT rats also had greater immunoreactivity in the SGZ than the vehicle and all 
reelin-treated groups (p values < .05) except for the CORT reelin repeated rats (p = .063) and  
greater immunoreactivity in the hilus than the vehicle reelin single, vehicle reelin repeated, and 
CORT reelin single (p < .05), but not vehicle (p =.077) or CORT reelin repeated rats (p = .113). 
Finally, the CORT rats had greater immunoreactivity in the molecular layer than all other groups 
(all p values < .05).  
In the contralateral hemisphere, the CORT rats had significantly greater GLUN2B 
immunoreactivity in the GCL than all other groups (all p values < .05), greater immunoreactivity 
in the SGZ than the vehicle and vehicle reelin acute (p values < .05), but not CORT reelin single 
(p = .090), vehicle reelin repeated (p = .063), or CORT reelin repeated rats (p = .233), and 
greater immunoreactivity in the molecular layer than all other groups (all p values < .05). No  
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Fig 5. Effects of reelin on GLUA1-ir cells at times 1 and 2. Panel A shows representative 
photomicrographs of GLUA1 expression in the subgranular zone. Panel B shows the effects of 
treatment on the number of GLUA1-ir cells. The CORT rats had significantly fewer GLUA1-ir 
cells than all other groups in the ipsilateral hemisphere (p < .05) and contralateral hemisphere (p 
< .05), indicating that reelin is acting rapidly to normalize this deficit. Panel C shows 
representative photomicrographs of GLUA1 expression in the subgranular zone at time 2. The 
CORT rats had significantly fewer GLUA1-ir cells in the ipsilateral hemisphere than the vehicle 
reelin single, CORT reelin single, vehicle reelin repeated, and CORT reelin repeated rats (p < 
.05). In the contralateral hemisphere, the CORT rats had significantly fewer GLUA1-ir cells than 
vehicle, vehicle reelin single, CORT reelin single, and CORT reelin repeated rats (p < .05). All 
data are represented as means ± standard error of the mean. VRS = vehicle reelin single; CRS = 
CORT reelin single; VRR = vehicle reelin repeated; CRR = CORT reelin repeated.  
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significant group differences were found for the contralateral hilus. We conducted optical 
densitometry of the sub regions CA3 and CA1, however no significant group differences were 
found (all p values > .05). 
At time 2, our analyses revealed significant group differences in the ipsilateral GCL (F(5, 
29) = 13.434, p < .001), SGZ (F(5, 29) = 9.858, p < .001), hilus (F(5, 29) = 11.591, p < .001), 
molecular layer (F(5, 29) = 5.828, p < .001) and the contralateral GCL (F(5, 29) = 15.211, p < 
.001), SGZ  (F(5, 29) = 10.628, p < .001), hilus (F(5, 29) = 7.273, p < .001), and molecular layer 
(F(5, 29) = 5.281, p < .01) (Fig. 7). Post hoc analyses revealed that the CORT rats had greater 
GLUN2B immunoreactivity within the ipsilateral GCL than all other groups (all p values 05), 
greater immunoreactivity in the ipsilateral SGZ than all other groups (p values < .05), greater 
immunoreactivity in the hilus than all other groups (p values < .05), and greater 
immunoreactivity in the ipsilateral molecular layer than the vehicle reelin acute, vehicle reelin 
repeated, and CORT reelin repeated rats (p values < .05) but not the vehicle (p = .081) or CORT 
reelin single (p = .636) rats. In the contralateral hemisphere, the CORT rats had significantly 
greater GLUN2B immunoreactivity within the GCL than all other groups (all p values < .05), 
greater immunoreactivity in the SGZ than all other groups (all p values < .05), greater GLUN2B 
immunoreactivity in the hilus than all other groups (p values < .05) except for the CORT reelin 
single-treated rats (p = .347), and greater immunoreactivity in the molecular layer than all other 
groups (p values < .05), except for the CORT reelin single rats (p = .723). We conducted optical 
densitometry of the sub regions CA3 and CA1, however no significant group differences were 
found (all p values > .05). 
3.7. Reelin Reduces CORT-Induced Deficits in GABAA b2/3-ir cells in the SGZ 
 We have previously found that CORT injections significantly reduce the number of 
GABAA b2/3-ir cells in the SGZ (Brymer et al., 2018). As reelin is released by GABAergic 
interneurons in the hippocampus, we investigated whether intrahippocampal reelin infusions 
could normalize this effect. At time 1, stereological analyses revealed group differences in the 
ipsilateral SGZ (F(5,29) = 5.90, p <.001) and contralateral SGZ (F(5,29) = 5.45, p < .01). Post 
hoc analyses showed that the CORT rats had significantly fewer GABAA b2/3-ir cells in the 
ipsilateral SGZ than all other groups (p values < .05) and significantly fewer GABAA b2/3-ir 
cells in the contralateral hemisphere than the vehicle, vehicle reelin repeated, and CORT reelin 
repeated rats (p values < .05), but not the vehicle reelin single (p = .068) or CORT reelin single 
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rats (p = .431). At time 2, our analyses revealed significant group differences in the ipsilateral 
SGZ (F(5,29) = 3.54, p < .05) but not the contralateral SGZ (F(5,29) = 1.89, p = .133). Post hoc 
analyses revealed that the CORT rats had significantly fewer GABAA b2/3-ir cells in the 
ipsilateral SGZ than the vehicle and CORT reelin single rats (p values < .05), but not the vehicle 
reelin single (p = .055), vehicle reelin repeated (p = .359) or CORT reelin repeated rats (p = 
.054) (Fig. 8.) 
4. Discussion  
Our results show that CORT produced clear behavioural and neurobiological changes across 
multiple measures. Specifically, CORT increased immobility time in the FST, impaired  
spatial memory on the OBL test, reduced hippocampal neurogenesis, decreased the number of 
GLUA1-ir cells in the SGZ, increased GLUN2B immunoreactivity across the DG, and dampened 
GABAA α2/3 expression levels. Importantly, intrahippocampal reelin infusions reversed these 
effects, suggesting that reelin could be exerting its antidepressant effects by facilitating 
hippocampal plasticity.  
Reelin as a fast-acting antidepressant 
 Previous work in our lab and others has demonstrated that CORT treatment in rats creates 
a depressive phenotype characterized by increased immobility time in the FST compared to 
control rats (Lussier et al., 2013a), inhibited sexual behaviour (Gorzalka, Hanson, & Hong, 
2001), decreased sucrose preference (David et al., 2009) and increased anxious behaviour in the 
predator odor test (Kalynchuk, Gregus, Boudrea, & Perrot-Sinal, 2004). We have recently shown 
that the TNF-α inhibitor etanercept and triclyclic antidepressant imipramine normalize 
immobility behaviour in the FST (Brymer, Fenton, Kalynchuk, & Caruncho, 2018; Fenton et al., 
2015). Unexpectedly, our results here show that a single infusion of reelin 24 hours before 
behavioural testing restored time spent immobile on the FST to control levels. Repeated reelin 
infusions produced the same effect. What was unexpected about these results was the fasting 
acting nature of reelin. We had strong reason to believe that reelin would show antidepressant 
properties, but we did not expect those effects to occur over such a fast timeline. Work in our lab 
has shown that CORT treatment selectively reduces the number of reelin-positive cells in the 
SGZ, and the time course for the development of depression-like behaviour coincides with the 
time course for decreased reelin expression (Lussier et al., 2013a). Furthermore, we have also 
demonstrated that heterozygous reeler mice, which express 50% of the normal levels of reelin,  
 130 
 
 
 131 
Fig 6. Effects of reelin on GLUN2B immunoreactivity at time 1. Panel A shows representative 
photomicrographs of GLUN2B expression in the dentate gyrus. Panel B shows the effects of 
treatment on GLUN2B expression in the ipsilateral hemisphere. CORT treatment increased 
GLUN2B immunoreactivity throughout the major subfields of the DG, and reelin reversed this. 
Panel C shows the effects of treatment on GLUN2B expression in the contralateral hemisphere. 
CORT treatment increased expression of GLUN2B throughout the major subfields of the DG, 
and reelin reversed this. All data are represented as means ± standard error of the mean. VRS = 
vehicle reelin single; CRS = CORT reelin single; VRR = vehicle reelin repeated; CRR = CORT 
reelin repeated. 
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Fig 7. Effects of reelin on GLUN2B immunoreactivity at time 2. Panel A shows representative 
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photomicrographs of GLUN2B immunoreactivity in the DG. Panel B shows the effects of 
treatment on GLUN2B immunoreactivity in the ipsilateral hemisphere. CORT treatment 
increased GLUN2B immunoreactivity throughout the major subfields of the DG, and reelin 
reversed this. Panel C shows the effects of treatment on GLUN2B immunoreactivity in the 
contralateral hemisphere. CORT treatment increased GLUN2B immunoreactivity throughout the 
major subfields of the DG, and reelin reversed this. All data are represented as means ± standard 
error of the mean. VRS = vehicle reelin single; CRS = CORT reelin single; VRR = vehicle reelin 
repeated; CRR = CORT reelin repeated. 
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Fig 8. Effects of reelin on GABAAb 2/3-ir cells at times 1 and 2. Panel A shows representative 
photomicrographs of GABAA b2/3 expression in the dentate gyrus at time 1. Panel B shows the effect of 
treatment on GABAA b2/3-ir cells in the subgranular zone. The CORT rats had significantly fewer 
GABAA b2/3-ir cells than all other groups in the ipsilateral hemisphere (p < .05). In the contralateral 
hemisphere, the CORT rats had significantly fewer GABAA b2/3-ir cells than the vehicle, vehicle reelin 
repeated, and CORT reelin repeated rats (p < .05). Panel C shows representative photomicrographs of 
GABAA b2/3-ir expression in the dentate gyrus at time 2. Panel D shows the effect of treatment on 
GABAA b2/3-ir cells in the subgranular zone. The CORT rats had significantly fewer GABAA b2/3-ir 
cells than the vehicle and CORT reelin single rats in the ipsilateral hemisphere (p < .05). All data are 
represented as means ± standard error of the mean. VRS = vehicle reelin single; CRS = CORT 
reelin single; VRR = vehicle reelin repeated; CRR = CORT reelin repeated. 
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are more susceptible to the depressogenic effects of CORT (Lussier et al., 2011). Work in 
humans confirms this observation, with depressed patients exhibiting a reduction in reelin-
positive hippocampal cells (Fatemi, Earle, & McMenomy, 2000). Taken together, our findings 
and the literature presented here suggest that reelin is critically involved in the pathogenesis of 
depression, and that increasing hippocampal reelin levels produces fast-acting antidepressant 
effects. How might reelin be achieving its fast-acting antidepressant effects? Our findings 
suggest a role for hippocampal neurogenesis or an interaction between glutamate and GABA. 
Reelin as a mediator of spatial learning and memory 
 Chronic stress impairs hippocampal dependent memory, with deficits in fear conditioning 
and OBL memory observed (Brymer, Fenton, Kalynchuk, & Caruncho, 2018; Hoffman, Lorson, 
Sanabria, Olive, & Conrad, 2014; Hattiangady et al., 2014). Reelin is critically involved in 
cognition, particularly spatial memory. For example, a single intraventricular injection of reelin 
in naïve mice has been reported to increase spatial learning and memory (Rogers et al., 2011). 
Furthermore, reelin supplementation in a mouse model of angelman syndrome recovers deficits 
in spatial learning and memory (Hethorn et al., 2015). Our findings are in line with previous 
research, as we report that intrahippocampal reelin infusions restore CORT-induced deficits in 
OBL memory, with as little as one infusion. This reinforces the idea that reelin is involved in 
spatial learning and memory, as the OBL is a hippocampal-dependent task. Hippocampal-
dependent memory requires NMDA receptor synaptic plasticity (Barker and Warburton, 2008), 
and hippocampal reelin regulates the composition and trafficking of NMDA receptor subunits 
(Bosch et al., 2016b). Interestingly, the OBL requires intact NMDA receptor synaptic plasticity 
within the hippocampus (Barker and Warburton, 2008). Therefore, a restoration of CORT-
induced reductions in reelin by intrahippocampal reelin infusions may have played a role in the 
normalization of cognitive behaviour, and most likely requires a contribution of glutamate.  
Reelin and hippocampal neurogenesis 
 The role of hippocampal neurogenesis in depression is currently unclear, as 
antidepressant effects can be achieved without increases in neurogenesis (Hanson, Owens, & 
Nemeroff, 2011) and studies of post-mortem hippocampal tissue from patients with depression 
have generally failed to find reductions in neurogenesis (Reif et al., 2006). However, Hill et al. 
(2015) have convincingly shown the causative role that neurogenesis plays in depression-like 
behaviour. Through a transgenic mouse line, hippocampal neurogenesis was increased, which in 
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turn rescued a CORT-induced depressive-phenotype. Work in our lab has shown that CORT 
decreases hippocampal neurogenesis, and the triclyclic antidepressant imipramine restores this 
(Fenton et al., 2015; Lussier et al., 2013a). Here, we report that CORT decreases both the 
number and maturation rate of newborn neurons in the DG. A single infusion of reelin 24 hours 
before sacrifice significantly increases the number of newborn neurons in the ipsilateral, but not 
contralateral hemisphere, but does not affect the maturation rate of these neurons; however, at 
time 2, a single infusion of reelin recovers both the number and maturation rate of these newborn 
neurons. These findings are consistent with those observed in the literature. Pujadas et al. (2010) 
found that mice overexpressing reelin have a significant increase in DCX-ir granule cells, 
accompanied by increased complexity in their dendrites. Furthermore, reeler mice show a 
significant reduction in newborn neurons in the DG (Won et al., 2006). Our results suggest that 
the fast-acting antidepressant effects of reelin are most likely not directly through an increase of 
neurogenesis, as this increase in proliferating neurons does not correspond to functional 
integration and maturation as corroborated by our dendritic complexity analyses. Our findings of 
reelin on glutamate and GABA dovetail nicely with the effects of reelin on neurogenesis and 
behaviour. 
Reelin and glutamate 
Chronic stress disrupts glutamatergic signaling in the hippocampus. This is typically 
manifested as a decrease in AMPA receptor expression and an increase in NMDA receptor 
expression. For example, stress has been shown to decrease phosphorylation of the AMPA 
receptor Ser831-GluA1 within the hippocampus, while increasing hippocampal GLUN2B 
receptor expression (Ciu, Wu, She, & Liu, 2012; Caudal, Godsil, Mailliet, Bergerot, & Jay,  
2010).  In line with these findings, we observed that the CORT rats had a significant decrease of 
GLUA1-ir cells in the SGZ, in addition to an increased expression of GLUN2B 
immunoreactivity throughout the DG. Interestingly, we found that either single or repeated 
intrahippocampal reelin infusions across both times 1 and 2 significantly increased the number of 
GLUA1-ir cells in the SGZ, and decreased GLUN2B immunoreactivity across the DG back to 
control levels. These findings are similar to those reported elsewhere. For example, application 
of reelin to cultured hippocampal CA1 neurons elevated AMPAR-mediated synaptic currents 
(Qiu et al., 2006) and heterozygous reeler mice display a significant reduction in GLUA1 subunit 
clustering in cultured hippocampal neurons (Qiu and Weeber, 2007). Furthermore, 
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overexpression of reelin through reelin –OE mice results in a significant reduction of GluN2B in 
cultured hippocampal neurons (Teixeira et al., 2011), and application of recombinant reelin to 
cultured hippocampal neurons leads to a significant reduction in both GLUN2B-mediated 
synaptic currents and duration of GLUN2B subunits within synapses (Groc et al., 2007). 
Therefore, the picture that emerges is that reelin alters the balance of glutamate by increasing 
AMPA and therefore hippocampal synaptic plasticity, and decreasing NMDA and excitotoxic 
events. 
Reelin and GABA 
 Previous work in our lab has shown that repeated CORT injections decrease GABAA 
receptor expression in the hippocampus and the number of GABA A α2/3-ir cells  (Brymer, 
Fenton, Kalynchuk, & Caruncho, 2018; Lussier, Romay-Tallon, Caruncho, & Kalynchuk, 
2013b). Here, we found that CORT decreased the number of GABA A α2/3-ir cells within the 
SGZ at both times 1 and 2. At time 1, we observed that a single intrahippocampal reelin infusion 
restored this deficit to control levels. Consistent with this finding, GAD67, the key enzyme 
regulating GABA synthesis, is co-expressed with reelin in GABAergic neurons. Reelin and 
GABA then bind to postsynaptic receptors distributed throughout dendrites, soma, and axon of 
pyramidal neurons (Costa et al., 2004). What therefore might emerge is that reelin is restoring 
the CORT induced GABAA receptor internalization, creating a neuroprotective mechanism that 
facilitates SGZ plasticity. 
The role of reelin in restoring the balance between GABA and glutamate 
  For the first time, we have reported here that a single intrahippocampal reelin infusion 
has fast-acting antidepressant actions accompanied by a restoration of hippocampal 
neurogenesis, glutamate, and GABA neurotransmission. What might be the mechanism behind 
the fast-acting antidepressant effects of reelin? We propose that one such pathway might be 
through a restoration of the CORT-induced imbalance between GABA and glutamate (Lussier, 
Romay-Tallon, Caruncho, & Kalynchuk, 2013b) . Here, we reported that CORT decreased the 
number of GLUA1-ir cells within the SGZ, increased GLUN2B immunoreactivity throughout 
the DG, and decreased the number of GABA A α2/3-ir cells within the SGZ. Remarkably, a 
single intrahippocampal reelin infusion restored these deficits. These results suggest that reelin is 
facilitating synaptic plasticity in the SGZ through an uncoupling of GABA and glutamate. By 
increasing AMPA, decreasing NMDA, and increasing GABAA activity, reelin would be 
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promoting SGZ plasticity in a rapid time course, which in turn would have pro-cognitive effects 
and would act to increase hippocampal neurogenesis. A question that remains to be tested is 
assessing the contribution of glutamate or GABA to reelin’s antidepressant effect, perhaps 
through animal knockdowns or antagonists.  
5. Conclusion 
In conclusion, the results provided here are the first to show that reelin has fast-acting 
antidepressant effects, which are accompanied by an increase in hippocampal neurogenesis, and 
a restoration of the balance between GABA and glutamate in the hippocampus. It is proposed 
that reelin’s antidepressant actions lie in uncoupling GABA and glutamate. Further work needs 
to be conducted to determine the extent of the contribution of GABA and glutamate to reelin’s 
antidepressant actions.   
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Abstract 
Depression remains difficult to treat, with a significant proportion of patients not responding to 
conventional antidepressants. Furthermore, antidepressants take weeks to achieve their 
therapeutic effects, which exacerbates the need for novel fast-acting antidepressants. Previous 
work in our lab has shown that a single intrahippocampal infusion of the extracellular matrix 
protein reelin rapidly reverses depression-like behaviour in the forced swim test (FST), alters 
hippocampal neurogenesis, and increases the number of GLUA1-ir cells in the subgranular zone. 
Here, we tested the involvement of AMPA receptors in the fast-acting antidepressant effects of 
reelin by infusing the AMPA antagonist CNQX after a single intrahippocampal reelin infusion 
during corticosterone (CORT) treatment. We then assessed changes in the FST, and examined 
hippocampal neurogenesis, Fos expression, and hilar microglia morphology. CORT injections 
increased the time spent immobile in the FST, decreased hippocampal neurogenesis, and 
contributed towards an active microglia phenotype. A single intrahippocampal reelin infusion 
decreased time spent immobile in the FST, increased the number but not the complexity of 
doublecortin (DCX)-ir cells, and did not alter the CORT induced microglial phenotype. A single 
intrahippocampal CNQX infusion following reelin increased the time spent immobile in the FST, 
increased the number but not the complexity of DCX-ir cells, increased the number of Fos cells 
active during the FST, and and did not alter the CORT induced microglial phenotype. These 
novel results demonstrate that CNQX blocks reelin’s fast-acting antidepressant effects on the 
FST without altering reelin’s effects on hippocampal neurogenesis or microglia morphology.  
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1. Introduction 
 Depression remains difficult to treat with conventional antidepressants, with estimates of 
treatment resistant depression occurring in 10-50% of depressed patients (Wiles, 2014; Al-Harbi, 
2012). As the majority of antidepressants target the monoamine system and a significant 
proportion of patients do not respond to medication, this suggests that the monoamine system per 
se is not necessarily a prerequisite for antidepressant action (Duman, 2014; Willner, Scheel-
Jruger, & Belzung, 2013, 2013; Blows, 2000). Therefore, there is a need for novel 
antidepressants that are not reliant on the monoaminergic system.  
 Both preclinical and human studies implicate impairments in the extracellular matrix 
protein reelin in the pathogenesis of depression (Lussier et al., 2013a; Fatemi, 2005). For 
example, work in our lab demonstrates that repeated corticosterone (CORT) injections in rats 
significantly reduces the number of reelin immunoreactive (IR) cells in the subgranular zone 
(SGZ) of the hippocampus (Brymer, Fenton, Kalynchuk, & Caruncho, 2018; Lussier et al., 
2013a). Moreover, heterozygous reeler mice, which express 50% of the normal level of reelin, 
are more susceptible to the depressogenic effects of CORT (Lussier, Romay-Tallon, Caruncho, 
& Kalynchuk, 2011). Confirming these findings, human post-mortem studies reveal a reduction 
in reelin-ir cells in the hippocampus of depressed patients (Fatemi, Earle, & McMenomy, 2000). 
These findings raise the question of whether reelin can produce an antidepressant effect. Our 
group has data that shows that a single infusion of recombinant reelin into the dorsal 
hippocampus of CORT-treated rats produces an antidepressant response in the forced-swim test 
(FST) in as little as 24 hours (Brymer et al., unpublished observations). Moreover, this rapid 
antidepressant response is accompanied by a restoration of doublecortin (DCX) cell number but 
not complexity in the SGZ. Interestingly, a single recombinant reelin infusion also increases the 
number of GLUA1-ir cells in the SGZ to control levels. This finding is particularly interesting, 
as heterozygous reeler mice display a significant reduction in GLUA1 subunit clustering in 
cultured hippocampal neurons (Qiu & Weeber, 2007). Therefore, in this experiment we 
examined whether blocking AMPA receptor activity can abolish the fast-acting antidepressant 
effect of reelin.  
 We hypothesized that recombinant reelin infusions into the dorsal hippocampus of 
CORT-treated rats would reverse depression-like behaviour on the FST. We also hypothesized 
that infusion of the AMPA antagonist CNQX into the dorsal hippocampus shortly before the FST 
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would abolish the fast-acting antidepressant effect of reelin. To test these hypotheses, rats 
underwent stereotaxic surgery to implant an indwelling cannula into the dorsal hippocampus, and 
then received 21 days of CORT or vehicle injections. We infused recombinant reelin into the 
dorsal hippocampus as well as CNQX in another subset of rats, and then assessed depression-like 
behaviour using the FST, and alterations in hippocampal neurogenesis, Fos protein expression, 
and microglial morphology. 
2. Materials and Methods 
2.1. Animals 
We used 30 adult male Long-Evans rats purchased from Charles River (QC, Canada). 
The rats weighed 200-250 g at the time of arrival from the breeder. Rats were individually 
housed in rectangular polypropylene cages containing standard laboratory bedding with access to 
food and water ad libitum. The rodent colony room was maintained at an ambient temperature of 
20 ± 1 °C on a 12:12 light-dark cycle (lights on at 7 am). All experimental procedures were in 
accordance with the guidelines of the Canadian Council and Animal Care and an animal care 
protocol approved by the University of Saskatchewan Committee on Animal Care and Supply. 
All efforts were made to minimize the number of rats used in the present study.  
2.2. Stereotaxic Surgery 
 Stereotaxic surgery was conducted as previously described (Botterill, Nogovoystin, 
Caruncho, & Kalynchuk, 2016; Botterill, Guskjolen, Marks, Caruncho, & Kalynchuk, 2015b). 
Each rat was deeply anesthetized with isoflurane (5% initial, 2-2.5% maintenance) and then 
secured into a stereotaxic apparatus using ear bars. Rats were given ketoprofen (Anafen, 
ketoprofren, 10 mg/kg s.c.) to reduce pain and inflammation. At flat skull position, a single 
cannula (C313G/spc, Plastics 1, Roanoke, VA, USA) was chronically implanted into the left 
hemisphere of the dorsal hippocampus using the following coordinates from the rat brain atlas 
(relative to bregma): -3.5 mm anteroposterior, +2.6 mm mediolateral, -3.1 mm dorsoventral 
(Paxinos & Watson, 1998). The cannula was secured to the skull with 4 jeweler screws and 
dental acrylic. A dummy cannula was then inserted into the guide cannula to prevent debris from 
entering the site during the course of the study. To minimize the risk of post-surgical infection, 
we administered the antibacterial-antifungal ointment Hibitane (Chlorhedixine acetate B.P. 1% 
[w/w]) daily around the incision site for at least one week after the surgery. 
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2.3. Experimental procedures 
2.3.1. CORT and Vehicle Injections 
 All rats were briefly handled once per day for seven days prior to the start of CORT 
injections. We then weight-matched the rats and randomly assigned them to one of the following 
six treatment groups: 21 days of vehicle injections (n = 5), 21 days of CORT injections (n = 5); 
vehicle + a single reelin infusion on day 21 (vehicle reelin single, n = 5); CORT + a single reelin 
infusion on day 21 (CORT reelin single, n = 5), vehicle + a single reelin infusion on day 21 + an 
infusion of CNQX on day 22, 30 minutes prior to the FST (vehicle reelin single CNQX, n = 5; 
and CORT + a single reelin infusion on day 21 + an infusion of CNQX on day 22, 30 minutes 
prior to the FST (CORT reelin single CNQX, n = 5) (Fig. 1). All CORT and vehicle injections 
were administered subcutaneously once per day between 9:00 and 10:00 am. CORT (Steraloids, 
Newport, RI, USA) was suspended in 0.9% physiological saline with 2% (v/v) Tween-80 
(Sigma-Aldrich) and given at a dose of 40 mg/kg in a volume of 1 ml/kg. Our lab has reported 
that the 40 mg/kg dose reliably increases depression-like behaviour in rats (Brymer et al., 2018; 
Lussier et al., 2013a). The body weight of each rat was recorded daily for the entire 21 days of 
CORT or vehicle injections.  
2.3.2. Intrahippocampal Reelin/CNQX infusions 
Intrahippocampal reelin and CNQX infusions were administered in a dedicated 
procedures room for the duration of the experiments. We used a 2 µl Hamilton syringe secured to 
an infusion pump (PHD 2000; Harvard Apparatus, Holliston, MA, USA). The tip of the 
Hamilton syringe was inserted into PE-50 tubing connected to an infusion needle (C313l/spc, 
Plastics 1) that extended 1 mm below the base of the guide cannula. The infusion needle was 
inserted into the guide cannula of each rat and secured to the base of the cannula pedestal. 
Recombinant reelin (3820-MR-025/CR; R & D Systems, Minneapolis, MN, USA) was 
reconstituted immediately prior to infusions to a working concentration of 1 µg per 1µl in 0.1 M 
PBS (pH = 7.4). A total of 1µl of reelin was infused at a rate of 0.5µl per minute over 2 minutes 
into the hippocampus. CNQX (Cat. No. 0190; Tocris Bioscience, Bristol, UK) was reconstituted 
immediately prior to infusions to a working concentration of 1 µg per 1µl in a solution 
containing 20% DMSO and 80% saline. A total of 1µl of CNQX was infused at a rate of 0.5µl 
per minute over 2 minutes.  The infusion needle was left in place for an additional two mins after 
the infusion to facilitate diffusion. We then slowly removed the infusion needle from the guide 
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cannula.  
 
 
Fig 1. Schematic representation of the experimental design of the study. Animals underwent 
stereotaxic surgery to implant an indwelling cannula into the left dorsal hippocampus. Animals 
were weight matched and received 21 days of 40 mg/kg of corticosterone (CORT) or vehicle 
injections. A subset of animals received a 1µg/µl of reelin on day 21 of CORT/vehicle injections, 
and a further subset also received a single 1 µg/µl CNQX infusion on day 22, 30 minutes prior to 
the FST. 
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2.4. Behavioural Testing 
2.4.1. FST 
 The FST was carried out in a dedicated procedures room that was not used for any other 
aspect of the study. All behaviours were recorded with a digital video camera and stored for 
offline analyses. The FST was conducted on day 22, the day after the final CORT injection and 
intrahippocampal reelin infusion (Fig. 1). We used a modified version of the Porsolt test, as 
previously described (Lussier et al., 2013a; Gregus, Wintink, Davis, & Kalynchuk, 2005). Each 
rat was individually placed in a Plexiglas swim tank (25 cm wide x 25 cm long x 60 cm high, 27 
± 2 °C water, 30 cm deep) for 10 minutes. We measured the duration of time each rat spent 
immobile, struggling, and swimming.  
2.5. Histology  
2.5.1. Perfusions  
Each rat was deeply anesthetized with 5% isoflurane and then transcardially perfused 
using room-temperature physiological saline, followed by ice-cold 4% (w/v) formaldehyde 
fixative (pH = 7.4). The brains were extracted from the cranial vault and immersed in the same 
formaldehyde fixative for 48 hours at 4 °C. The brains were then sectioned in the coronal plane 
at 30 µm on a vibrating microtome (VT1200s, Leica Biosystems, Nussloch, Germany). Sections 
were collected and stored at −20 °C until use in a cryoprotectant solution containing 30% (w/v) 
sucrose, 1% (w/v) polyvinylpyrrolidone, and 30% (v/v) ethylene glycol in 0.1 M PBS (pH = 
7.4).  
2.5.2. Immunohistochemistry  
 We used a standard immunohistochemistry technique with widely used and commercially 
available antibodies for all of our assays. Immunostaining was done on free-floating sections in 
six-well tissue culture plates under gentle agitation for every step. To ensure consistent 
immunohistochemical processing, we processed all sections in unison with treatment groups 
counterbalanced across all tissue plates. To confirm the specificity of our antibodies, we omitted 
the primary antibody from an additional well of free-floating sections. In the absence of the 
primary antibody, we were unable to detect any immunoreactive cells.  
 Doublecortin immunohistochemistry was run as previously described (Botterill, Brymer, 
Caruncho, & Kalynchuk, 2015a; Lussier et al., 2013a). Sections underwent heat-induced epitope 
retrieval in sodium citrate buffer (pH = 6.0) at 85 °C for 30 mins. The sections were then blocked 
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in 5% (v/v) normal goat serum (NGS), 1% (w/v) bovine serum albumin (BSA), and 0.5% (v/v) 
Triton X-100 in 0.1 M TBS (pH = 7.4), followed by incubation in a rabbit anti-DCX polyclonal 
primary antibody (1:1000; Cell Signalling Technologies) diluted in blocking solution for 24 
hours at room temperature. On the following day, the sections were treated with 5% (v/v) H2O2 
in 0.1 M TBS for 30 minutes to block endogenous peroxidase activity. The sections were then 
incubated for 1 hour in biotinylated goat anti-rabbit secondary antibody (1:500; Vector 
Laboratories) diluted in 5% (v/v) NGS, 1% (w/v) BSA, and 0.5% (v/v) Triton X-100 in 0.1 M 
TBS, followed by avidin-biotin peroxidase complex (1:500, Vector Laboratories) for 1 hour. 
Sections were then rinsed with 0.175 M sodium acetate (pH = 6.8) and visualized with 0.025% 
(w/v) DAB, 4.167% NiSO4, and 0.002% (v/v) H2O2. The sections were then mounted onto 
glass slides using 0.2 M PB (pH = 7.4), air dried overnight, dehydrated using a series of graded 
alcohols, cleared in xylene, and coverslipped with Permount mounting medium (Fisher 
Scientific, Fair Lawn, NJ, USA).  
Fos immunohistochemistry was run as previously described (Botterill et al., 2014). 
Sections were treated with 0.3% H202 in 0.1 M PBS for 30 minutes to block endogenous 
peroxidase activity. The sections then underwent heat-induced epitope retrieval in sodium citrate 
buffer (pH = 6.0) at 85°C for 30 minutes. The sections were then blocked in 5% (v/v) normal 
goat serum (NGS), 1% (w/v) bovine serum albumin (BSA), and 0.3% (v/v) Triton X-100 in 0.1 
M TBS (pH = 7.4), followed by incubation in a rabbit anti-Fos polyclonal primary antibody 
(1:2000; Abcam) diluted in blocking solution for 72 hours at 4°C. After 72 hours, the sections 
were incubated for 2 hours in biotinylated goat anti-rabbit secondary antibody (1:500; Vector 
Laboratories) diluted in 5% (v/v) NGS, 1% (w/v) BSA, and 0.3% (v/v) Triton X-100 in 0.1 M 
TBS, followed by avidin-biotin peroxidase complex (1:500, Vector Laboratories) for 1 hour. 
Sections were then rinsed with 0.175 M sodium acetate (pH = 6.8) and visualized with 0.025% 
(w/v) DAB, 4.167% NiSO4, and 0.002% (v/v) H2O2. The sections were then mounted onto 
glass slides using 0.2 M PB (pH = 7.4), air dried overnight, dehydrated using a series of graded 
alcohols, cleared in xylene, and coverslipped with Permount mounting medium (Fisher 
Scientific, Fair Lawn, NJ, USA).  
 To examine microglia cell morphology, CD11b immunohistochemistry was conducted. 
Briefly, free-floating sections were rinsed in 0.1 M TBS (pH = 7.4) and incubated in 1% H202 
for 30 min to block endogenous peroxidase activity. The sections were then blocked in a 0.3% 
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(v/v) Triton X-100 TBS buffer containing 5% (v/v) normal horse serum (NHS) for 1 hour at 
room temperature, followed by incubation with primary mouse anti-CD11b, clone OX-42, 
monoclonal antibody diluted in blocking solution (1:200; Millipore, USA) for 48 hours at room 
temperature. The tissue was then incubated with a biotiylnated secondary antibody (horse anti-
mouse; 1:200; Sigma-Aldrich) for 2 hours at room temperature, and then in an avidin-biotin 
complex (1:500. Vector Laboratories, USA) for 30 minutes at room temperature. 
Immunolabelling was visualized with 0.05% (w/v) DAB, 4.167% (w/v) nickel ammonium 
sulphate, and 0.0078% (v/v) H202 diluted in 0.175 M sodium acetate. The sections were then 
mounted onto glass slides using 0.2 M PB (pH = 7.4), air dryed overnight, dehyrdrated using a 
series of graded alcohols, cleared in xylens, and coverslipped with Permount mounting medium 
(Fisher Scientific, Fair Lawn, NJ, USA).  
2.5.2.1. Quantification of immunohistochemistry 
2.5.2.1.1. DCX cell counting  
 Quantification of immunolabelling was conducted as previously described (Botterill, 
Brymer, Caruncho, & Kalynchuk, 2015a; Lussier et al., 2013a). All analyses were performed by 
researchers blind to the treatment conditions. Immunostained sections were examined using a 
Nikon Eclipse E800 microscope with a motorized stage and digital camera (MicroFire, 
Optronics, Goleta, CA, USA) connected to a dedicated stereology computer. The dentate SGZ 
(defined as a two-cell width zone in between the inner granule cell layer and the hilus) and 
granule cell layer (GCL) were traced at 4 X magnification using a computerized stereology 
program for DCX-ir cells (StereoInvestigator, MicroBrightfield, Williston, VT, USA). DCX was 
counted in both the ipsilateral and contralateral hemispheres at 40 x magnification. All counts 
utilized unbiased stereology using a modified optical fractionator method that excludes cells in 
focus at the uppermost focal plane to reduce oversampling (Lussier et al., 2013a). The total 
number of DCX-ir cells was estimated using the following formula: Ntotal = ∑Q− × 1 / ssf × 
A(x, y step) / a(frame) × t / h. ∑Q− represents the number of counted cells, ssf is the section 
sampling fraction (1 in 12), A(x, y step) is the area associated with each x, y movement (10,000 
µm2), a(frame) is the area of the counting frame (3600 µm2), t is the weighted average section 
thickness, and h is the height of the dissector (12 µm) (Botterill, 2015a; Fenton et al, 2015; 
Lussier et al, 2013a.). To avoid counting sectioning artifacts, we used a guard zone of 2 µm. 
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2.5.2.1.2. Characterization of immature DCX-ir neurons 
 We utilized a dendritic categorization method that our laboratory has used in the past 
(Botterill, Brymer, Caruncho, & Kalynchuk, 2015a; Lussier et al., 2013a) to determine if our 
intrahippocampal reelin and CNQX infusions paradigm altered the dendritic morphology of 
immature DCX-ir neurons. A meander scan method was used to randomly select 100 DCX-ir 
cells from each rat. A researcher blind to the experimental conditions then assigned the cell to 
one of six complexity categories based on both the presence and extent of apical dendrites (Fig. 
3). The proliferative stage encompassed categories one (no process) or two (one small process). 
Category three (medium process reaching the granule cell layer) and category four (process 
reaching the molecular layer) made up the intermediate stage of development. Finally, category 
five (one major process extending into the molecular layer) and category six (defined dendritic 
tree with delicate dendritic branching in the granule cell layer) represented the postmitotic stage. 
Data are presented as the percentage of DCX-ir cells in each of the six categories.  
2.5.2.1.3. Fos cell counting 
Quantification of FOS immunoreactivity was quantified as previously described (Botterill 
et al., 2014) on a minimum of five sections per brain with 300 µm between sections. Contours 
were traced at 4 X magnification with a brain atlas serving as a guide (Paxinos & Watson, 1998). 
Fos-ir cells were counted within these contours at 20 X magnification using a meander scan 
profile counting method (Knapska & Maren, 2009). We divided the total number of Fos-ir cells 
in each region by the total area captured within the traced contours (in µm) to determine the 
density of Fos-ir cells within each traced region for each subject. This density value was then re-
expressed as the number of Fos-ir cells per mm2. Therefore, our reported values reflect the 
average number of Fos-ir cells within a defined contour within each region (Botterill et al., 
2014). 
2.5.2.1.4. Morphological analyses of microglia in the hilus 
 The morphology of randomly selected microglia cells in the hilus was examined using a 
neuron tracing system (Neurolucida; Microbrightfield) linked to a Nikon microscope. Eight 
microglial cells per rat (5 rats per group) were randomly selected and individually traced in their 
entirety on the live image using a 100 X lens with oil immersion. The following criteria were 
followed for selection of microglial hilar cells: (1) location of the cell body in the hilus; (2) full 
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staining of the cell body and its processes; (3) most microglial processes unobscured by 
background staining or by other cells. NeuroExplorer software (Microbrightfield) was used for 
the quantification of somatic and process morphological parameters. Somatic metrics included 
cell body and ferret maximum (the longest diameter of the soma). Total process length, number 
of nodes and ends, average process diameter, and the number of primary processes were all 
quantified. We conducted a Sholl analysis in which the cell body was placed at the center of 
concentric circles (with incrementing diamters of 10 µm), and the number of intersections at all 
radial distances were quantified (Lebedeva, 2017). 
2.6 Statistical Analyses 
All statistical analyses were carried out using IBM’s Statistical Package for Social 
Sciences v24. We determined statistical significance using one-way analysis of variance 
(ANOVA), and post hoc comparisons were made using Tukey HSD when appropriate. The 
criterion for statistical significance was set at p < 0.05. All graphs depict the mean ± standard 
error of the mean. 
3. Results 
3.1. CORT had Significant Effects on body Weight 
 Figure 2 shows the effects of treatment on body weight. Consistent with previous reports 
from our lab (Brymer, Fenton, Kalynchuk, & Caruncho, 2018; Fenton et al., 2015; Lussier et al., 
2013a), CORT had significant effects on body weight. Significant group differences were found 
on days 7 (F(5, 29) = 5.251, p < .01), 14 (F(5, 29) = 10.233, p < .001), and 21 (F(5, 29) = 11.42, 
p < .001). Post hoc analyses revealed that the CORT rats weighed significantly less than the 
vehicle rats on day 7 (p < .05), significantly less than the vehicle and vehicle reelin single CNQX 
rats on day 14 (p values < .05), and significantly less than the vehicle, vehicle reelin single, and 
vehicle reelin single CNQX rats on day 21 (p values < .05). Both the CORT reelin single and 
CORT reelin single CNQX rats weighed significantly less than the vehicle rats on day 7 (p 
values < .05), significantly less than the vehicle and vehicle reelin single CNQX rats on day 14 
(p values < .05), and significantly less than the vehicle, vehicle reelin single, and vehicle reelin 
single CNQX rats on day 21 (p values < .05). Finally, the vehicle reelin single rats weighed 
significantly less than the vehicle rats on day 7 (p value < .05).  
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3.2. CNQX Abolishes the fast-Acting Antidepressant Effects of Reelin on the FST 
 Figure 2 shows the effect of treatment on FST behaviour. We found significant group 
differences for immobility (F(5, 29) = 12.433, p < .001), struggling (F(5, 29) =2.652, p < .05), 
and swimming (F(5, 29) = 9.494, p < .001). Post hoc analyses revealed that the CORT and 
CORT reelin single CNQX rats spent significantly more time immobile than all other groups (p 
values < .05), and the CORT rats spent significantly less time swimming than the vehicle, 
vehicle reelin single, and CORT reelin single rats (p values < .05). Finally, the CORT reelin 
single CNQX rats spent significantly less time swimming than the vehicle, vehicle reelin single, , 
and CORT reelin single rats (p values < .05). 
3.3. Reelin and CNQX increase DCX cell counts 
Figure 3 shows the results of our DCX analyses. Consistent with previous reports from 
our lab (Brymer, Fenton, Kalynchuk, & Caruncho, 2018; Fenton et al., 2015), we found a 
significant main effect of treatment on the total number of DCX-ir cells (F(5, 29) = 3.859, p < 
.05). Post hoc analyses revealed that the CORT rats had significantly fewer DCX-ir cells in the 
ipsilateral hemisphere than the CORT reelin single and CORT reelin single CNQX rats (p values 
< .05), but did not differ from the vehicle (p = .231), vehicle reelin single (p = .637), or vehicle 
reelin single CNQX rats (p = .839). No group differences were found when combining the 
ipsilateral and contralateral hemispheres (p values > .05).  
We also found significant group differences for our dendritic complexity analyses. 
Significant group differences emerged for the % of cells in categories 1 (F(5, 29) = 8.054, p < 
.001), 2 (F(5, 29) = 67.242, p < .001), 4 (F(5, 29) = 9.649, p < .001), 5 (F(5, 29) = 23.314, p < 
.001), and 6 (F(5, 29) = 15.193, p < .001). Post hoc analyses showed that the CORT and CORT 
reelin single CNQX rats had significantly more category 1 cells than the vehicle and vehicle 
reelin single CNQX rats (p values < .05), while the CORT reelin single CNQX rats had 
significantly more category 1 cells than the vehicle reelin single CNQX rats (p = .008). The 
CORT, CORT reelin single, and CORT reelin single CNQX rats had significantly more category 
2 cells than all other groups (p values < .05), and they also had significantly fewer category 5 
cells than all other groups (p values < 05). The CORT and CORT reelin single rats had 
significantly fewer category 6 cells than the vehicle, vehicle reelin single, and vehicle reelin 
single CNQX rats (p values < .05), and the CORT reelin single CNQX rats had significantly 
fewer category 6 cells than the vehicle and vehicle reelin CNQX rats (p values < .05). 
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Fig 2. Mean body weight through days 1-21 of CORT/vehicle injections. Treatment with CORT 
decreased body weight, and reelin and reelin + CNQX did not recover this. Panel B-D; CORT 
increased depression-like behaviour in the FST, which was reversed by reelin, and CNQX 
blocked the effects of reelin. The CORT and CORT reelin CNQX rats spent significantly more 
time immobile than all other groups (panel B) (p values < .05). Panel C shows the effect of 
treatment on time spent struggling. Panel D shows the effect of treatment on time spent 
swimming. The CORT rats spent significantly less time swimming than the vehicle, vehicle 
reelin single, and CORT reelin single rats (p values < .05), and the CORT reelin CNQX rats 
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spent significantly less time swimming than the vehicle, vehicle reelin single, and CORT reelin 
single rats (p values < .05). All data are represented as means ± standard error of the mean. 
and CORT reelin single rats (p values < .05).  
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3.4. CNQX Increases the Number of Fos+ cells in the SGZ During the FST 
Figure 4 shows the results of our Fos analyses. We found a significant main effect of 
treatment on the number of Fos-ir cells in both the ipsilateral (F(5, 29) = 5.341, p < .01) and 
and contralateral (F(5, 29) = 3.948, p < .01) hemispheres. Post hoc analyses revealed that in the 
ipsilateral hemisphere, the CORT reelin single CNQX rats had significantly more Fos-ir cells 
than the vehicle, vehicle reelin single, and CORT reelin single rats (p values < .05), and the 
vehicle reelin single CNQX rats had significantly more Fos-ir cells than the vehicle reelin single 
rats (p = .047). In the contralateral hemisphere, the vehicle reelin single CNQX rats had 
significantly more Fos-ir cells than the vehicle reelin single rats (p = .025).  
3.5. CORT Alters Microglial cell Morphology 
Figure 5 shows the results of our microglia morphology analyses. We found a significant 
main effect of treatment on process length (F(5, 29) = 9.935, p < .001), process nodes (F(5, 29) = 
8.225 , p < .001), process endings (F(5, 29) = 5.632, p < .001), and process intersections (F(5, 
29) = 6.395, p < .001). Post hoc analyses revealed that the vehicle rats had significantly longer 
process lengths than the CORT, CORT reelin single, and CORT reelin single CNQX rats (p 
values < .05), the CORT reelin single rats had significantly shorter process lengths than the 
vehicle reelin single CNQX rats (p = .008), and the vehicle reelin single CNQX rats had a 
significantly longer process length than the CORT reelin single and CORT reelin single CNQX 
rats (p values < .05). In terms of the number of process nodes, the CORT rats had significantly 
fewer process nodes than the vehicle reelin single CNQX rats (p = .003), the CORT reelin single 
rats had significantly fewer process nodes than the vehicle, vehicle reelin single, and vehicle 
reelin single CNQX rats (p values < .05), and the CORT reelin single CNQX rats had 
significantly fewer process nodes than the vehicle reelin single CNQX rats (p = .004). The 
vehicle reelin single CNQX rats had significantly more process endings than the CORT, CORT 
reelin single, and CORT reelin single CNQX rats (p values < .05). Finally, the vehicle rats had 
significantly more process intersections than the CORT, CORT reelin single, and CORT reelin 
single CNQX rats (p values < .05), and the vehicle reelin single CNQX rats had significantly 
more process intersections than the CORT reelin single and CORT reelin single CNQX rats (p 
values < .05). 
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Fig 3. Effects of intrahippocampal reelin and CNQX-treatment on hippocampal neurogenesis. 
CORT had significant effects on hippocampal neurogenesis. Panel A shows representative 
photomicrographs of doublecortin expression in the granule cell/subgranular zone (Scale bar = 
200 µm). A higher magnification image is shown in the insets (Scale bar = 50 µm). Panel B and 
C shows the effects of treatment on the number of doublecortin-ir cells in the granule 
cell/subgranular zone. Overall, the CORT rats had significantly fewer doublecortin-ir cells than 
the CORT reelin single and CORT reelin single CNQX rats in the ipsilateral hemisphere (p 
values < .05). Panel D shows the quantified categorization of dendritic complexity using 
doublecortin staining. Group differences are described in the text. All data are represented as 
means ± standard error of the mean. VRS = vehicle reelin single; CRS = CORT reelin single; 
VRCNQX = vehicle reelin single CNQX; CRCNQX = CORT reelin single CNQX. 
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Fig 4. Fos immunoreactivity in the subgranular zone. Panel A shows representative 
photomicrographs of Fos in the SGZ (Scale bar = 200 µm). A higher magnification image is 
shown in the inset (Scale bar = 50 µm). Panel B shows the effect of treatment on the number of 
Fos-ir cells in the SGZ. Overall, the CORT reelin single CNQX rats had significantly more Fos-
ir cells in the ipsilateral hemisphere than the vehicle, vehicle reelin, and CORT reelin single rats 
(p values < .05), and the vehicle reelin single CNQX rats had significantly more Fos-ir cells than 
the CORT-reelin single rats (p < .05). In the contralateral hemisphere, the vehicle reelin single 
CNQX rats had significantly more Fos-ir cells than the vehicle reelin single rats (p < .05). All 
data are represented as means ± standard error of the mean. VRS = vehicle reelin single; CRS = 
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CORT reelin single; VRCNQX = vehicle reelin single CNQX; CRCNQX = CORT reelin single 
CNQX. 
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Fig 5. The effect of treatment on microglia cell morphology. Panel A shows representative 3D 
reconstructions of 1 microglial cell created with Neurolucida software. Panels B-G show the 
results of our microglia cell morphology analyses. Overall, treatment with CORT decreased the 
average microgalial cell length, and the numbers of nodes, endings, and processes. Treatment 
with reelin and reelin + CNQX did not normalize these measures. All data are represented as 
 160 
means ± standard error of the mean. VRS = vehicle reelin single; CRS = CORT reelin single; 
VRCNQX = vehicle reelin single CNQX; CRCNQX = CORT reelin single CNQX 
single, and vehicle reelin single CNQX rats (p values < .05), and the CORT reelin single CNQX 
rats had significantly fewer process nodes than the vehicle reelin single CNQX rats (p = .004). 
The vehicle reelin single CNQX rats had significantly more process endings than the CORT, 
CORT reelin single, and CORT reelin single CNQX rats (p values < .05). Finally, the vehicle 
rats had significantly more process intersections than the CORT, CORT reelin single, and CORT 
reelin single CNQX rats (p values < .05), and the vehicle reelin single CNQX rats had 
significantly more process intersections than the CORT reelin single and CORT reelin single 
CNQX rats (p values < .05). 
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4. Discussion 
 Our results show that repeated CORT treatment in rats increases immobility time in the 
FST, decreases hippocampal neurogenesis, and contributes towards an activated migroglia 
phenotype. A single intrahippocampal reelin infusion reverses the effect of CORT on time spent 
immobile in the FST, and restores the number DCX-ir cells, but it did not alter the effect of  
CORT on the complexity of DCX-ir cells or the activated microglial phenotype. Finally, a single 
intrahippocampal CNQX infusion blocks the effect of reelin on immobility time in the FST, and 
increases the number of Fos-ir cells active during the FST. These results suggest that CNQX is 
blocking the fast-acting antidepressant effects of reelin on the FST without altering reelin’s 
effects on hippocampal neurogenesis or microglia morphology. 
 Treatment with CORT produces clearly stratified behaviours on the FST, characterized 
by increased immobility time and a decreased time spent swimming (Lebedeva, Caruncho, & 
Kalynchuk, 2017; Fenton et al., 2015). The results from the current experimental paradigm are 
consistent with the above observations, as CORT treatment increased time spent immobile and 
decreased swimming time. Additionally, we observed that a single intrahippocampal reelin 
infusion reversed the above effects in as little as 24 hours, in line with previous results from our 
group (Brymer et al., unpublished observations). While it is unexpected that reelin has fast-acting 
antidepressant effects, it is not without precedent in the literature. For example, reductions in 
reelin expression in the hippocampus have been observed in post-mortem tissue from patients 
with depression (Fatemi, Earle, & McMenomy, 2000). The work in human patients parallels 
those observed in preclinical studies, as CORT treatment reduces the number of reelin-ir cells in 
the SGZ (Lussier et al., 2013a). Furthermore, we have demonstrated that heterozygous reeler 
mice are more susceptible to the deleterious effects of CORT than are control animals (Lussier, 
Romay-Tallon, Caruncho, & Kalynchuk, 2011). Work elsewhere has shown that reelin 
overexpression prevents the behavioural phenotypes of both schizophrenia and bipolar disorder 
(Teixeira et al., 2011). A particularly novel finding from the current experiment was that an 
intrahippocampal CNQX infusion in rats treated with CORT and reelin  blocked the rapid 
antidepressant effects of reelin on the FST. This suggests that the fast-acting antidepressant 
effect requires a contribution from AMPA receptors. The involvement of AMPA in an 
antidepressant response is consistent with those observed in the literature. For example, the 
antidepressant effects of zinc in the FST are abolished by application of NBQX, an AMPA 
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antagonist (Szewczyk, KUubera, & Nowak, 2010). Furthermore, Zanos et al (2016) convincingly 
showed that the ketamine metabolite (2R,6R)-HNK’s fast-acting antidepressant effects were 
prevented by NBQX. Therefore, the idea that reelin is acting at least in part through AMPA to 
achieve its antidepressant effects is in line with those observed elsewhere.  
 Our stereological analyses revealed that CORT treatment decreased both the number and 
complexity of DCX-ir cells in the GCL/SGZ, consistent with previous reports from our lab 
(Brymer, Fenton, Kalynchuk, & Caruncho, 2018; Fenton et al., 2015; Lussier et al., 2013a). A 
single intrahippocampal reelin infusion increased the number but not complexity of DCX-ir 
cells, and CNQX produced the same effect. The role of hippocampal neurogenesis in the 
pathogenesis of depression is currently unclear, owing to a number of factors. First, 
antidepressant effects can be achieved without corresponding increases in neurogenesis (Hanson, 
Owens, & Nemeroff, 2011). Second, studies of post-mortem tissue from patients with depression 
have not typically revealed reductions in neurogenesis (Reif et al., 2006). However, more recent 
post-mortem studies report reductions in hippocampal neurogenesis (Boldrini et al., 2012). 
Additionally, Hill, Sahay, and Ren (2015) demonstrated that increasing neurogenesis was 
sufficient to alleviate depression-like behaviour on the FST. This suggests that neurogenesis per 
se plays a contributive role in antidepressant responses. 
 The finding that a single intrahippocampal reelin infusion and CNQX increases the 
number of DCX-ir cells in the ipsilateral hemisphere is consistent with those observed in the 
literature. For example, reeler mice, which express 50% of the normal levels of reelin, have a 
significant reduction in newborn neurons in the DG (Won et al., 2006), and Pujadas et al. (2010) 
found that mice overexpressing reelin have a significant increase in DCX-ir granule cells. 
However, our results show no effects of reelin or CNQX on the complexity of DCX-ir cells, 
which suggests that these cells are not mature or functionally integrated, therefore they are not 
likely contributing to the observed antidepressant response of reelin.  
 Our meander scan analyses revealed a pattern of increased Fos immunoreactivity in 
CORT treated rats and decreased Fos immunoreactivity in reelin treated rats, however this did 
not reach statistical significance. On the other hand, CNQX in reelin-treated rats significantly 
increased Fos immunoreactivity above and beyond that of vehicle and CORT rats. Fos, a 
member of the immediate early gene family and marker of neuronal activation (Botterill, 
Guskjolen, Marks, Caruncho, & Kalynchuk, 2015b), is typically expressed after exposure to a 
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stimulus, as a marker of the cells that were active during the behaviour. It has been reported that 
chronic stress results in persistent elevations in Fos immunoreactivity in the hippocampus (Lam 
et al., 2018; Hoffman, Lorson, Sanabria, Olive, & Conrad, 2014; Matsuda et al., 1996) and 
amygdala (Perrotti et al., 2004) following the FST or fear conditioning. To our knowledge, the 
work presented here is the first to show the effects of repeated CORT treatment on Fos 
expression following the FST. Why might CORT and CNQX treatment be increasing Fos 
expression following the FST? It has been hypothesized that the observed elevations of Fos 
expression during chronic stress might be a result of increased numbers of cells actively 
contributing towards a fear memory (Hoffman et al., 2014), suggesting a contribution of the 
amygdala. While Fos expression in the amygdala was not quantified in the current experiment, 
based on work presented elsewhere (Hoffman et al., 2014) it would be expected that our 
treatment would result in increased Fos expression in the amygdala.  
 To observe changes in microglia morphology in response to stress, we traced a subset of 
CD11B+ microglia and their processes in the hilus. The CORT rats displayed reduced process 
length, a reduced ramification of processes (represented by a decrease in the number of 
branching nodes and ends) and a decrease in the number of process intersections. Interestingly, 
treatment with reelin and CNQX did not alter these effects, suggesting that activated microglia 
may not be involved in the depressogenic effects of CORT.  An activated microglia phenotype is 
characterized by reductions in microglia cell ramifications and a retraction of branches (Beynon 
& Walker, 2012). The morphology of microglia is coupled with their functional properties 
(Stence, Waite, & Dailey, 2001), and activated microglia release pro-inflammatory cytokines and 
nitric oxide synthase (Lebedeva, 2017; Liu & Hong, 2003). Elevated levels of pro-inflammatory 
cytokines are observed under conditions of chronic stress (Brymer, Fenton, Kalynchuk, & 
Caruncho, 2018) and can lead to a depression-like phenotype (Young, Bruno, & Pomara,, 2014). 
The fact that we observed antidepressant effects of reelin with an activated microglia phenotype 
suggests 1 of 2 scenarios: the antidepressant effects of reelin are not directly reliant on a 
reduction of proinflammatory cytokines, or sufficient time has not elapsed for reelin to alter the 
microglia morphology into a ramified state. However, as antidepressant effects were observed 
without corresponding changes in microglia morphology, this suggests that microglia per se are 
not part of reelin’s immediate antidepressant effects. 
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5. Conclusion 
In conclusion, we have shown that repeated CORT increases the time spent immobile in 
the FST, decreases hippocampal neurogenesis, and contributes towards an activated microglia 
phenotype. A single intrahippocampal reelin infusion decreases time spent immobile in the FST, 
increased the number but not complexity of DCX-ir cells, and contributed towards an activated 
microglia phenotype. Finally, a single intrahippocampal CNQX infusion in reelin-treated rats 
increases the time spent immobile in the FST, increases the number but not complexity of DCX-
ir cells, increases the number of Fos-ir cells in the SGZ, and contributes towards an activated 
microglia phenotype. The results presented here suggest that the fast-acting antidepressant 
effects of reelin involve a contribution of AMPA signalling, but neurogenesis and microglia 
morphology might not be necessary.  
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CHAPTER 6 
GENERAL DISCUSSION 
6.1. Summary of the Main Findings 
 The primary purpose of this dissertation was to investigate the antidepressant potential of 
TNF-α antagonists and reelin on corresponding neurobiological alterations and behavioural 
measures in the CORT model of depression. Towards this end, I examined the effects of repeated 
CORT injections and etanercept and reelin administration on a well-validated measure of 
depression-like behaviour, object-recognition memory, prepulse inhibition, hippocampal 
neurogenesis, reelin expression, GABAAb2/3-ir cells, GluA1-ir cells, GluN2B, Fos, and 
microglial activation.  
 In Chapter 2, I examined the effect of repeated CORT injections on rodent behaviour in 
the FST, object-location, object-in-place, object-recognition, and prepulse inhibition. To examine 
this question, I administered 21 days of repeated CORT injections (40 mg/kg) and then started 
behavioural testing using the above measures. CORT increased the time spent immobile in the 
FST and decreased the time spent swimming and struggling. CORT produced a dissociation in 
object memory, with rodents exhibiting impairments on the object-location and object-in-place 
memory tests, while performance on the object-recognition memory was spared. Finally, CORT 
significantly impaired prepulse inhibition, with the CORT rats displaying lower overall startle 
amplitudes and prepulse inhibition for 30 ms intervals. This pattern of results suggests that 
CORT treatment is significantly effecting both the hippocampus (object-location) and pre frontal 
cortex (object-in-place) while sparing integrity of the perirhinal cortex (object-recognition) and 
disrupting sensorimotor gating. Chapter 2 provided a paradigm to subsequently study the effects 
of different classes of putative antidepressants on memory performance in the CORT model.  
 In Chapter 3, I examined the effects of repeated CORT injections and concurrent 
injections of the TNF-α inhibitor etanercept on the FST, object-location, object-in-place 
memory, and markers of hippocampal plasticity. To address this question, I administered 21 days 
of repeated CORT injections (40 mg/kg) and semi-weekly etanercept injections (0.8 mg/kg) 
followed by behavioural testing and post-mortem analyses of neurobiology. My results revealed 
that similar to Chapter 2, CORT injections increased the time spent immobile and decreased the 
time spent swimming and struggling in the FST. Importantly, etanercept reversed this pattern of 
behaviour, suggesting an antidepressant response. CORT also impaired performance on the 
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object-location and object-in-place memory tests, with etanercept reversing both of these 
deficits. Analysis of hippocampal neurogenesis revealed that CORT treatment significantly 
decreased the number of newborn neurons while also decreasing their dendritic complexity. 
Etanercept injections significantly increased the number of newborn neurons and their dendritic 
complexity. Corresponding to past research in our lab, CORT decreased the number of reelin 
cells in the SGZ, and etanercept reversed this. This finding indicates that the antidepressant 
effects of etanercept may be through an increase in reelin positive cells, as we have shown that 
the onset of depression-like behaviour coincides with the loss of reelin cells in the SGZ (Lussier 
et al., 2013a). Finally, CORT decreased the number of GABAAb2/3-ir cells in the SGZ, and 
etanercept reversed this. Collectively, my findings indicate that etanercept is acting to reverse 
depression-like behaviour, reductions in hippocampal neurogenesis, reelin expression, and 
GABAA b2/3-ir cells produced by CORT administration. The fact that etanercept increased reelin 
positive cells was of particular interest, and raises the question of whether reelin could be a novel 
antidepressant. This question was examined in detail in Chapters 4 and 5.  
 In Chapter 4, I investigated the effect of exogenous reelin application on the FST, 
object-location memory, and markers of hippocampal plasticity. To examine this question, I 
conducted stereotaxic surgery to implant an indwelling cannula into the left dorsal hippocampus.  
I then administered repeated CORT injections (40 mg/kg) for 21 days, and administered 
intrahippocampal reelin infusions (1 µg/µl) in a repeated (3X) or acute (1X) fashion during the 
period of CORT injections. Rats were sacrificed immediately after the FST or after completing 
the object-location memory test. Similar what I reported in Chapters 2 and 3, CORT increased 
the time spent immobile and decreased the time spent swimming and struggling in the FST. A 
single reelin infusion significantly decreased time spent immobile in the FST and increased 
swimming and struggling times at both time points examined. Reelin also reversed CORT-
induced impairment on the object-location memory test. Similar to Chapter 3, CORT decreased 
the number of newborn neurons and their dendritic complexity. Interestingly, a single reelin 
infusion increased the number of immature neurons in CORT-treated rats after the FST, but did 
not affect dendritic complexity. Meanwhile, in rats completing the object-location memory test, a 
single reelin infusion increased both the number of immature neurons and their dendritic 
complexity. This finding suggests that, as a single infusion of reelin produced an antidepressant 
response at both time points while neurogenesis was not completely restored at time point 1, 
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neurogenesis may not be a contributing factor in the antidepressant effects of reelin.  
CORT also decreased the number of GluA1-ir cells in the SGZ, and reelin reversed this 
reduction at both time points. In contrast to GluA1, CORT increased GluN2B immunoreactivity 
throughout the major subfields of the DG, with reelin acting to normalize this effect. Similar to 
Chapter 3, CORT decreased the number of GABAAb2/3-ir cells in the SGZ, and reelin reversed 
this at both time points. Collectively, my findings indicate that reelin is achieving rapid anti-
depressant responses in the FST, which is accompanied by corresponding alterations in markers 
of hippocampal plasticity. The finding that reelin rapidly increased the number of GluA1-ir cells 
is of particular interest. Targeted deletion of the GluA1 subunit in mice creates a depression-like 
phenotype (Chourbaji et al., 2008), and the fast-acting antidepressant effects of the ketamine 
metabolite (2R, 6R) – HNK were associated with increased phosphorylation of AMPARs (Zanos 
et al., 2016). This suggests that the fast-acting antidepressant effects of reelin may occur through 
an increase in AMPA receptor activation, in particular GluA1. Chapter 5 will address the 
question of the role of AMPA in the antidepressant effects produced by reelin. 
 In Chapter 5, I investigated the role of AMPA receptors in the dentate gyrus in the fast-
acting antidepressant effects of reelin. I conducted stereotaxic surgery to implant an indwelling 
cannula into the left dorsal hippocampus. Rats then underwent 21 days of repeated CORT 
injections (40 mg/kg). A subset of rats received a single intrahippocampal reelin infusion (1 
µg/µl) on day 21 of CORT injections. Rats that received reelin also received a single 
intrahippocampal CNQX infusion (1µg/µl) on day 22, 30 minutes before the FST. Rats then 
underwent the FST, and were sacrificed immediately after for post-mortem analyses of 
neurogenesis, Fos, and microglia activation. Similar to what was reported in Chapters 3 and 4, 
CORT decreased the number of immature neurons and their dendritic complexity. A single reelin 
application significantly increased the number of surviving neurons, while not altering their 
dendritic complexity. In a similar vein, CNQX increased the number of surviving newborn 
neurons without altering their dendritic complexity. This finding further reinforces the point that, 
while the number of newborn neurons are increased, their dendritic complexity is not in both 
reelin and reelin CNQX treated rats. This suggests that neurogenesis per se is not involved in 
reelin’s effects on the FST, in particular immobility. CORT produced a non-significant increase 
in the number of Fos positive cells in the SGZ, with reelin causing a non-significant decrease in 
the number of Fos positive cells. Application of CNQX resulted in a significant increase in the 
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number of Fos positive cells. Finally, CORT contributed towards an active microglia phenotype, 
characterized by a retraction of processes. Both reelin and CNQX did not alter the CORT-
induced active microglia phenotype.  
 Chapter 5 was an important conclusion to the current dissertation. Here, we were able to 
mechanistically show that the fast-acting antidepressant effects of reelin require a contribution of 
AMPA receptor signaling, as blocking this abolishes reelin’s fast-acting antidepressant effects. 
This is an valuable point to make, as we can say with confidence that we know at least one of the 
ways that reelin is working. From here, future studies can begin to tease apart the contribution of 
the different AMPA subunits in relation to their contribution to reelin’s antidepressant effects.  
 The overall results of this dissertation demonstrate the importance of inflammation and 
hippocampal plasticity in an animal model of depression. Specifically, the experimental data 
presented here indicates that repeated CORT injections increase depression-like behaviour in the 
FST, impair both object-location and object-in-place memory while sparing object-recognition 
memory, and disrupt prepulse inhibition. The TNF-α inhibitor etanercept reverses depression-
like behaviour and cognition, while also restoring several markers of hippocampal plasticity, 
importantly reelin. Reelin application can rapidly reverse CORT-induced increases in 
depression-like behaviour and deficits in cognition. Furthermore, reelin reverses several 
neurobiological markers associated with hippocampal plasticity in a rapid manner. The final 
experiment of my dissertation provides evidence that the fast-acting antidepressant effects of 
reelin require a contribution of AMPA signaling.  
6.2. Behavioural Alterations in the CORT model of Depression 
 The CORT model is widely recognized for producing similar behavioural alterations as 
those seen in depression. The hallmarks of depression include anhedonia, lowered mood, and a 
sense of learned helplessness, or the act of giving up because nothing is going to end up working 
out. These behaviours are typically examined in the CORT model by assessing alterations in the 
FST and sucrose preference test after exposure to CORT. These studies have consistently shown 
that repeated CORT treatment produces a cluster of effects on the FST, characterized by 
increased time spent immobile, decreased time spent struggling, and decreased time spent 
swimming (Gregus, Wintink, Davis, & Kalynchuk, 2005; Hill, Brotto, Lee, & Gorzalka, 2003; 
Johnson, Fournier, & Kalynchuk, 2006; Kalynchuk, Gregus, Boudreau, & Perrot-Sinal, 2004; 
Marks, Fournier, & Kalynchuk, 2006; Zhao, Shen, Ma, & Du, 2008; Zhao, Xie, Dai, Wang, & 
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Huang, 2009). In a similar vein, the results of Chapters 2, 3, 4, and 5 support these observations. 
For example, I have shown that repeated CORT injections consistently increase the time spent 
immobile, and decrease both the time spent swimming and struggling. These findings are 
important as they add validity and face value to the CORT model of depression by suggesting 
that the model consistently measures what it is intended to.  
 Another focus of behavioural research in the CORT model is on the effects of CORT on 
anhedonic behaviour. While not a part of the current dissertation, reports have shown that 
repeated CORT injections increase anhedonia on the sucrose preference test, characterized by a 
decreased preference for sucrose over unsweetened water (Dwivedi, Roy, Lugli, Rizavi, Zhang, 
& Smalheiser, 2015; Sturn, Becker, Schroeder, Bikei-Gorzo, & Zimmer, 2015; Lebedeva, 2017). 
Work in our lab has investigated to what extent the increased immobility time in the FST is due 
to possible changes in muscle tone. Marks, Fournier, and Kalynchuk (2009) showed that CORT 
treated rats do not behave differently than vehicle rats on tests of muscle strength, indicating that 
CORT is not simply decreasing muscle tone and making the animals weak, explaining their 
increased immobility time.  
 Compared to the research conducted on measures of depression-like behaviour, there has 
been less focus on the effects of repeated CORT injections on learning and memory. The little 
research that is available has been conducted mainly on fear memory. These results consistently 
show that CORT enhances the acquisition and recall of fear conditioning (Hui et al., 2004; 
Marks, Fenton, Guskjolen, & Kalynchuk, 2015; Marks & Kalynchuk, 2017; Monsey et al., 
2014). However, what has been missing from the literature is the effects of systemic CORT (i.e., 
21 days of subcatenous injections) on other types of memory, particularity hippocampal and 
PFC-dependent memory and tests of sensorimotor gating. The current dissertation aimed to 
address this gap in the literature by running a series of experiments that examine the effects of 
repeated CORT injections on tests of hippocampal and PFC-dependent memory and 
sensorimotor gating. 
  The findings of the current dissertation show that repeated CORT injections impair 
performance on both the object-location and object-in-place memory tests, while sparing 
performance on object-recognition memory. This is an intriguing finding, as it suggests a 
dissociation between hippocampal and prefrontal cortex-dependent measures of memory and 
perirhinal cortex memory. Therefore, it might be that the perirhinal cortex is more resilient to the 
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deleterious effects of glucocorticoids or can resist them longer than can the hippocampus and 
prefrontal cortex over the course of 21 days of high dose CORT injections. However, it is 
important to point out that a study by Darcet et al. (2014) reported that CORT impaired 
performance on the object-recognition memory test. However, this can potentially be explained 
by their use of a longer CORT exposure period (28 days), their method of delivery (drinking 
water), and not quantifying the discrimination ratio. The finding that both hippocampal and PFC 
dependent memory are impaired by CORT treatment are in line with other reports in the 
literature, which show deficits in both of these areas as a result of chronic stress (Conrad, Galea, 
Kuroda, & McEwen, 1996; Diamond, Park, Heman, & rose, 1999; Goodman & McIntyre, 2017; 
Kleen, Sitomer, Kileen, & Conrad, 2006; Lee & Goto, 2015; Mika et al., 2012; Mizoguchi et al., 
2000). Importantly, human studies indicate that depressed patients are impaired on tasks that 
require the hippocampus and PFC (Newcomer, Craft, Hershey, Askins, & Bardgett, 1994; Rose 
& Ebmeier, 2006). Therefore, the findings of impaired memory after CORT treatment serves to 
add to the validity of the CORT model as a tool to investigate the behavioural alterations 
associated with depression.  
 CORT also produced alterations in prepulse inhibition. Specifically, CORT decreased 
overall startle amplitudes and increased prepulse inhibition on 30 ms intervals. This is a novel 
finding, and indicates that CORT treatment is disrupting sensorimotor gating. To date, little to no 
research has been conducted examining the effects of CORT on prepulse inhibition, suggesting 
the need of further studies to fully elucidate the effects of CORT on this behaviour. Collectively, 
my results suggest that object-memory testing and prepulse inhibition are ideally suited to tease 
apart CORT-induced deficits in memory and sensorimotor gating.  
6.3. The role of inflammation and TNF-α in Depression-like Behaviour, Cognition, and 
Markers of Hippocampal Plasticity 
 TNF-α is consistently elevated in response to chronic stress in both humans and rodents 
(Glovatchcka, Ennes, Mayer, & Bradesi, 2012; Halaris et al., 2012; Miller, Maletic, & Raison, 
2009; Nievas et al., 2011; Vogelzangs et al., 2012; Yang et al., 2014). In particular, TNF-α 
expression is significantly increased in the major subfields of the hippocampus, including the 
DG, CA1, and CA3 (Yang et al., 2015), in addition to the PFC (Couch et al., 2013) following 
stress. Under conditions that elicit TNF-α release, for example chronic stress, TNF-α is released 
peripherally and acts on toll-like receptor 4 on circumventricular organs and the choroid plexus, 
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which in turn stimulates microglia to secrete pro-inflammatory cytokines (among them TNF-α), 
resulting in neurodegenerative events and an increase of apoptotic neuronal death (Bortolato et 
al., 2015). High circulating levels of TNF-α are associated with depression-like behaviour, with 
studies consistently showing elevated levels of TNF-α in depressed patients (Biesmans et al., 
2015; Bizik et al., 2014; Jangpangi et al., 2014; Mikova, Yakomova, Bosmans, Kenis, & Maes, 
2001). Depressive symptoms in lupus patients are correlated with increased circulating levels of 
TNF-α (Mak et al., 2013; Postal et al., 2016). Therefore, it follows that if TNF-α is elevated in 
the serum of depressed patients, then strategies to reduce this will have antidepressant effects, 
which turns out to be the case. For example, patients with rheumatoid arthritis and plaque 
psoriasis taking prescribed etanercept report significant reductions in depressive symptoms 
(Kekow et al., 2011; Gelfand, Kimball, & Mostow, 2008). Moreover, infliximab infusions in 
Crohns Disease patients significantly reduces depressive symptoms, and this alleviation of 
symptoms was correlated with decreases in proinflammatory cytokines (Guloksuz, Wichers, & 
Kenis, 2013). Finally, psoriasis patients with comorbid psychiatric conditions report 
improvement in mood and overall well-being when taking infliximab (Bassukas, Hyphantis, 
Gamvroulia, Giatanis, & Mavreas, 2008).  
 The results of Chapter 3 are consistent with these findings. Specifically, I found that 
repeated CORT injections significantly increased the time spent immobile on the FST. In 
contrast, etanercept injections in CORT treated rats significantly decreased the time spent 
immobile, suggestive of an antidepressant response. It must be acknowledged that serum TNF-α 
levels were not collected in this study, and therefore it cannot be conclusively said that TNF per 
se is responsible for the depressogenic and antidepressant effects observed here. However, it is 
particularly interesting that etanercept administration reversed the CORT-induced depression-
like behaviour in light of work done by Raison et al. (2013). Here, Raison et al. showed that 
infliximab infusion in treatment resistant depression patients alleviated depressive symptoms but 
only in patients with a high baseline level of inflammation. Therefore, it is likely that 
proinflammatory cytokines, in particular TNF- α, are elevated as a result of CORT treatment. 
However, further studies are required to examine the cytokine profile resulting from CORT 
treatment.  
 Although TNF-α is most widely studied for its effects on inflammation, autoimmune 
disorders, and depression, the important role that TNF-α plays in learning and memory is 
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increasingly being recognized (McIntyre et al., 2015). Indeed, several studies have demonstrated 
that either administration of TNF-α or genetic manipulation through transgenic animals creates 
robust alterations in learning and memory. For example, in a mouse model of multiple sclerosis, 
where animals display upwards of 3 times as much TNF-α as controls in the hippocampus, 
significant deficits in the expression of fear learning and memory are observed (Habbas et al., 
2015). Furthermore, exposing rodents to lipopolysaccharide, a gram negative bacteria which 
creates a state of inflammation, produces impairments on context-object location discrimination, 
and this deficit is associated with high levels of proinflammatory cytokines, for example TNF-α 
(Czerniawski et al., 2015). Chronic restraint stress can also elevate hippocampal TNF-α levels, 
and this has been linked to impairments in a passive avoidance learning test (Azadbakht et al., 
2015). Finally, studies of breast-cancer survivors reveal reduced hippocampal volumes and 
deficits in verbal memory performance that are associated with elevated circulating levels of 
TNF-α (Kesler et al., 2013). Taken together, increased levels of TNF-α impair learning and 
memory, which suggests that lowering these elevated TNF-α levels will correspond to 
improvements in cognitive functioning. The results of Chapter 3 fit in nicely with these findings. 
I have shown that repeated CORT injections significantly impair performance on both object-
location and object-in-place memory, and that etanercept administration restores both of these 
measures to control levels. How might etanercept administration be acting to restore deficits in 
object-location and object-in-place memory? One possibility is an increase in markers of 
hippocampal plasticity, for example reelin.  
 TNF-α is involved in the promotion of several markers of hippocampal plasticity. For 
example, TNF-α dynamically regulates neurogenesis. High circulating levels of TNF-α promote 
apoptotic neuronal death (Bortolato et al., 2015). On the other hand, low levels of TNF-α are 
known to produce the opposite effect, promoting hippocampal neurogenesis through increased 
proliferation of neural precursor cells (Fan et al., 2011). TNF-α alters the surface expression of 
AMPA and GABAA receptors by increasing AMPA receptor expression and decreasing 
GABAA receptors (Stellwagen et al., 2005), which may contribute to the excitotoxic effects of 
upregulated TNF-α in a chronic stress paradigm (Bortolato et al., 2015). The normalization of 
GABAA receptor expression in SGZ cells by peripheral etanercept may represent a 
neuroprotective mechanism. There is also preliminary evidence to suggest that TNF-α is 
involved in reelin signaling. Interestingly, in a mouse model of aging, a viral-induced infection 
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increased inflammation and reduced the number of reelin-expressing interneurons (Doehner and 
Knuesel, 2010). The results of Chapter 3 correspond with the pattern of results described above. I 
found that repeated CORT injections reduced hippocampal neurogenesis, decreased the number 
of GABAA b2/3-ir cells in the SGZ, and reduced the number of reelin positive cells in the SGZ. 
Etanercept administration acted to reverse all of the above described alterations. This suggests 
that etanercept is acting to restore key aspects of hippocampal plasticity altered by CORT 
exposure. It is particularly interesting that reelin is involved in the regulation of hippocampal 
neurogenesis and GABA expression, suggesting that etanercept’s increase of hippocampal reelin 
may be a primary effect driving the increase in markers of hippocampal plasticity and 
corresponding antidepressant effects.  
6.4. The influence of Reelin on Depression-like Behaviour and Cognition 
 It is widely recognized that chronic stress decreases hippocampal reelin expression in 
animal models (Lussier et al., 2009; Caruncho et al., 2016; Palacios-Garcia et al., 2015: Brymer 
et al., 2018). In fact, the timeline for a reduction of reelin-expressing neurons in the hippocampus 
has been shown to correspond to the development of depression-like behaviour in rodents 
(Lussier et al., 2013a). For example, work in our lab has investigated the onset of depression-like 
behaviour and its relation to hippocampal reelin expression. Here, rats were treated with CORT 
for 21 days, and behaviour on the FST and reelin expression was investigated. It was found that 
depression-like behaviour starts to manifest on day 14 of CORT treatment. Moreover, reductions 
in hippocampal reelin expression are also observed after 14 days of treatment, suggesting that the 
onset of depression-like behaviour corresponds to a reduction in reelin expression. Heterozygous 
reeler mice, which express 50% of the normal levels of reelin, are more susceptible to the 
deleterious effects of repeated CORT injections. Reelin overexpression has been shown to 
prevent the behavioural manifestation of both schizophrenia and bipolar disorder (Teixeira et al., 
2011). Recently, Fenton et al. (2015) showed that treatment with the tricyclic antidepressant drug 
in rodents reverses depression-like behaviour and increases hippocampal reelin expression. 
Similarly, the results of Chapter 3 show that etanercept administration reverses depression-like 
behaviour and increases hippocampal reelin expression. This observation is interesting because it 
suggests that antidepressant responses correspond to an increase in reelin expression. It follows 
then that increasing reelin expression will convey an antidepressant effect. This idea is consistent 
with the findings of Chapters 4 and 5. In Chapter 4, I found that intrahippocampal reelin 
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infusions significantly reversed depression-like behaviour on the FST. Importantly, this 
antidepressant effect occurred from just a single infusion, 24 hours before behavioural testing. In 
Chapter 5, I replicated my finding from Chapter 4, again showing that a single intrahippocampal 
reelin infusion significantly reverses depression-like behaviour in the FST. The finding that 
reelin has fast-acting antidepressant effects was a novel finding, and raises exciting possibilities 
about the potential mechanism behind this effect, a topic covered in the next section. Overall, the 
results described here suggest that chronic stress decreases hippocampal reelin expression, and a 
part of the action of antidepressants may be to increase reelin expression. My findings are 
consistent with these observations, as we show that a single intrahippocampal reelin infusion has 
fast-acting antidepressant effects in a rodent model of depression. 
 Reelin regulates multiple aspects of synaptic plasticity, and is therefore unsurprisingly 
involved in promoting learning and memory. Palacios-Garcia et al. (2015) exposed rat pups in 
utero to prenatal stress and examined reelin expression and cognitive functioning during adult-
hood of these same rats. Prenatal stress exposure significantly reduced hippocampal reelin 
expression in adulthood. Furthermore, this deficit in reelin expression was correlated with 
increased motor activity and impairments in passive avoidance conditioning and the Morris 
water maze. Interestingly, treadmill exercise in autistic rats has been shown to recover reelin 
signaling and alleviate autism-induced deficits in spatial learning memory (Seo et al., 2013). 
Dorsal forebrain reelin-dab1 knockout mice display behavioural abnormalities commonly seen 
across several common neuropsychiatric disorders, including bipolar and schizophrenia. 
Specifically, reelin-dab1 knockout mice present with impairments in prepulse inhibition, 
increased locomotor activity, impaired working memory in the Y-maze and T-maze, and 
decreased freezing during contextual fear conditioning (Imai et al., 2017). In an intriguing study, 
Rogers et al. (2011) showed that reelin supplementation in naïve mice enhances cognitive ability, 
specifically spatial learning and memory, in addition to promoting LTP. If reelin 
supplementation enhances learning and memory in naïve mice, than it would be expected that 
reelin supplementation would recover cognitive functioning in animal models of disorders 
characterized by cognitive deficits, and this turns out to be the case. For example, heterozygous 
reeler mice present with deficits in prepulse inhibition and contextual fear conditioning. A single 
invraventricular reelin infusion significantly reversed the above described deficits in prepulse 
inhibition and contextual fear conditioning (Rogers et al., 2012). Furthermore, intraventricular 
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exogenous reelin infusions recover synaptic function and cognitive deficits in a mouse model of 
Angelman syndrome (Hethorn et al., 2015).  
Collectively, the findings described above suggest that reductions in reelin signaling 
impair learning and memory processes, and that reelin supplementation can restore cognitive 
functioning. The findings from Chapter 4 are consistent with those described here. We have 
shown that repeated CORT injections impair rodent performance on object-location memory 
paradigms, and that reelin treatment restores performance back to control levels on this measure. 
Specifically, in a similar vein to Rogers et al. (2012), we observed that single reelin infusion 
restores cognitive deficits induced by repeated CORT treatment. However, a potential direction 
for future research would be to examine if reelin can ameliorate other forms of cognitive 
impairment induced by the CORT model of depression, for example contextual fear 
conditioning.  
Reelin, as an extracellular matrix protein, plays several key roles in synaptic plasticity. 
Given reelin’s prominent role in development as a regulator of cortical development and 
lamination, it is not surprising that reelin is involved in the regulation of adult neurogenesis. 
Pujadas et al. (2010) found that mice overexpressing reelin have a significant increase in the 
number of DCX-ir granule cells, accompanied by increased complexity in their dendrites. 
Furthermore, reeler mice show a significant reduction in newborn neurons in the DG (Won et al., 
2006). Along these same lines, Teixeira et al. (2012) showed that reelin overexpression 
accelerates dendritic growth of adult-generated neurons, and inactivation of the reelin signaling 
pathway impairs adult hippocampal neurogenesis. My findings from Chapters 4 and 5 are in line 
with those described above. Specifically, I found that CORT decreased both the number and 
complexity of adult-generated neurons in the GCL/SGZ. Reelin reversed both of these measures, 
however the time of the infusion determined the effect. When rodents are sacrificed immediately 
after completing the FST, reelin restores the number but not complexity of DCX cells, however 
if rodents are sacrificed a week later, then a single reelin infusion restores both the number and 
complexity of DCX cells. As an antidepressant effect is observed in rats that were sacrificed 
immediately after completing the FST, this suggests that neurogenesis per se might not be a 
contributing factor to reelin’s antidepressant effects on the FST. 
Collectively, my findings indicate that reelin infusions have fast-acting antidepressant 
effects on the FST and object-location memory test that are accompanied by increases in both the 
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number and complexity of adult generated neurons in the GCL/SGZ. These findings are in line 
with those observed in the literature, and serve to further reinforce the point that reelin plays a 
pivotal role in adult hippocampus neurogenesis. To definitively examine the contribution of 
neurogenesis to reelin’s antidepressant effect, a series of studies could be completed looking at 
the effects of reelin infusions on depression-like behaviour in rats where neurogenesis is 
suppressed/ablated. If reelin infusions in this paradigm do not produce an antidepressant effect, 
than it can conceivably be concluded that reelin’s antidepressant effects are dependent on 
neurogenesis. 
6.5. The Importance of Glutamate 
  The relationship between depression and glutamate is a complex issue. Overall trends 
about patterns of change in glutamate in depression is difficult, as some receptors are increased 
while others are decreased. However, when looking specifically at the receptors GluA1 and 
GluN2B, the relationship becomes clearer. Chronic stress decreases the expression of GluA1, 
particularly in the hippocampus. Phosphorylation of GluA1 in response to stress decreases in 
both the hippocampus and mPFC, while increasing in the amygdala (Caudal et al., 2010). At the 
level of synapses, chronic stress decreases AMPA receptor mediated synaptic excitation at 
hippocampal CA1 synapses (Kallarackal et al., 2013). In an interesting study, Zhang et al. (2013) 
showed that the antidepressant and cognitive enhancer tianeptine reduces the surface diffusion of 
AMPA receptors through a calmodulin-dependent protein kinase II mechanism. This mechanism 
acts to prevent the CORT-induced dispersal of surface AMPA, restoring LTP. Further 
reinforcing the role of GluA1 in depression, Zanos et al. (2016) showed that the fast-acting 
antidepressant effects of ketamine were associated with an increase of GluA1 in the 
hippocampus. Chourbaji et al. (2008) convincingly showed that targeted deletion of GluA1 in 
mice leads to a depression-like phenotype, leading support to the glutamate hypothesis of 
depression, which posits that depression is a disorder characterized by disruptions in 
glutamatergic signaling. The findings from Chapter 4 are consistent with those observed 
elsewhere. I found that repeated CORT injections significantly reduced the number of GluA1-ir 
cells in the SGZ, with reelin treatment increasing this back to control levels. That this effect 
occurred with a single infusion of reelin suggests that reelin’s fast-acting antidepressant effect 
might involve a contribution of AMPA, and specifically GluA1 signaling.  
In contrast to GluA1, which is decreased in depression, expression of GluN2B typically 
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increases in response to stress. For example, stress is concomitant with an upregulation of 
hippocampal GLUN2B expression within the molecular layer (Ciu et al., 2012; Kreutz & Sala, 
2012). Interestingly, duloxetine, a SNRI, decreased depression-like behaviour and concomitantly 
decreased Glun2B expression back down to control levels (Calabrese et al., 2012). Prolonged 
elevation of Glun2B signaling can have damaging effects in the brain, as this signaling drives 
excitotoxicity --- in vitro work demonstrates that elevated GLUN2B leads to a rapid influx of 
calcium ions into the cell, trigging an excitotoxic event (Von Engelhardt et al., 2007). Over time, 
this excitotoxity can lead to inflammation or atrophy of the hippocampus, potentially paralleling 
the reductions in hippocampal volume observed in depressed patients (Bremner et al., 2000). 
Similar to the research described above, my findings in Chapter 4 indicate that repeated CORT 
injections increase GluN2B expression across the major subfields of the DG. Reelin treatment 
significantly reduced GluN2B expression back down to control levels. The finding of reelin 
decreasing GluN2B expression back down to control levels is in line with those found elsewhere: 
Overexpression of reelin through reelin overexpressing mice results in a significant reduction of 
GluN2B in cultured hippocampal neurons (Teixeira et al., 2011). Therefore, it would appear that 
reelin is acting to quickly reduce excitotoxic events in the hippocampus, which might be a part of 
its antidepressant response.  
The finding that reelin quickly restored the number of GluA1-ir cells in the SGZ was of 
particular interest to this dissertation. As mentioned previously, GluA1 knockout mice display 
depression-like behaviour (Chourbaji et al., 2008), and heterozygous reeler mice display a 
significant reduction in GLUA1 subunit clustering in cultured hippocampal neurons (Qiu and 
Weeber, 2007). These findings suggest that GluA1 may be involved in the pathogenesis of 
depression, and that reelin is involved in GluA1 signaling. In Chapter 5, we therefore 
hypothesized that the fast-acting antidepressant effects of reelin require a contribution of AMPA, 
and tested this by infusing the AMPA antagonist CNQX after reelin treatment. Confirming our 
hypothesis, CNQX blocked reelin’s fast-acting antidepressant effects on the FST. Therefore, my 
findings indicate that reelin’s antidepressant response requires the contribution of AMPA 
receptor signaling. Future studies should investigate the specific AMPA subunits that contribute 
to reelin’s antidepressant response.  
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6.6. Limitations 
6.6.1. Clinical Relevance of the CORT Model of Depression 
 Animal models of depression have long been viewed with skepticism in the greater 
scientific field. Criticism of animal models of depression comes in a variety of flavors. First, 
many depression symptoms are considered to be uniquely human (e.g., suicidal behaviour, guilt) 
and therefore they cannot be replicated in an animal model. Second, the diagnosis of depression 
itself has even met criticism, mostly for symptoms involving weight gain or loss, increased or 
decreased appetite, increased or decreased sleep, which some opponents argue necessitates 
multiple sub- diagnoses of depression (Nestler & Hyman, 2010). The last major criticism of 
animal models of depression is that some core aspects that have been modeled (e.g., anhedonia, 
despair) are still only approximate correlates of the human disorder (Nestler, 2010).  
 Despite these criticisms, several animal models of depression have been successfully 
developed that capture several key aspects of the depressive syndrome. The experiments of this 
dissertation focused on the use of the exogenous CORT administration model. This model has  
been met with criticism, mainly for the use of high doses of CORT. In this model, high doses (40 
mg/kg) are required in order to produce robust alterations in depression-like behaviour in rats 
within 14 days, though lower doses are effective in mice (Zhao, Xie, Dai, Wang, & Huang, 
2009). This is in sharp contrast to the plasma levels of CORT released during stressful 
encounters in rodents, which range from 2-5 mg/kg. Therefore, it is argued that the dose of 
CORT used in this model is supraphysiological (Sandi, 1996). While these criticisms are valid, 
there is a specific rationale for using this dosage of CORT. Mainly, the problem with other 
animal models of depression, for example restraint stress or chronic unpredictable stress (CUS), 
is that differences emerge in the amount of stress each animal experiences in response to each of 
the stressors. The CUS model has also been criticized for being the least reproducible stress 
model (Willner, 1997). For example, one rodent may not have the same levels of plasma CORT 
released during a period of cage tilting as opposed to another rodent, thereby raising the issue of 
individual differences. The CORT model circumvents this issue by ensuring that each animal 
receives the same amount of CORT each time. Therefore, on a basic level, individual differences 
are minimized and the effects of glucocorticoids on the brain and behaviour can be more easily 
teased apart. Therefore, despite the criticisms aimed at the CORT model of depression, it is the 
authors opinion that these criticisms are offset by greater experimental control of potentially 
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confounding variables. 
6.6.2. Sex Differences 
 The current dissertation employed the use of male rats. This is an issue with the current 
body of work, as depression does not only affect males. In fact, women are over 2 times as likely 
to suffer from depression as are men, and this trend persists across multiple cultures (Angst et al., 
2002). Investigating this from a preclinical perspective, female rodents have higher circulating 
CORT levels and an increased CORT response following stress exposure compared to males 
(Seale et al., 2004). It is then surprising that females rodents are in fact more resilient to the 
effects of stress compared to males. For example, CUS exerts more pronounced effects on 
depression-like behaviour in male rats as compared to female rats (Dalla et al., 2005), and Hill et 
al. (2004) reported that 20 days of CORT injections failed to increase depression-like behaviour 
in female rats. Differences also emerge in terms of neurobiology. Although neurogenesis in the 
dorsal and ventral hippocampus is decreased in male rats in response to stress, neurogenesis is 
only decreased in the ventral hippocampus of female rats (Brummelte & Galea, 2010). 
Furthermore, repeated stress failed to produce atrophy of dendrites of pyramidal neurons in the 
hippocampus of female rats, while in male rats this effect was observed (Galea et al., 1997). 
These data suggest that females, despite having increased HPA axis activity, possess greater 
stress resiliency. 
 A potential explanation of female rodents enhanced stress resiliency might be explained 
by fluctuations in gonadal hormones. For example, during proestrus (high circulating estrogen 
levels), female rats display fewer depression and anxiety-like behaviours compared to both male 
rats and female rats in diestrus (Frye & Walf, 2002). In humans, females are at an increased risk 
of developing depression during the postpartum period, which is characterized by decreased 
estradiol levels (Brummelte & Galea, 2010). Finally, higher estrogen levels are associated with 
increased hippocampal cell proliferation and decreased cell death. Therefore, it appears that 
fluctuations in gonadal hormones might confer a neuroprotective effect, helping to explain the 
increased stress resiliency in female rodents. However, more work is needed in female rodents, 
as female humans are still 2 times more likely to develop depression than are men.  
6.7. Future Directions 
6.7.1. The Effects of CORT in aged rats 
 Depression is not restricted to the young. Rates of depression in older adults are similar in 
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prevalence to the rest of the general population (10.3%; Barua, Ghosh, Kar, & Basilio, 2011). 
Despite this, little work has been done on the effects of chronic stress in aged rats. The current 
dissertation used 2-3 month old rats, which corresponds to the young adulthood to adulthood 
phase in humans. It would be interesting to see the effects of repeated CORT injections in aged 
rats on measures of depression-like behaviour, for example anhedonia and despair, as it is known 
that the symptoms of depression in older adults differ from young adults. Older adults typically 
report greater degrees of aches and pain compared to young adults for example (Barua, 2011). It 
is well-known that neurogenesis decreases across the lifespan. An intriguing hypothesis would 
be that aged rats are more susceptible to the deleterious effects of CORT than young rats due to 
decreased levels of neurogenesis. A way to examine this would be to first determine levels of 
neurogenesis in aged rodents, and then breed for a line of aged rodents with consistently reduced 
levels of neurogenesis. These animals could then be exposed to repeated CORT injections to see 
if they are more susceptible compared to aged rats with higher levels of neurogenesis.  
6.7.2. Determining the Timecourse of Reelin’s Antidepressant Response 
 One of the most promising directions for future research generated from this dissertation 
is to examine the timecourse of reelin’s antidepressant response. In Chapter 4, I examined the 
effects of reelin on neurobiological markers of hippocampal plasticity either 24 hours after the 
last infusion or 7 days after. However, the FST was only conducted the day after the last 
infusion, begging the question of what the rodents behaviour would look like on the FST after 7 
days. Ketamine, which achieves similar antidepressant effects in rodents and humans, can sustain 
an antidepressant effect from a single infusion for as long as 2 weeks (Cusin, Hilton, Nirenberg, 
& Fava, 2012). Therefore, it would be interesting to see if reelin can achieve a similar 
antidepressant response 2 weeks after the last infusion. To test this hypothesis, a study could be 
conducted where, similar to Chapters 4 and 5, reelin is infused on day 21 of CORT injections. 
Then, different groups of rats could then be tested on the FST at day 22, sacrificed, another 
group only tested on the FST at day 23, sacrificed, and so on. This experimental design would 
allow for one to determine when reelin’s antidepressant response ceases. This would be an 
interesting area of research to pursue, as the discovery of another compound that can achieve 
antidepressant effects after a single infusion for upwards of 2 weeks would generate intense 
interest in the greater scientific community. 
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6.7.3. Examining the Contribution of Neurogenesis to Reelin’s Antidepressant Response  
 A particularly interesting finding from the current dissertation was the effects of reelin on 
hippocampal neurogenesis. In Chapters 4 and 5, I found that a single reelin infusion significantly 
increased the number, but not complexity, of adult-generated neurons in animals sacrificed 
immediately after the FST. These same animals showed reversals in immobility time on the FST. 
This suggests that neurogenesis itself might not be important in reversing total immobility time 
on the FST. However, we were not able to answer this casually. To approach this question, 
rodents could be used and exposed to irradiation to ablate hippocampal neurogenesis. These 
same animals could then be given reelin infusions and then tested on the FST. Such a paradigm 
would allow for one to casually determine if neurogenesis per se is required for reelin’s fast-
acting antidepressant response. Based off the findings from my dissertation, I would hypothesize 
that ablating hippocampal neurogenesis would not block reelin’s antidepressant effects. Such a 
question is important, as the area of neurogenesis and depression is a contentious issue, with 
monthly reports finding altered neurogenesis in depression and others not finding any effect.  
6.8. Conclusions  
 The purpose of this dissertation was to use a well-validated animal model of depression 
to evaluate the antidepressant effects of TNF-α and reelin on associated behavioural and 
neurobiological markers effected by stress. The main findings from this body of work was that 
CORT impaired hippocampal and PFC-dependent memory and produced alterations to prepulse 
inhibition. Moreover, I demonstrated that TNF-α inhibitors exhibited antidepressant effects in an 
animal model of depression which corresponded to restored cognitive functioning and 
normalized markers of hippocampal plasticity. Finally, I showed that reelin infusions have fast-
acting antidepressant effects in an animal model of depression, accompanied by restored 
cognitive functioning and normalized markers of hippocampal plasticity. Importantly, I showed 
that reelin’s antidepressant response requires a contribution of AMPA signaling. Collectively, 
my findings reveal novel compounds with antidepressant properties that warrant further 
investigation into their potential use in humans.  
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